[
  {
    "id": 170853,
    "drug": {
      "current_status": "DORMANT",
      "id": 101067,
      "drug_code": 99517,
      "updated_date": "2020-11-09T00:55:03-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369770,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02505797",
      "brand_name": "MINT-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663003"
    },
    "created_date": "2022-10-02T14:32:45-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02505797",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "discontinuation_date": "2022-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-10-03T05:00:03-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MINT-LEVOFLOXACIN",
    "en_drug_common_name": "Levofloxacin",
    "fr_drug_brand_name": "Mint-Levofloxacin",
    "fr_drug_common_name": "Levofloaxacin",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170856,
    "drug": {
      "current_status": "DORMANT",
      "id": 101069,
      "drug_code": 99519,
      "updated_date": "2020-11-09T00:55:03-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369772,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02505819",
      "brand_name": "MINT-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663004"
    },
    "created_date": "2022-10-02T14:34:50-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02505819",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "discontinuation_date": "2022-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-10-03T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MINT-LEVOFLOXACIN",
    "en_drug_common_name": "Levofloxacin",
    "fr_drug_brand_name": "Mint-Levofloxacin",
    "fr_drug_common_name": "Levofloaxacin",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170859,
    "drug": {
      "current_status": "DORMANT",
      "id": 101068,
      "drug_code": 99518,
      "updated_date": "2020-11-09T00:55:03-05:00",
      "company": {
        "id": 1368,
        "created_date": "2017-03-09T13:24:16-05:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 13221,
        "mfr_code": "",
        "name": "MINT PHARMACEUTICALS INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6575 DAVAND DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5T 2M3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8369771,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02505800",
      "brand_name": "MINT-LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663005"
    },
    "created_date": "2022-10-02T14:36:47-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02505800",
    "company_name": "MINT PHARMACEUTICALS INC",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "discontinuation_date": "2022-10-02T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-10-03T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "MINT-LEVOFLOXACIN",
    "en_drug_common_name": "Levofloxacin",
    "fr_drug_brand_name": "Mint-Levofloxacin",
    "fr_drug_common_name": "Levofloaxacin",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 count bottles",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170875,
    "drug": {
      "current_status": "MARKETED",
      "id": 62757,
      "drug_code": 91953,
      "updated_date": "2025-05-15T02:34:36-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8260858,
          "ingredient": {
            "id": 3000,
            "ingredient_code": 12945,
            "en_name": "BIVALIRUDIN",
            "fr_name": "Bivalirudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02435268",
      "brand_name": "BIVALIRUDIN FOR INJECTION",
      "brand_name_fr": "BIVALIRUDINE POUR INJECTION",
      "descriptor": "SINGLE USE VIAL. 50MG/ML RECONSTITUTED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148342001"
    },
    "created_date": "2022-10-03T02:28:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02435268",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-10-15T00:00:00-04:00",
    "estimated_end_date": "2022-12-19T00:00:00-05:00",
    "actual_end_date": "2022-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-03T03:48:30-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to a production delay, we will be encountering a supply interruption \r\non our Bivalirudin for Injection 250 mg/vial SD Vial 10 mL effective October 15, 2022 until December 19, 2022.",
    "fr_comments": "Au nom de Fresenius Kabi Canada Ltée, j’ai le regret de vous aviser qu’en raison d’un retard de production, nous \r\nallons éprouver une interruption d’approvisionnement qui va toucher notre présentation de Bivalirudine pour injection à 250 mg/mL en fioles DU de 10 mL du 15 octobre 2022 au 19 décembre 2022.",
    "en_drug_brand_name": "BIVALIRUDIN FOR INJECTION",
    "en_drug_common_name": "BIVALIRUDIN FOR INJECTION",
    "fr_drug_brand_name": "Bivalirudine pour injection",
    "fr_drug_common_name": "Bivalirudine pour injection",
    "en_ingredients": "BIVALIRUDIN",
    "fr_ingredients": "Bivalirudine",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170878,
    "drug": {
      "current_status": "MARKETED",
      "id": 100745,
      "drug_code": 99116,
      "updated_date": "2020-08-04T23:50:45-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265329,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02501554",
      "brand_name": "FENTANYL CITRATE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302002"
    },
    "created_date": "2022-10-03T02:32:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02501554",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "N01AH",
    "atc_description": "ANESTHETICS, GENERAL",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2023-01-23T00:00:00-05:00",
    "actual_end_date": "2023-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-16T14:15:41-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that our available inventory of Fentanyl Citrate Injection, USP 50 mcg/mL 2 mL SD Vial is short dated. The current available inventory expires October 31, 2022. We will be \r\nfacing a supply interruption as fresh inventory is expected to be available January 23, 2023. Please continue to order the short-dated product.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer que les stocks disponibles de Citrate de fentanyl injectable, USP à 50 mcg/mL en fioles DU de 2 mL sont à présent de courte datation. Les stocks actuels disponibles vont atteindre leur péremption le 31 octobre 2022. De plus, nous allons être confrontés à une interruption d’approvisionnement, car les nouveaux stocks ne devraient être disponibles que le 23 janvier 2023. Nous vous invitons donc à poursuivre vos commandes du produit à courte datation.",
    "en_drug_brand_name": "FENTANYL CITRATE INJECTION, USP",
    "en_drug_common_name": "FENTANYL CITRATE INJECTION, USP",
    "fr_drug_brand_name": "Citrate de fentanyl injectable, USP",
    "fr_drug_common_name": "Citrate de fentanyl injectable, USP",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nEPIDURAL",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nÉpidurale",
    "drug_package_quantity": "2mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170881,
    "drug": {
      "current_status": "MARKETED",
      "id": 14684,
      "drug_code": 74976,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255280,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02264315",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596004"
    },
    "created_date": "2022-10-03T02:36:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264315",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-10-03T00:00:00-04:00",
    "estimated_end_date": "2023-01-21T00:00:00-05:00",
    "actual_end_date": "2023-01-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-26T16:35:48-05:00",
    "status": "resolved",
    "en_comments": "We will also be facing a supply interruption on our Heparin Sodium Injection, USP 1 000 USP units/mL MD Vial 10 mL effective October 3, 2022 until January 21, 2023.",
    "fr_comments": "Nous allons également subir une interruption d’approvisionnement qui va toucher notre présentation d’Héparine sodique injectable, USP à 1000 unités/mL en fioles DM de 10 mL du 3 octobre 2022 au 21 janvier 2023.",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "HEPARIN SODIUM INJECTION, USP",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "1000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170884,
    "drug": {
      "current_status": "MARKETED",
      "id": 7382,
      "drug_code": 49817,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253293,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230640",
      "brand_name": "TOBRAMYCIN INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230001"
    },
    "created_date": "2022-10-03T02:48:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230640",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "estimated_end_date": "2023-01-17T00:00:00-05:00",
    "actual_start_date": "2022-09-01T00:00:00-04:00",
    "actual_end_date": "2022-09-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-03T18:54:24-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBRAMYCIN INJECTION",
    "en_drug_common_name": "TOBRAMYCIN INJECTION",
    "fr_drug_brand_name": "Tobramycine injectable",
    "fr_drug_common_name": "Tobramycine injectable",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "40MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170887,
    "drug": {
      "current_status": "MARKETED",
      "id": 8142,
      "drug_code": 5402,
      "updated_date": "2025-05-15T02:30:33-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250751,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "00533688",
      "brand_name": "TOBRAMYCIN FOR INJECTION",
      "brand_name_fr": "TOBRAMYCINE POUR INJECTION",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "60581",
      "number_of_ais": "1",
      "ai_group_no": "0110230006"
    },
    "created_date": "2022-10-03T02:54:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00533688",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "estimated_end_date": "2023-09-27T00:00:00-04:00",
    "actual_start_date": "2022-09-20T00:00:00-04:00",
    "actual_end_date": "2023-09-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-09-27T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be extending the backorder on our Tobramycin for Injection, 1.2 g PBP Vial 50 mL until September 27, 2023.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer qu’en raison de retards d’expédition, la rupture de stock touchant notre présentation de Tobramycine pour injection à 1,2 g en GFP de 50 mL va se prolonger jusqu’au 27 septembre 2023.",
    "en_drug_brand_name": "TOBRAMYCIN FOR INJECTION",
    "en_drug_common_name": "TOBRAMYCIN FOR INJECTION",
    "fr_drug_brand_name": "Tobramycine pour injection",
    "fr_drug_common_name": "Tobramycine pour injection",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "1.2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "50 mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170890,
    "drug": {
      "current_status": "MARKETED",
      "id": 25614,
      "drug_code": 88027,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259251,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02395150",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION",
      "brand_name_fr": "CHLORURE DE SODIUM À 0,9 % POUR PERFUSION",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2022-10-03T02:57:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395150",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-10-01T00:00:00-04:00",
    "actual_end_date": "2022-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-12-05T04:12:34-05:00",
    "status": "resolved",
    "en_comments": "Fresenius Kabi Canada regrets to advise that due to increased demand, our Sodium Chloride 0.9% Injection freeflex® Bag 1000 mL will be placed on allocation effective October 1, 2022. Customers will be allocated 200% of historical monthly demand.",
    "fr_comments": "Fresenius Kabi Canada a le regret de vous informer qu’en raison d’une augmentation de la demande, notre présentation de Chlorure de sodium injectable à 0,9 % en sacs freeflexMD de 1000 mL sera mise sous allocation à compter du 1er octobre 2022. Les clients se verront attribuer 200 % de la demande mensuelle historique.",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE INJECTION",
    "en_drug_common_name": "0.9% SODIUM CHLORIDE INJECTION",
    "fr_drug_brand_name": "Chlorure de sodium injectable",
    "fr_drug_common_name": "Chlorure de sodium injectable",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "1000mL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170947,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 3408,
      "drug_code": 18639,
      "updated_date": "2025-12-03T01:09:00-05:00",
      "company": {
        "id": 94,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 9307,
        "mfr_code": "AZC08",
        "name": "ASTRAZENECA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1004 MIDDLEGATE ROAD, SUITE 5000",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4Y 1M4",
        "post_office_box": "",
        "contact_information": "Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com."
      },
      "drug_ingredients": [
        {
          "id": 8301215,
          "ingredient": {
            "id": 194,
            "ingredient_code": 11164,
            "en_name": "TAMOXIFEN",
            "fr_name": "Tamoxifène (Citrate de tamoxifène)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02048485",
      "brand_name": "NOLVADEX-D TAB 20MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80909",
      "number_of_ais": "1",
      "ai_group_no": "0131293002"
    },
    "created_date": "2022-10-03T14:57:06-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02048485",
    "company_name": "ASTRAZENECA CANADA INC",
    "atc_number": "L02BA",
    "atc_description": "HORMONE ANTAGONISTS AND RELATED AGENTS",
    "discontinuation_date": "2023-03-21T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-03-21T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "All remaining stock has been sold.",
    "fr_supply_disruption_mitigation": "All remaining stock has been sold.",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-03-22T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "NOLVADEX-D TAB 20MG",
    "en_drug_common_name": "tamoxifen citrate",
    "fr_drug_brand_name": "NOLVADEX -D",
    "fr_drug_common_name": "citrate de tamoxifène",
    "en_ingredients": "TAMOXIFEN",
    "fr_ingredients": "citrate de tamoxifène",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170954,
    "drug": {
      "current_status": "MARKETED",
      "id": 6724,
      "drug_code": 44185,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 458,
        "created_date": "2017-03-09T13:22:47-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 12573,
        "mfr_code": "",
        "name": "GE HEALTHCARE CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1919 MINNESOTA COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C9",
        "post_office_box": "",
        "contact_information": "800-387-7146   \r\n\r\ncanadainfo@gehealthcare.com"
      },
      "drug_ingredients": [
        {
          "id": 8253159,
          "ingredient": {
            "id": 2234,
            "ingredient_code": 8092,
            "en_name": "IOHEXOL",
            "fr_name": "Iohexol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "518",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02172739",
      "brand_name": "OMNIPAQUE 240",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "T9819",
      "number_of_ais": "1",
      "ai_group_no": "0116846003"
    },
    "created_date": "2022-10-03T18:32:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02172739",
    "company_name": "GE HEALTHCARE CANADA INC",
    "atc_number": "V08AB",
    "atc_description": "X-RAY CONTRAST MEDIA, IODINATED",
    "anticipated_start_date": "2022-10-05T00:00:00-04:00",
    "estimated_end_date": "2022-10-31T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-11-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OMNIPAQUE 240",
    "en_drug_common_name": "iohexol injection USP",
    "fr_drug_brand_name": "Omnipaque 240",
    "fr_drug_common_name": "iohexol injectable USP",
    "en_ingredients": "IOHEXOL",
    "fr_ingredients": "Iohexol",
    "drug_strength": "518MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVASCULAR\r\nSUBARACHNOIDAL\r\nINTRAVASCULAR\r\nSUBARACHNOIDAL",
    "drug_route_fr": "Intravasculaire\r\nSous-arachnoÏdienne\r\nIntravasculaire\r\nSous-arachnoÏdienne",
    "drug_package_quantity": "20 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170957,
    "drug": {
      "current_status": "MARKETED",
      "id": 25588,
      "drug_code": 87999,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259246,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394839",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162001"
    },
    "created_date": "2022-10-03T18:49:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394839",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2023-01-16T00:00:00-05:00",
    "actual_start_date": "2022-10-03T00:00:00-04:00",
    "actual_end_date": "2023-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-10T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE",
    "fr_drug_brand_name": "ESOMEPRAZOLE",
    "fr_drug_common_name": "ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170960,
    "drug": {
      "current_status": "MARKETED",
      "id": 19254,
      "drug_code": 80510,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8256734,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256733,
          "ingredient": {
            "id": 3484,
            "ingredient_code": 20396,
            "en_name": "OLMESARTAN MEDOXOMIL",
            "fr_name": "Olmésartan médoxomil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02319632",
      "brand_name": "OLMETEC PLUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252502003"
    },
    "created_date": "2022-10-03T21:33:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319632",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "anticipated_start_date": "2022-10-29T00:00:00-04:00",
    "estimated_end_date": "2022-12-14T00:00:00-05:00",
    "actual_start_date": "2022-10-29T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OLMETEC PLUS",
    "en_drug_common_name": "Olmesartan medoxomil and hydrochlorothiazide tablets",
    "fr_drug_brand_name": "OLMETEC PLUS",
    "fr_drug_common_name": "comprimés d'olmésartan médoxomil et hydrochlorothiazide",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nOLMESARTAN MEDOXOMIL",
    "fr_ingredients": "Hydrochlorothiazide",
    "drug_strength": "25MG\r\n40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170965,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2022-10-03T22:55:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-10-04T00:00:00-04:00",
    "estimated_end_date": "2023-02-01T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2023-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-02-09T14:37:36-05:00",
    "status": "resolved",
    "en_comments": "Effective January 1, 2023, allocations for our Sodium Chloride Injection, USP 4 mmol/mL PBP Vial 100 mL will be increased to cover the 200 mL backorder. Contract customers will be allocated 100% of historical 100 mL demand plus 100% of historical 200 mL demand at a 2:1 ratio (2 vial of 100 mL = 1 vial of 200 mL), and 100% of historical 30 mL demand at a 1:2 ratio (1 vial of 100 mL = 2 vials of 30 mL).",
    "fr_comments": "À compter du 1er janvier 2022, les allocations sur le Chlorure de sodium injectable, USP à 4 mmol/mL en fioles GFP de 100 mL seront augmentées pour compenser la rupture de stock du 200 mL. Les clients sous contrat se verront attribuer 100 % de la demande historique du 100 mL plus 100 % de celle du 200 mL selon un ratio de 2:1 (2 fioles de 100 mL = 1 fiole de 200 mL), ainsi que 100 % de celle du 30 mL selon un ratio de 1:2 (1 fiole de 100 mL = 2 fioles de 30 mL).",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "Chlorure de sodium injectable USP",
    "fr_drug_common_name": "Chlorure de sodium injectable USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "100mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170968,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2022-10-03T22:57:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-10-03T00:00:00-04:00",
    "actual_start_date": "2022-10-03T00:00:00-04:00",
    "actual_end_date": "2022-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-12-05T04:14:53-05:00",
    "status": "resolved",
    "en_comments": "Due to the early availability of our 100 mL format, effective October 3, 2022 allocations for our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 200 mL have been reduced. Contract customers are allocated 100% of historical monthly demand of the 200 mL only.",
    "fr_comments": "En raison de la disponibilité précoce de notre format de 100 mL, les allocations visant notre présentation de Chlorure de sodium injectable, USP à 4 mEq/mL en MaxivialMD de 200 mL ont été réduites à compter du 3 octobre 2022. Les clients contractuels se voient attribuer 100 % de la demande mensuelle historique du format de 200 mL uniquement.",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "Chlorure de sodium injectable USP",
    "fr_drug_common_name": "Chlorure de sodium injectable USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "200mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170971,
    "drug": {
      "current_status": "MARKETED",
      "id": 3562,
      "drug_code": 18937,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252402,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "234",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02139510",
      "brand_name": "SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "CHLORURE DE SODIUM INJECTABLE, USP",
      "descriptor": "SINGLE-DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "81223",
      "number_of_ais": "1",
      "ai_group_no": "0100053008"
    },
    "created_date": "2022-10-03T22:58:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02139510",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-10-03T00:00:00-04:00",
    "estimated_end_date": "2023-02-01T00:00:00-05:00",
    "actual_start_date": "2022-10-03T00:00:00-04:00",
    "actual_end_date": "2023-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-02-09T14:38:01-05:00",
    "status": "resolved",
    "en_comments": "Product is on 100% allocation. We will be encountering a supply interruption on our Sodium Chloride Injection, USP 4 mEq/mL SD Vial 30 mL effective December 1, 2022 until February 1, 2023. Effective December 1, 2022, allocations for our Sodium Chloride Injection, USP 4 mEq/mL Maxivial® 100 mL will be increased. Contract customers will be allocated 100% of historical 100 mL demand plus 100% of historical 30 mL demand on a 1:2 ratio (1 vial of 100 mL = 2 vials of 30 mL).",
    "fr_comments": "Produit es sur 100 % allocation.\r\n\r\nFresenius Kabi Canada a le regret de vous informer qu’un retard de production entraînera une interruption d’approvisionnement qui va toucher notre préparation de Chlorure de sodium injectable, USP à 4 mEq/mL en fioles DU de 30 mL du 1er décembre 2022 et au 1er février 2023. À compter du 1er décembre 2022, les allocations sur le Chlorure de sodium injectable, USP à 4 mEq/mL en MaxivialMD de 100 mL seront augmentées. Les clients contractuels se verront attribuer 100 % de la demande du 100 mL plus 100 % de la demande historique du 30 mL, selon un ratio de 1:2 (1 fiole de 100 mL = 2 fioles de 30 mL).",
    "en_drug_brand_name": "SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "Chlorure de sodium injectable USP",
    "fr_drug_common_name": "Chlorure de sodium injectable USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "234MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "30mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170974,
    "drug": {
      "current_status": "MARKETED",
      "id": 19264,
      "drug_code": 80536,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256738,
          "ingredient": {
            "id": 3490,
            "ingredient_code": 1739,
            "en_name": "CLADRIBINE",
            "fr_name": "Cladribine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02319918",
      "brand_name": "CLADRIBINE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124270001"
    },
    "created_date": "2022-10-03T23:01:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02319918",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "L01BB",
    "atc_description": "ANTIMETABOLITES",
    "anticipated_start_date": "2022-10-03T00:00:00-04:00",
    "estimated_end_date": "2022-12-31T00:00:00-05:00",
    "actual_start_date": "2022-10-03T00:00:00-04:00",
    "actual_end_date": "2022-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-12-05T04:42:53-05:00",
    "status": "resolved",
    "en_comments": "Product is on 100% allocation",
    "fr_comments": "Produit es sur 100 % allocation",
    "en_drug_brand_name": "CLADRIBINE INJECTION",
    "en_drug_common_name": "CLADRIBINE INJECTION",
    "fr_drug_brand_name": "Cladribine injectable",
    "fr_drug_common_name": "Cladribine injectable",
    "en_ingredients": "CLADRIBINE",
    "fr_ingredients": "Cladribine",
    "drug_strength": "1MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170977,
    "drug": {
      "current_status": "MARKETED",
      "id": 11554,
      "drug_code": 68448,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254307,
          "ingredient": {
            "id": 328,
            "ingredient_code": 7219,
            "en_name": "DIPYRIDAMOLE",
            "fr_name": "Dipyridamole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02244475",
      "brand_name": "DIPYRIDAMOLE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106621005"
    },
    "created_date": "2022-10-03T23:02:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244475",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AC",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-12-01T00:00:00-05:00",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2023-01-01T00:00:00-05:00",
    "actual_end_date": "2023-02-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-04-03T14:19:44-04:00",
    "status": "resolved",
    "en_comments": "Product on 100% allocation\r\n.",
    "fr_comments": "Produit sur allocation 100 %.",
    "en_drug_brand_name": "DIPYRIDAMOLE INJECTION, USP",
    "en_drug_common_name": "DIPYRIDAMOLE INJECTION, USP",
    "fr_drug_brand_name": "Dipyridamole injectable USP",
    "fr_drug_common_name": "Dipyridamole injectable USP",
    "en_ingredients": "DIPYRIDAMOLE",
    "fr_ingredients": "Dipyridamole",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170980,
    "drug": {
      "current_status": "MARKETED",
      "id": 14684,
      "drug_code": 74976,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 160,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 16555,
        "mfr_code": "",
        "name": "FRESENIUS KABI CANADA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "165 GALAXY BLVD, SUITE 100",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9W 0C8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255280,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02264315",
      "brand_name": "HEPARIN SODIUM INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0104596004"
    },
    "created_date": "2022-10-03T23:06:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02264315",
    "company_name": "FRESENIUS KABI CANADA LTD",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-10-03T00:00:00-04:00",
    "estimated_end_date": "2023-02-08T00:00:00-05:00",
    "actual_start_date": "2022-10-03T00:00:00-04:00",
    "actual_end_date": "2023-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-02-09T14:37:08-05:00",
    "status": "resolved",
    "en_comments": "Product is on 100% allocation",
    "fr_comments": "Produit es sur 100 % allocation",
    "en_drug_brand_name": "HEPARIN SODIUM INJECTION, USP",
    "en_drug_common_name": "HEPARIN SODIUM INJECTION, USP",
    "fr_drug_brand_name": "Héparine sodique injectable, USP",
    "fr_drug_common_name": "Héparine sodique injectable, USP",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "1000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "30 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 170996,
    "drug": {
      "current_status": "MARKETED",
      "id": 55423,
      "drug_code": 95367,
      "updated_date": "2025-05-15T02:35:54-04:00",
      "company": {
        "id": 1352,
        "created_date": "2017-03-09T13:24:13-05:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 12457,
        "mfr_code": "",
        "name": "CUBIST PHARMACEUTICALS LLC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "TRIBSCHENSTRASSE 60",
        "province": "LUZERN",
        "country": "SWITZERLAND",
        "city": "6005 LUZERN",
        "postal_code": "6005",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262572,
          "ingredient": {
            "id": 3422,
            "ingredient_code": 20161,
            "en_name": "DAPTOMYCIN",
            "fr_name": "Daptomycine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02465493",
      "brand_name": "CUBICIN RF",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152298001"
    },
    "created_date": "2022-10-04T13:26:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02465493",
    "company_name": "CUBIST PHARMACEUTICALS LLC",
    "atc_number": "J01XX",
    "atc_description": "OTHER ANTIBACTERIALS",
    "anticipated_start_date": "2022-10-26T00:00:00-04:00",
    "estimated_end_date": "2022-11-09T00:00:00-05:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2022-11-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-08T12:44:59-05:00",
    "status": "resolved",
    "en_comments": "Sunovion Pharmaceuticals Canada Inc. regrets to advise of an anticipated shortage of CUBICIN RF®. Current inventories are anticipated to be depleted approximately October 26, 2022. We are working with buyers to manage order allotment in an effort to minimize the impact as much as possible. The next shipment of inventory is expected to be available by late October 2022. We will provide updates as new information becomes available.\r\nCustomer Service / service à la clientèle : 1-888-363-0205 Email / courriel : csrsunovion@accuristix.com",
    "fr_comments": "Sunovion Pharmaceuticals Canada Inc. regrets to advise of an anticipated shortage of CUBICIN RF®. Current inventories are anticipated to be depleted approximately October 26, 2022. We are working with buyers to manage order allotment in an effort to minimize the impact as much as possible. The next shipment of inventory is expected to be available by late October 2022. We will provide updates as new information becomes available.\r\nCustomer Service / service à la clientèle : 1-888-363-0205 Email / courriel : csrsunovion@accuristix.com.",
    "en_drug_brand_name": "CUBICIN RF",
    "en_drug_common_name": "DAPTOMYCIN FOR INJECTION",
    "fr_drug_brand_name": "CUBICIN RF",
    "fr_drug_common_name": "DAPTOMYCINE POUR INJECTION",
    "en_ingredients": "DAPTOMYCIN",
    "fr_ingredients": "Daptomycine",
    "drug_strength": "500MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 mL Vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171004,
    "drug": {
      "current_status": "MARKETED",
      "id": 3844,
      "drug_code": 1937,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8250339,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00301175",
      "brand_name": "PRED FORTE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "45779",
      "number_of_ais": "1",
      "ai_group_no": "0106295001"
    },
    "created_date": "2022-10-04T15:03:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00301175",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2022-10-04T00:00:00-04:00",
    "estimated_end_date": "2023-08-28T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2023-08-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-01-30T14:40:47-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRED FORTE",
    "en_drug_common_name": "prednisolone acetate suspension",
    "fr_drug_brand_name": "Pred Forte",
    "fr_drug_common_name": "Acétate de prednisolone",
    "en_ingredients": "PREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de prednisolone",
    "drug_strength": "1%",
    "drug_dosage_form": "DROPS\r\nDROPS",
    "drug_dosage_form_fr": "Gouttes\r\nGouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5mL and 10mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171016,
    "drug": {
      "current_status": "MARKETED",
      "id": 7764,
      "drug_code": 50823,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253399,
          "ingredient": {
            "id": 2418,
            "ingredient_code": 11458,
            "en_name": "LATANOPROST",
            "fr_name": "Latanoprost"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02231493",
      "brand_name": "XALATAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132916001"
    },
    "created_date": "2022-10-04T15:56:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02231493",
    "company_name": "UPJOHN CANADA ULC",
    "atc_number": "S01EE",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-12-14T00:00:00-05:00",
    "estimated_end_date": "2023-03-22T00:00:00-04:00",
    "actual_start_date": "2022-12-14T00:00:00-05:00",
    "actual_end_date": "2023-03-23T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-05T16:19:47-04:00",
    "status": "resolved",
    "en_drug_brand_name": "XALATAN",
    "en_drug_common_name": "XALATAN",
    "fr_drug_brand_name": "XALATAN",
    "fr_drug_common_name": "XALATAN",
    "en_ingredients": "LATANOPROST",
    "fr_ingredients": "Latanoprost",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "2.5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171025,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 60216,
      "drug_code": 96515,
      "updated_date": "2025-05-15T04:25:38-04:00",
      "company": {
        "id": 3128,
        "created_date": "2017-08-17T01:15:06-04:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16816,
        "mfr_code": "",
        "name": "KNIGHT THERAPEUTICS INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "100 ALEXIS-NIHON BLVD., SUITE 600",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4M 2P2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8357808,
          "ingredient": {
            "id": 17575,
            "ingredient_code": 276,
            "en_name": "BUPRENORPHINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de buprénorphine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02474921",
      "brand_name": "PROBUPHINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126788005"
    },
    "created_date": "2022-10-04T16:30:08-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02474921",
    "company_name": "KNIGHT THERAPEUTICS INC.",
    "atc_number": "N07BC",
    "discontinuation_date": "2023-07-03T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-05-30T00:00:00-04:00",
    "decision_reversal": false,
    "en_supply_disruption_mitigation": "Our current inventory of Probuphine (80 mg buprenorphine hydrochloride implant) is anticipated to deplete by May 2023.",
    "fr_supply_disruption_mitigation": "Notre inventaire actuel de Probuphine (implant de chlorhydrate de buprénorphine de 80 mg) devrait être épuisé d'ici mai 2023.",
    "en_discontinuation_comments": "We regret to announce that following inventory depletion, this product will be officially discontinued and will no longer be marketed in Canada. The reason for discontinuation is due to the inability to successfully acquire continued supply and is unrelated to any safety concerns.",
    "fr_discontinuation_comments": "Nous avons le regret d'annoncer qu'après l'épuisement des stocks, ce produit sera officiellement cessé et ne sera plus commercialisé au Canada. La raison de la cessation de la vente du produit est due à notre incapacité d'assurer un approvisionnement continu de ce produit et elle n'est aucunement liée à un problème de sécurité avec le produit.",
    "discontinuance_reason": {
      "id": 4,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-04T17:30:40-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PROBUPHINE",
    "en_drug_common_name": "Buprenorphine hydrochloride implant",
    "fr_drug_brand_name": "Probuphine",
    "fr_drug_common_name": "Implant de chlorhydrate de buprénorphine",
    "en_ingredients": "BUPRENORPHINE HYDROCHLORIDE",
    "fr_ingredients": "chlorhydrate de buprénorphine",
    "drug_strength": "80MG",
    "drug_dosage_form": "IMPLANT",
    "drug_dosage_form_fr": "Implant",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "Implant kit has 4 individually pouched Probuphine implants.",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171038,
    "drug": {
      "current_status": "MARKETED",
      "id": 34,
      "drug_code": 10040,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251278,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "900",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060208",
      "brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69686",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2022-10-04T18:20:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060208",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-10-04T00:00:00-04:00",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-01T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "en_drug_common_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_brand_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "fr_drug_common_name": "0.9% SODIUM CHLORIDE INJECTION, USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "900MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250mL (JB0049)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171057,
    "drug": {
      "current_status": "MARKETED",
      "id": 6798,
      "drug_code": 4432,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250634,
          "ingredient": {
            "id": 644,
            "ingredient_code": 781,
            "en_name": "VITAMIN B12",
            "fr_name": "Vitamine B12"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00521515",
      "brand_name": "VITAMIN B12",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57597",
      "number_of_ais": "1",
      "ai_group_no": "0108437002"
    },
    "created_date": "2022-10-04T18:35:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00521515",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B03BA",
    "atc_description": "VITAMIN B12 AND FOLIC ACID",
    "estimated_end_date": "2022-10-14T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VITAMIN B12",
    "en_drug_common_name": "VITAMIN B12",
    "fr_drug_brand_name": "VITAMIN B12",
    "fr_drug_common_name": "VITAMIN B12",
    "en_ingredients": "VITAMIN B12",
    "fr_ingredients": "Vitamine B12",
    "drug_strength": "1000MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "1ML 10LIAM",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171060,
    "drug": {
      "current_status": "MARKETED",
      "id": 9856,
      "drug_code": 63983,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253772,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02240434",
      "brand_name": "FENTANYL CITRATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302002"
    },
    "created_date": "2022-10-04T18:39:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240434",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N01AH",
    "atc_description": "ANESTHETICS, GENERAL",
    "estimated_end_date": "2022-12-16T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-28T19:57:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FENTANYL CITRATE INJECTION USP",
    "en_drug_common_name": "FENTANYL CIT",
    "fr_drug_brand_name": "FENTANYL CITRATE INJECTION USP",
    "fr_drug_common_name": "FENTANYL CIT",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "50MCG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "EPIDURAL\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nEPIDURAL\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Épidurale\r\nIntraveineuse\r\nIntramusculaire\r\nÉpidurale\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML 10LIAM",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171063,
    "drug": {
      "current_status": "MARKETED",
      "id": 16,
      "drug_code": 10026,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251269,
          "ingredient": {
            "id": 26,
            "ingredient_code": 10146,
            "en_name": "HALOPERIDOL",
            "fr_name": "Halopéridol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00808652",
      "brand_name": "HALOPERIDOL INJ 5MG/ML USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69669",
      "number_of_ais": "1",
      "ai_group_no": "0101774001"
    },
    "created_date": "2022-10-04T18:41:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00808652",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N05AD",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-10-21T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HALOPERIDOL INJ 5MG/ML USP",
    "en_drug_common_name": "HALOPERIDOL",
    "fr_drug_brand_name": "HALOPERIDOL INJ 5MG/ML USP",
    "fr_drug_common_name": "HALOPERIDOL",
    "en_ingredients": "HALOPERIDOL",
    "fr_ingredients": "Halopéridol",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1ML 10LIAM",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171074,
    "drug": {
      "current_status": "MARKETED",
      "id": 3850,
      "drug_code": 19409,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252485,
          "ingredient": {
            "id": 154,
            "ingredient_code": 3776,
            "en_name": "METOCLOPRAMIDE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de métoclopramide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02185431",
      "brand_name": "METOCLOPRAMIDE HYDROCHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81703",
      "number_of_ais": "1",
      "ai_group_no": "0109394003"
    },
    "created_date": "2022-10-04T18:46:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02185431",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A03FA",
    "atc_description": "PROPULSIVES",
    "estimated_end_date": "2022-12-02T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-12T04:37:54-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METOCLOPRAMIDE HYDROCHLORIDE INJECTION",
    "en_drug_common_name": "METOCLOPRAMIDE HCL",
    "fr_drug_brand_name": "METOCLOPRAMIDE HYDROCHLORIDE INJECTION",
    "fr_drug_common_name": "METOCLOPRAMIDE HCL",
    "en_ingredients": "METOCLOPRAMIDE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de métoclopramide",
    "drug_strength": "5MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171077,
    "drug": {
      "current_status": "MARKETED",
      "id": 57789,
      "drug_code": 95719,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8262776,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02468719",
      "brand_name": "SANDOZ PRAVASTATIN TABLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2022-10-04T18:47:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02468719",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-12T04:38:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PRAVASTATIN TABLETS",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "SANDOZ PRAVASTATIN TABLETS",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB BO",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171080,
    "drug": {
      "current_status": "MARKETED",
      "id": 21314,
      "drug_code": 83712,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257547,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351889",
      "brand_name": "SANDOZ RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841002"
    },
    "created_date": "2022-10-04T18:49:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351889",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-10-21T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "SANDOZ RIZATRIPTAN ODT",
    "fr_drug_common_name": "RIZATRIPTAN ODT",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6ODT UD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171083,
    "drug": {
      "current_status": "MARKETED",
      "id": 21312,
      "drug_code": 83711,
      "updated_date": "2025-05-15T02:32:42-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257546,
          "ingredient": {
            "id": 2720,
            "ingredient_code": 11899,
            "en_name": "RIZATRIPTAN",
            "fr_name": "Rizatriptan (Benzoate de rizatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02351870",
      "brand_name": "SANDOZ RIZATRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137841001"
    },
    "created_date": "2022-10-04T18:50:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02351870",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-10-21T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ RIZATRIPTAN ODT",
    "en_drug_common_name": "RIZATRIPTAN",
    "fr_drug_brand_name": "SANDOZ RIZATRIPTAN ODT",
    "fr_drug_common_name": "RIZATRIPTAN",
    "en_ingredients": "RIZATRIPTAN",
    "fr_ingredients": "RIZATRIPTAN",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6ODT UD",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171105,
    "drug": {
      "current_status": "MARKETED",
      "id": 718,
      "drug_code": 11624,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251554,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8251553,
          "ingredient": {
            "id": 466,
            "ingredient_code": 2322,
            "en_name": "DOPAMINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de dopamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00761834",
      "brand_name": "DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72439",
      "number_of_ais": "2",
      "ai_group_no": "0217918002"
    },
    "created_date": "2022-10-04T20:41:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00761834",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "C01CA",
    "atc_description": "CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES",
    "anticipated_start_date": "2022-10-04T00:00:00-04:00",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-01T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 200mg/250mL bags (DIN 00761850) are available as alternatives if they align with clinical practice.",
    "fr_comments": "Les produits Baxter, Dopamine Hydrochloride et 5% Dextrose USP – 400mg/250mL (DIN 00761826) et 200mg/250mL (DIN 00761850)  peut être utilisé comme alternatives s'ils correspondent à la pratique clinique.",
    "en_drug_brand_name": "DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP",
    "en_drug_common_name": "DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP",
    "fr_drug_brand_name": "DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP",
    "fr_drug_common_name": "DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP",
    "en_ingredients": "DEXTROSE\r\nDOPAMINE HYDROCHLORIDE",
    "fr_ingredients": "Dextrose\r\nChlorhydrate de dopamine",
    "drug_strength": "50MG\r\n3.2MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171165,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 9852,
      "drug_code": 63981,
      "updated_date": "2025-05-15T03:59:44-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8329578,
          "ingredient": {
            "id": 2706,
            "ingredient_code": 11894,
            "en_name": "EPROSARTAN",
            "fr_name": "Éprosartan (Mésylate d'éprosartan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02240432",
      "brand_name": "TEVETEN",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0137701002"
    },
    "created_date": "2022-10-05T14:43:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240432",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "actual_start_date": "2022-01-03T00:00:00-05:00",
    "actual_end_date": "2023-08-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-10T17:54:20-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVETEN",
    "en_drug_common_name": "EPROSARTAN",
    "fr_drug_brand_name": "TEVETEN",
    "fr_drug_common_name": "EPROSARTAN",
    "en_ingredients": "EPROSARTAN",
    "fr_ingredients": "EPROSARTAN",
    "drug_strength": "400MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2x14",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171168,
    "drug": {
      "current_status": "MARKETED",
      "id": 30900,
      "drug_code": 93037,
      "updated_date": "2025-05-15T02:35:05-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261421,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "MG",
          "base": false
        },
        {
          "id": 8261420,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "320",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "MG",
          "base": false
        },
        {
          "id": 8261419,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "MG",
          "base": false
        }
      ],
      "din": "02445158",
      "brand_name": "CREON MINIMICROSPHERES MICRO",
      "brand_name_fr": "CREON MINIMICROSPHÈRES MICRO",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "3",
      "ai_group_no": "0302964039"
    },
    "created_date": "2022-10-05T14:44:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445158",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "anticipated_start_date": "2022-10-25T00:00:00-04:00",
    "estimated_end_date": "2023-01-17T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-01-17T18:00:37-05:00",
    "status": "resolved",
    "en_comments": "Globally Allocated SKU",
    "fr_comments": "Globally Allocated SKU",
    "en_drug_brand_name": "CREON MINIMICROSPHERES MICRO",
    "en_drug_common_name": "CREON MINIMICROSPHERES MICRO",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES MICRO",
    "fr_drug_common_name": "CREON MINIMICROSPHERES MICRO",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "320UNIT\r\n5100UNIT\r\n5000UNIT",
    "drug_dosage_form": "GRANULES FOR SUSPENSION, DELAYED RELEASE",
    "drug_dosage_form_fr": "Granules pour suspension, à libération retardée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "20G",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171171,
    "drug": {
      "current_status": "MARKETED",
      "id": 1522,
      "drug_code": 13302,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 178,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16524,
        "mfr_code": "",
        "name": "BGP PHARMA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251750,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251749,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1600",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251748,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25500",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01985205",
      "brand_name": "CREON MINIMICROSPHERES 25",
      "brand_name_fr": "CREON MINIMICROSPHERES 25",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74650",
      "number_of_ais": "3",
      "ai_group_no": "0302964041"
    },
    "created_date": "2022-10-05T14:46:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01985205",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2022-10-18T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-10-25T17:22:47-04:00",
    "status": "resolved",
    "en_comments": "Globally Allocated SKU",
    "fr_comments": "Globally Allocated SKU",
    "en_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "en_drug_common_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_brand_name": "CREON MINIMICROSPHERES 25",
    "fr_drug_common_name": "CREON MINIMICROSPHERES 25",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "1600UNIT\r\n25500UNIT\r\n25000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "25",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171183,
    "drug": {
      "current_status": "MARKETED",
      "id": 17140,
      "drug_code": 78174,
      "updated_date": "2025-12-03T00:31:13-05:00",
      "company": {
        "id": 1700,
        "created_date": "2017-03-09T13:25:18-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17140,
        "mfr_code": "",
        "name": "ENDO OPERATIONS LTD.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1ST FLOOR, MINERVA HOUSE, SIMMONSCOURT ROAD",
        "province": "DUBLIN",
        "country": "IRELAND",
        "city": "BALLSBRIDGE",
        "postal_code": "D04 H9P8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256048,
          "ingredient": {
            "id": 3208,
            "ingredient_code": 13904,
            "en_name": "TRAMADOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de tramadol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02296411",
      "brand_name": "TRIDURAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151694001"
    },
    "created_date": "2022-10-05T18:27:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02296411",
    "company_name": "PALADIN LABS INC.",
    "atc_number": "N02AX",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-10-06T00:00:00-04:00",
    "estimated_end_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2022-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-10-15T05:00:04-04:00",
    "status": "resolved",
    "en_comments": "CR",
    "fr_comments": "CR",
    "en_drug_brand_name": "TRIDURAL",
    "en_drug_common_name": "Tridural",
    "fr_drug_brand_name": "Tridural",
    "fr_drug_common_name": "Tridural",
    "en_ingredients": "TRAMADOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de tramadol",
    "drug_strength": "300MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171205,
    "drug": {
      "current_status": "MARKETED",
      "id": 49953,
      "drug_code": 93883,
      "updated_date": "2025-12-03T00:33:04-05:00",
      "company": {
        "id": 1760,
        "created_date": "2017-03-09T13:25:38-05:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 15083,
        "mfr_code": "",
        "name": "DR REDDY'S LABORATORIES LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "SURVEY NOS. 42, 45, 46 & 54, INNOVATION PLAZA, BACHUPALLY",
        "province": "TELANGANA",
        "country": "INDIA",
        "city": "MEDCHAL-MALKAJGIRI",
        "postal_code": "500090",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261805,
          "ingredient": {
            "id": 3194,
            "ingredient_code": 13053,
            "en_name": "BORTEZOMIB",
            "fr_name": "Bortézomib (Bortézomib, ester boronique de mannitol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02452456",
      "brand_name": "BORTEZOMIB FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "SINGLE USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150433001"
    },
    "created_date": "2022-10-05T19:45:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02452456",
    "company_name": "DR REDDY'S LABORATORIES LTD",
    "atc_number": "L01XG",
    "anticipated_start_date": "2022-10-30T00:00:00-04:00",
    "estimated_end_date": "2022-11-14T00:00:00-05:00",
    "actual_end_date": "2022-11-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-11-15T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "N/A",
    "fr_comments": "N/A",
    "en_drug_brand_name": "BORTEZOMIB FOR INJECTION",
    "en_drug_common_name": "Bortezomib",
    "fr_drug_brand_name": "Bortezomib for Injection",
    "fr_drug_common_name": "Bortezomib",
    "en_ingredients": "BORTEZOMIB",
    "fr_ingredients": "Bortezomib",
    "drug_strength": "3.5MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171209,
    "drug": {
      "current_status": "MARKETED",
      "id": 568,
      "drug_code": 11227,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 8719,
        "created_date": "2018-09-18T14:00:07-04:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 17456,
        "mfr_code": "",
        "name": "USPHARMA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "13900 NW 57TH COURT",
        "province": "FLORIDA",
        "country": "UNITED STATES",
        "city": "MIAMI",
        "postal_code": "33014",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251484,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "01911910",
      "brand_name": "NITRO-DUR 0.2",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71752",
      "number_of_ais": "1",
      "ai_group_no": "0103615026"
    },
    "created_date": "2022-10-05T19:52:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01911910",
    "company_name": "USPHARMA LTD",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "estimated_end_date": "2022-12-05T00:00:00-05:00",
    "actual_start_date": "2022-09-23T00:00:00-04:00",
    "actual_end_date": "2023-02-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2023-02-13T22:20:28-05:00",
    "status": "resolved",
    "en_comments": "Resolved",
    "en_drug_brand_name": "NITRO-DUR 0.2",
    "en_drug_common_name": "Nitro-Dur",
    "fr_drug_brand_name": "NITRO-DUR 0.2",
    "fr_drug_common_name": "Nitro-Dur",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.2MG",
    "drug_dosage_form": "PATCH (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Timbre (à libération prolongée)",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "30 pouches per carton",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171211,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2022-10-05T19:52:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-10-11T00:00:00-04:00",
    "estimated_end_date": "2022-10-25T00:00:00-04:00",
    "actual_start_date": "2022-10-11T00:00:00-04:00",
    "actual_end_date": "2022-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-26T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "en_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "250 mL (JB0062P)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171215,
    "drug": {
      "current_status": "MARKETED",
      "id": 200,
      "drug_code": 10511,
      "updated_date": "2025-05-15T02:30:50-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251349,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060348",
      "brand_name": "5% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70437",
      "number_of_ais": "1",
      "ai_group_no": "0102181006"
    },
    "created_date": "2022-10-05T19:54:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060348",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-10-14T00:00:00-04:00",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2022-11-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-01T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "en_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_brand_name": "5% DEXTROSE INJECTION, USP",
    "fr_drug_common_name": "5% DEXTROSE INJECTION, USP",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "5G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500mL (JB0048)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171218,
    "drug": {
      "current_status": "MARKETED",
      "id": 564,
      "drug_code": 11225,
      "updated_date": "2025-05-15T02:30:51-04:00",
      "company": {
        "id": 8719,
        "created_date": "2018-09-18T14:00:07-04:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 17456,
        "mfr_code": "",
        "name": "USPHARMA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "13900 NW 57TH COURT",
        "province": "FLORIDA",
        "country": "UNITED STATES",
        "city": "MIAMI",
        "postal_code": "33014",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251482,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "01911902",
      "brand_name": "NITRO-DUR 0.4",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "71750",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2022-10-05T19:59:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01911902",
    "company_name": "USPHARMA LTD",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2022-10-17T00:00:00-04:00",
    "estimated_end_date": "2022-12-05T00:00:00-05:00",
    "actual_end_date": "2023-02-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2023-02-13T22:21:38-05:00",
    "status": "resolved",
    "en_comments": "Resolved",
    "en_drug_brand_name": "NITRO-DUR 0.4",
    "en_drug_common_name": "Nitro-Dur",
    "fr_drug_brand_name": "Nitro-Dur 0.4",
    "fr_drug_common_name": "Nitro-Dur",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "PATCH (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Timbre (à libération prolongée)",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "30 pouches per carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171221,
    "drug": {
      "current_status": "MARKETED",
      "id": 2228,
      "drug_code": 14742,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 8719,
        "created_date": "2018-09-18T14:00:07-04:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 17456,
        "mfr_code": "",
        "name": "USPHARMA LTD",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "13900 NW 57TH COURT",
        "province": "FLORIDA",
        "country": "UNITED STATES",
        "city": "MIAMI",
        "postal_code": "33014",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251993,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02011271",
      "brand_name": "NITRO-DUR 0.8",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76413",
      "number_of_ais": "1",
      "ai_group_no": "0103615027"
    },
    "created_date": "2022-10-05T20:02:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02011271",
    "company_name": "USPHARMA LTD",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2022-12-12T00:00:00-05:00",
    "estimated_end_date": "2023-01-02T00:00:00-05:00",
    "actual_end_date": "2023-02-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2023-02-13T22:22:54-05:00",
    "status": "resolved",
    "en_comments": "Resolved",
    "en_drug_brand_name": "NITRO-DUR 0.8",
    "en_drug_common_name": "Nitro-Dur",
    "fr_drug_brand_name": "Nitro-Dur 0.8",
    "fr_drug_common_name": "Nitro-Dur",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.8MG",
    "drug_dosage_form": "PATCH (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Timbre (à libération prolongée)",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "30 pouches per carton",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171228,
    "drug": {
      "current_status": "MARKETED",
      "id": 55369,
      "drug_code": 94721,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262243,
          "ingredient": {
            "id": 1642,
            "ingredient_code": 10303,
            "en_name": "ACETYLCYSTEINE",
            "fr_name": "Acétylcystéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02459906",
      "brand_name": "ACETYLCYSTEINE SOLUTION USP",
      "brand_name_fr": "SOLUTION D'ACÉTYLCYSTÉINE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100024001"
    },
    "created_date": "2022-10-06T13:58:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02459906",
    "company_name": "HIKMA CANADA LIMITED",
    "atc_number": "R05CB",
    "atc_description": "EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",
    "estimated_end_date": "2023-01-20T00:00:00-05:00",
    "actual_start_date": "2022-10-06T00:00:00-04:00",
    "actual_end_date": "2023-01-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-02T15:06:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETYLCYSTEINE SOLUTION USP",
    "en_drug_common_name": "ACETYLCYSTEINE SOLUTION USP",
    "fr_drug_brand_name": "ACETYLCYSTEINE SOLUTION USP",
    "fr_drug_common_name": "ACETYLCYSTEINE SOLUTION USP",
    "en_ingredients": "ACETYLCYSTEINE",
    "fr_ingredients": "Acétylcystéine",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVENOUS\r\nINHALATION\r\nORAL\r\nINTRAVENOUS\r\nINHALATION",
    "drug_route_fr": "Orale\r\nIntraveineuse\r\nInhalation\r\nOrale\r\nIntraveineuse\r\nInhalation",
    "drug_package_quantity": "30ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171234,
    "drug": {
      "current_status": "MARKETED",
      "id": 102215,
      "drug_code": 100870,
      "updated_date": "2021-09-09T05:14:26-04:00",
      "company": {
        "id": 17117,
        "created_date": "2021-09-09T05:10:09-04:00",
        "updated_date": "2025-05-15T02:30:25-04:00",
        "company_code": 16301,
        "mfr_code": "",
        "name": "DR. REDDY'S LABORATORIES CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "5580 EXPLORER DRIVE, SUITE 204",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 4Y1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266527,
          "ingredient": {
            "id": 886,
            "ingredient_code": 7558,
            "en_name": "CLOBETASOL PROPIONATE",
            "fr_name": "Propionate de clobétasol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02519437",
      "brand_name": "REDDY-CLOBETASOL SHAMPOO",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110995001"
    },
    "created_date": "2022-10-06T17:21:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02519437",
    "company_name": "DR. REDDY'S LABORATORIES CANADA INC.",
    "atc_number": "D07AD",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2022-11-14T00:00:00-05:00",
    "actual_end_date": "2022-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-11-11T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Allocation",
    "fr_comments": "Allocation",
    "en_drug_brand_name": "REDDY-CLOBETASOL SHAMPOO",
    "en_drug_common_name": "clobetasol propionate",
    "fr_drug_brand_name": "REDDY-CLOBETASOL SHAMPOO",
    "fr_drug_common_name": "CLOBETASOL PROPIONATE",
    "en_ingredients": "CLOBETASOL PROPIONATE",
    "fr_ingredients": "Propionate de clobétasol",
    "drug_strength": "0.05%",
    "drug_dosage_form": "SHAMPOO",
    "drug_dosage_form_fr": "Shampoing",
    "drug_route": "TOPICAL",
    "drug_route_fr": "Topique",
    "drug_package_quantity": "120ml bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171243,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 12932,
      "drug_code": 72117,
      "updated_date": "2025-05-15T04:07:26-04:00",
      "company": {
        "id": 1026,
        "created_date": "2017-03-09T13:23:38-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 11463,
        "mfr_code": "",
        "name": "GILEAD SCIENCES CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "400",
        "street_name": "6925 CENTURY AVENUE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 7K2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8338546,
          "ingredient": {
            "id": 3068,
            "ingredient_code": 13233,
            "en_name": "ADEFOVIR DIPIVOXIL",
            "fr_name": "Adéfovir dipivoxil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247823",
      "brand_name": "HEPSERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149364001"
    },
    "created_date": "2022-10-06T19:57:57-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02247823",
    "company_name": "GILEAD SCIENCES CANADA INC",
    "atc_number": "J05AF",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "discontinuation_date": "2022-12-21T00:00:00-05:00",
    "anticipated_discontinuation_date": "2022-12-21T00:00:00-05:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Global Discontinuation",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-12-27T14:38:58-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "HEPSERA",
    "en_drug_common_name": "adefovir dipivoxil",
    "fr_drug_brand_name": "HEPSERA",
    "fr_drug_common_name": "adéfovir dipivoxil",
    "en_ingredients": "ADEFOVIR DIPIVOXIL",
    "fr_ingredients": "Adéfovir dipivoxil",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 tablets per bottle",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171258,
    "drug": {
      "current_status": "MARKETED",
      "id": 11508,
      "drug_code": 68260,
      "updated_date": "2025-05-15T02:31:16-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8254281,
          "ingredient": {
            "id": 2140,
            "ingredient_code": 637,
            "en_name": "FLUTICASONE PROPIONATE",
            "fr_name": "Propionate de fluticasone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02244293",
      "brand_name": "FLOVENT HFA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0124685003"
    },
    "created_date": "2022-10-07T13:37:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02244293",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "R03BA",
    "atc_description": "OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS",
    "estimated_end_date": "2022-10-26T00:00:00-04:00",
    "actual_start_date": "2022-10-06T00:00:00-04:00",
    "actual_end_date": "2022-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-10-27T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FLOVENT HFA",
    "en_drug_common_name": "fluticasone propionate inhalation aerosol",
    "fr_drug_brand_name": "FLOVENT HFA",
    "fr_drug_common_name": "propionate de fluticasone en aérosol pour inhalation",
    "en_ingredients": "FLUTICASONE PROPIONATE",
    "fr_ingredients": "Propionate de fluticasone",
    "drug_strength": "250MCG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "ORAL\r\nINHALATION\r\nORAL\r\nINHALATION",
    "drug_route_fr": "Orale\r\nInhalation\r\nOrale\r\nInhalation",
    "drug_package_quantity": "1x120",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171261,
    "drug": {
      "current_status": "MARKETED",
      "id": 65806,
      "drug_code": 97717,
      "updated_date": "2025-12-03T00:34:17-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8263989,
          "ingredient": {
            "id": 486,
            "ingredient_code": 7746,
            "en_name": "HEPATITIS B SURFACE ANTIGEN",
            "fr_name": "Antigène de surface du virus de l'hépatite b (recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "0.5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02487020",
      "brand_name": "ENGERIX-B",
      "brand_name_fr": "",
      "descriptor": "PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0119570002"
    },
    "created_date": "2022-10-07T13:46:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02487020",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2022-10-24T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-13T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Limited supply available for public programs. Supply unavailable for the private market.",
    "fr_comments": "Approvisionnement limité réservé aux programmes publics d’immunisation. Aucun approvisionnement disponible pour le marché privé.",
    "en_drug_brand_name": "ENGERIX-B",
    "en_drug_common_name": "Hepatitis B vaccine (recombinant)",
    "fr_drug_brand_name": "ENGERIX-B",
    "fr_drug_common_name": "Vaccin contre l’hépatite B (recombinant)",
    "en_ingredients": "HEPATITIS B SURFACE ANTIGEN",
    "fr_ingredients": "Antigène de surface du virus de l'hépatite b (recombiné)",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1s",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171268,
    "drug": {
      "current_status": "MARKETED",
      "id": 57689,
      "drug_code": 94736,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 1226,
        "created_date": "2017-03-09T13:23:58-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 11979,
        "mfr_code": "",
        "name": "AURO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "3700 STEELES AVENUE WEST, SUITE 402",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "WOODBRIDGE",
        "postal_code": "L4L 8K8",
        "post_office_box": "",
        "contact_information": "Anahita Rostami"
      },
      "drug_ingredients": [
        {
          "id": 8262254,
          "ingredient": {
            "id": 3528,
            "ingredient_code": 20435,
            "en_name": "ARIPIPRAZOLE",
            "fr_name": "Aripiprazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02460076",
      "brand_name": "AURO-ARIPIPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152514004"
    },
    "created_date": "2022-10-07T15:22:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02460076",
    "company_name": "AURO PHARMA INC",
    "atc_number": "N05AX",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2023-07-30T00:00:00-04:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2023-06-12T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-06-28T20:06:21-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AURO-ARIPIPRAZOLE",
    "en_drug_common_name": "ARIPIPRAZOLE",
    "fr_drug_brand_name": "Auro-Aripiprazole",
    "fr_drug_common_name": "Aripiprazole",
    "en_ingredients": "ARIPIPRAZOLE",
    "fr_ingredients": "Aripiprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171307,
    "drug": {
      "current_status": "MARKETED",
      "id": 13368,
      "drug_code": 72998,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254849,
          "ingredient": {
            "id": 1584,
            "ingredient_code": 1255,
            "en_name": "OCTREOTIDE",
            "fr_name": "Octréotide (Acétate d'octréotide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248641",
      "brand_name": "OCTREOTIDE ACETATE OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121548002"
    },
    "created_date": "2022-10-07T16:01:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248641",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "H01CB",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "estimated_end_date": "2022-10-21T00:00:00-04:00",
    "actual_start_date": "2022-10-06T00:00:00-04:00",
    "actual_end_date": "2022-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 6,
      "en_reason": "Shortage of an inactive ingredient or component.",
      "fr_reason": "Pénurie d’un ingrédient ou d’un composant inerte",
      "active": true
    },
    "updated_date": "2022-10-22T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "OCTREOTIDE ACETATE OMEGA",
    "en_drug_common_name": "OCTREOTIDE ACETATE INJECTION 500MCG/ML",
    "fr_drug_brand_name": "OCTREOTIDE ACETATE OMEGA",
    "fr_drug_common_name": "OCTREOTIDE ACETATE INJECTION 500MCG/ML",
    "en_ingredients": "OCTREOTIDE",
    "fr_ingredients": "OCTREOTIDE",
    "drug_strength": "500MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "5 x 1mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171338,
    "drug": {
      "current_status": "MARKETED",
      "id": 66079,
      "drug_code": 93987,
      "updated_date": "2025-05-15T02:35:18-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261859,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02453347",
      "brand_name": "JAMP-DORZOLAMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128558001"
    },
    "created_date": "2022-10-07T16:14:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02453347",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2023-03-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-12T03:36:56-04:00",
    "status": "resolved",
    "en_drug_brand_name": "JAMP-DORZOLAMIDE",
    "en_drug_common_name": "Dorzolamide Eye Drops, BP",
    "fr_drug_brand_name": "JAMP-Dorzolamide",
    "fr_drug_common_name": "Collyre de dorzolamide, BP",
    "en_ingredients": "DORZOLAMIDE",
    "fr_ingredients": "dorzolamide (sous forme de chlorhydrate de dorzolamide)",
    "drug_strength": "2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171341,
    "drug": {
      "current_status": "MARKETED",
      "id": 102365,
      "drug_code": 100989,
      "updated_date": "2021-10-08T05:17:36-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266617,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02520699",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162001"
    },
    "created_date": "2022-10-07T16:16:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02520699",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-15T12:54:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "Esomeprazole Magnesium Delayed Release Tablets",
    "fr_drug_brand_name": "Esomeprazole",
    "fr_drug_common_name": "Ésoméprazole magnésien en comprimés à libération retardée",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "Esomeprazole",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171344,
    "drug": {
      "current_status": "MARKETED",
      "id": 102366,
      "drug_code": 100990,
      "updated_date": "2021-10-08T05:17:36-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266618,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02520702",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2022-10-07T16:17:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02520702",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-15T12:58:16-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "Esomeprazole Magnesium Delayed Release Tablets",
    "fr_drug_brand_name": "Esomeprazole",
    "fr_drug_common_name": "Ésoméprazole magnésien en comprimés à libération retardée",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "Esomeprazole",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171347,
    "drug": {
      "current_status": "MARKETED",
      "id": 102366,
      "drug_code": 100990,
      "updated_date": "2021-10-08T05:17:36-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266618,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02520702",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2022-10-07T16:19:18-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02520702",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-15T12:59:19-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "Esomeprazole Magnesium Delayed Release Tablets",
    "fr_drug_brand_name": "Esomeprazole",
    "fr_drug_common_name": "Ésoméprazole magnésien en comprimés à libération retardée",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "Esomeprazole",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171350,
    "drug": {
      "current_status": "MARKETED",
      "id": 101985,
      "drug_code": 100590,
      "updated_date": "2021-07-08T05:10:08-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266336,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516551",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2022-10-07T16:20:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516551",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-24T15:26:32-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride Extended-Release Capsules, Mfr. Std.",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de Venlafaxine gélules à libération prolongée, Norme mfr.",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171353,
    "drug": {
      "current_status": "MARKETED",
      "id": 101985,
      "drug_code": 100590,
      "updated_date": "2021-07-08T05:10:08-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266336,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516551",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294005"
    },
    "created_date": "2022-10-07T16:22:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516551",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-24T15:27:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride Extended-Release Capsules, Mfr. Std.",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de Venlafaxine gélules à libération prolongée, Norme mfr",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "150MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171356,
    "drug": {
      "current_status": "MARKETED",
      "id": 101984,
      "drug_code": 100589,
      "updated_date": "2021-07-08T05:10:08-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266335,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516543",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2022-10-07T16:23:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516543",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-24T15:30:00-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride Extended-Release Capsules, Mfr. Std.",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de Venlafaxine gélules à libération prolongée, Norme mfr",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171359,
    "drug": {
      "current_status": "MARKETED",
      "id": 101984,
      "drug_code": 100589,
      "updated_date": "2021-07-08T05:10:08-04:00",
      "company": {
        "id": 298,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4415,
        "mfr_code": "JPC10",
        "name": "JAMP PHARMA CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1310 RUE NOBEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BOUCHERVILLE",
        "postal_code": "J4B 5H3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8266335,
          "ingredient": {
            "id": 2548,
            "ingredient_code": 11336,
            "en_name": "VENLAFAXINE",
            "fr_name": "Venlafaxine (Chlorhydrate de venlafaxine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02516543",
      "brand_name": "VENLAFAXINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131294001"
    },
    "created_date": "2022-10-07T16:24:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02516543",
    "company_name": "JAMP PHARMA CORPORATION",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-11-10T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-15T12:50:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "VENLAFAXINE XR",
    "en_drug_common_name": "Venlafaxine Hydrochloride Extended-Release Capsules, Mfr. Std.",
    "fr_drug_brand_name": "Venlafaxine XR",
    "fr_drug_common_name": "Chlorhydrate de Venlafaxine gélules à libération prolongée, Norme mfr",
    "en_ingredients": "VENLAFAXINE",
    "fr_ingredients": "Venlafaxine",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171386,
    "drug": {
      "current_status": "MARKETED",
      "id": 15590,
      "drug_code": 76280,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255589,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277158",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548002"
    },
    "created_date": "2022-10-07T16:39:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277158",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-10-07T00:00:00-04:00",
    "estimated_end_date": "2022-11-04T00:00:00-04:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-07T18:27:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171389,
    "drug": {
      "current_status": "MARKETED",
      "id": 54628,
      "drug_code": 95927,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262887,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470292",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548014"
    },
    "created_date": "2022-10-07T16:40:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470292",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-10-07T00:00:00-04:00",
    "estimated_end_date": "2022-10-21T00:00:00-04:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-10-21T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-10-22T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171392,
    "drug": {
      "current_status": "MARKETED",
      "id": 4210,
      "drug_code": 20083,
      "updated_date": "2025-05-15T02:30:59-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252625,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02216205",
      "brand_name": "TRUSOPT",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "82384",
      "number_of_ais": "1",
      "ai_group_no": "0128558001"
    },
    "created_date": "2022-10-07T16:43:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02216205",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01EC",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-10-07T00:00:00-04:00",
    "estimated_end_date": "2022-11-18T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-11-16T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TRUSOPT",
    "en_drug_common_name": "Dorzolamide hydrochloride ophthalmic solution",
    "fr_drug_brand_name": "Trusopt",
    "fr_drug_common_name": "Collyre de chlorhydrate de dorzolamide",
    "en_ingredients": "DORZOLAMIDE",
    "fr_ingredients": "Solution ophtalmique stérile de dorzolamide à 2 % poids/volume, voie ophtalmique",
    "drug_strength": "2%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171417,
    "drug": {
      "current_status": "MARKETED",
      "id": 7124,
      "drug_code": 48231,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253240,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02229873",
      "brand_name": "APO-ACETAMINOPHEN CAPLETS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0102009001"
    },
    "created_date": "2022-10-07T19:18:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229873",
    "company_name": "APOTEX INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2022-10-28T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-21T14:06:18-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-ACETAMINOPHEN CAPLETS",
    "en_drug_common_name": "ACETAMINOPHEN",
    "fr_drug_brand_name": "APO-ACETAMINOPHEN",
    "fr_drug_common_name": "ACETAMINOPHEN",
    "en_ingredients": "ACETAMINOPHEN",
    "fr_ingredients": "Acétaminophène",
    "drug_strength": "325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "1000 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171422,
    "drug": {
      "current_status": "MARKETED",
      "id": 15968,
      "drug_code": 76748,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255703,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281821",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2022-10-07T19:45:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281821",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-12-16T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-12-02T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-05T13:07:14-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171427,
    "drug": {
      "current_status": "MARKETED",
      "id": 11152,
      "drug_code": 67426,
      "updated_date": "2025-12-03T00:30:47-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254187,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02243508",
      "brand_name": "APO-PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2022-10-07T19:54:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243508",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-11-04T00:00:00-04:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-04T13:24:08-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PRAVASTATIN",
    "en_drug_common_name": "PRAVASTATIN",
    "fr_drug_brand_name": "APO-PRAVASTATIN",
    "fr_drug_common_name": "PRAVASTATIN",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171430,
    "drug": {
      "current_status": "MARKETED",
      "id": 12532,
      "drug_code": 71246,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254604,
          "ingredient": {
            "id": 282,
            "ingredient_code": 1221,
            "en_name": "SIMVASTATIN",
            "fr_name": "Simvastatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247012",
      "brand_name": "APO-SIMVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122415004"
    },
    "created_date": "2022-10-07T19:58:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247012",
    "company_name": "APOTEX INC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-11-25T00:00:00-05:00",
    "actual_start_date": "2022-10-04T00:00:00-04:00",
    "actual_end_date": "2022-11-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-25T20:38:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-SIMVASTATIN",
    "en_drug_common_name": "SIMVASTATIN",
    "fr_drug_brand_name": "APO-SIMVASTATIN",
    "fr_drug_common_name": "SIMVASTATIN",
    "en_ingredients": "SIMVASTATIN",
    "fr_ingredients": "Simvastatine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171433,
    "drug": {
      "current_status": "MARKETED",
      "id": 15772,
      "drug_code": 76506,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8255645,
          "ingredient": {
            "id": 3290,
            "ingredient_code": 18938,
            "en_name": "INSULIN GLULISINE",
            "fr_name": "Insuline glulisine (source: ADN recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02279460",
      "brand_name": "APIDRA",
      "brand_name_fr": "",
      "descriptor": "10ML VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151630001"
    },
    "created_date": "2022-10-07T20:37:36-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279460",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2023-07-31T00:00:00-04:00",
    "actual_start_date": "2022-10-06T00:00:00-04:00",
    "actual_end_date": "2023-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-12T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard d'approvisionnement. La pénurie peut être intermittente, car Sanofi peut recevoir des expéditions partielles, d'ici jusqu'à la résolution complète prévue à la « date estimée de fin ».La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "APIDRA",
    "en_drug_common_name": "Apidra Vials",
    "fr_drug_brand_name": "APIDRA",
    "fr_drug_common_name": "Apidra vials",
    "en_ingredients": "INSULIN GLULISINE",
    "fr_ingredients": "INSULIN GLULISINE",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "1",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171467,
    "drug": {
      "current_status": "MARKETED",
      "id": 101018,
      "drug_code": 99489,
      "updated_date": "2020-10-02T23:55:50-04:00",
      "company": {
        "id": 7815,
        "created_date": "2018-05-03T02:30:12-04:00",
        "updated_date": "2025-05-15T02:30:23-04:00",
        "company_code": 17067,
        "mfr_code": "",
        "name": "AVIR PHARMA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "660 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "BLAINVILLE",
        "postal_code": "J7C 3V4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265610,
          "ingredient": {
            "id": 3000,
            "ingredient_code": 12945,
            "en_name": "BIVALIRUDIN",
            "fr_name": "Bivalirudine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02505517",
      "brand_name": "BIVALIRUDIN INJECTION",
      "brand_name_fr": "BIVALIRUDINE INJECTABLE",
      "descriptor": "SINGLE USE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148342002"
    },
    "created_date": "2022-10-11T15:53:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02505517",
    "company_name": "AVIR PHARMA INC.",
    "atc_number": "B01AE",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "anticipated_start_date": "2022-10-11T00:00:00-04:00",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2022-10-11T00:00:00-04:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-02-27T14:52:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BIVALIRUDIN INJECTION",
    "en_drug_common_name": "Bivalirudin infection",
    "fr_drug_brand_name": "Bivalirudin Injectable 250mg/50mL 10vials",
    "fr_drug_common_name": "Bivalirudin Injectable 250mg/50mL 10vials",
    "en_ingredients": "BIVALIRUDIN",
    "fr_ingredients": "Bivalirudine",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS",
    "drug_route_fr": "Intraveineuse",
    "drug_package_quantity": "vials",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171472,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14534,
      "drug_code": 74816,
      "updated_date": "2025-05-15T04:09:50-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8340839,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262800",
      "brand_name": "STRATTERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434001"
    },
    "created_date": "2022-10-11T20:58:39-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02262800",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2023-08-30T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-09-22T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_discontinuation_comments": "Pour toutes questions, communiquez avec le Centre de relations avec la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés).",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-09-07T22:39:36-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STRATTERA",
    "en_drug_common_name": "atomoxetine capsules",
    "fr_drug_brand_name": "STRATTERA",
    "fr_drug_common_name": "capsules d’atomoxétine",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister package of 28 capsules",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171474,
    "drug": {
      "current_status": "MARKETED",
      "id": 65758,
      "drug_code": 95877,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8262860,
          "ingredient": {
            "id": 2314,
            "ingredient_code": 11115,
            "en_name": "INSULIN LISPRO",
            "fr_name": "Insuline lispro"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02469898",
      "brand_name": "ADMELOG",
      "brand_name_fr": "",
      "descriptor": "3ML CARTRIDGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131614001"
    },
    "created_date": "2022-10-11T21:03:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469898",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2023-07-31T00:00:00-04:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2023-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-06-15T19:13:50-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard d'approvisionnement. La pénurie peut être intermittente, car Sanofi peut recevoir des expéditions partielles, d'ici jusqu'à la résolution complète prévue à la « date estimée de fin ».La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "ADMELOG",
    "en_drug_common_name": "Admelog Cartridge",
    "fr_drug_brand_name": "ADMELOG",
    "fr_drug_common_name": "Admelog Cartridge",
    "en_ingredients": "INSULIN LISPRO",
    "fr_ingredients": "Insuline lispro",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "5 cartridges/box",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171480,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14536,
      "drug_code": 74817,
      "updated_date": "2025-05-15T04:09:50-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8340840,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262819",
      "brand_name": "STRATTERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434002"
    },
    "created_date": "2022-10-11T21:11:23-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02262819",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2024-04-23T00:00:00-04:00",
    "anticipated_discontinuation_date": "2024-04-23T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_discontinuation_comments": "Pour toutes questions, communiquez avec le Centre de relations avec la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés).",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-04-24T19:15:16-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STRATTERA",
    "en_drug_common_name": "atomoxetine capsules",
    "fr_drug_brand_name": "STRATTERA",
    "fr_drug_common_name": "capsules d’atomoxétine",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine",
    "drug_strength": "18MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister package of 28 capsules",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171485,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14538,
      "drug_code": 74820,
      "updated_date": "2025-05-15T04:09:50-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8340841,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262827",
      "brand_name": "STRATTERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434003"
    },
    "created_date": "2022-10-11T21:21:43-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02262827",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2023-09-21T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-09-20T00:00:00-04:00",
    "decision_reversal": false,
    "fr_supply_disruption_mitigation": "La date d’approvisionnement restante prévue pourrait être affectée en fonction de tout changement de la demande.",
    "en_discontinuation_comments": "For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_discontinuation_comments": "Pour toutes questions, communiquez avec le Centre de relations avec la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés).",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-09-25T21:08:46-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STRATTERA",
    "en_drug_common_name": "atomoxetine capsules",
    "fr_drug_brand_name": "STRATTERA",
    "fr_drug_common_name": "capsules d’atomoxétine",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister package of 28 capsules",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171488,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14540,
      "drug_code": 74822,
      "updated_date": "2025-05-15T04:09:50-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8340842,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262835",
      "brand_name": "STRATTERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434004"
    },
    "created_date": "2022-10-11T21:24:27-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02262835",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2023-05-02T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_discontinuation_comments": "Pour toutes questions, communiquez avec le Centre de relations avec la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés).",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-05-05T19:25:32-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STRATTERA",
    "en_drug_common_name": "atomoxetine capsules",
    "fr_drug_brand_name": "STRATTERA",
    "fr_drug_common_name": "capsules d’atomoxétine",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine",
    "drug_strength": "40MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister package of 28 capsules",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171491,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14542,
      "drug_code": 74823,
      "updated_date": "2025-05-15T04:09:50-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8340843,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02262843",
      "brand_name": "STRATTERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434005"
    },
    "created_date": "2022-10-11T21:27:41-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02262843",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2024-01-19T00:00:00-05:00",
    "anticipated_discontinuation_date": "2024-01-19T00:00:00-05:00",
    "decision_reversal": false,
    "fr_supply_disruption_mitigation": "La date d’approvisionnement restante prévue pourrait être affectée en fonction de tout changement de la demande.",
    "en_discontinuation_comments": "For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_discontinuation_comments": "Pour toutes questions, communiquez avec le Centre de relations avec la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés).",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-01-22T21:06:34-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "STRATTERA",
    "en_drug_common_name": "atomoxetine capsules",
    "fr_drug_brand_name": "STRATTERA",
    "fr_drug_common_name": "capsules d’atomoxétine",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister package of 28 capsules",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171495,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15758,
      "drug_code": 76495,
      "updated_date": "2025-05-15T04:11:19-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8342610,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279347",
      "brand_name": "STRATTERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434006"
    },
    "created_date": "2022-10-11T21:32:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02279347",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2024-03-21T00:00:00-04:00",
    "anticipated_discontinuation_date": "2024-03-22T00:00:00-04:00",
    "decision_reversal": false,
    "fr_supply_disruption_mitigation": "La date d’approvisionnement restante prévue pourrait être affectée en fonction de tout changement de la demande.",
    "en_discontinuation_comments": "For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_discontinuation_comments": "Pour toutes questions, communiquez avec le Centre de relations avec la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés).",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2024-03-22T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STRATTERA",
    "en_drug_common_name": "atomoxetine capsules",
    "fr_drug_brand_name": "STRATTERA",
    "fr_drug_common_name": "capsules d’atomoxétine",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine",
    "drug_strength": "80MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister package of 28 capsules",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171498,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 15760,
      "drug_code": 76496,
      "updated_date": "2025-05-15T04:11:19-04:00",
      "company": {
        "id": 254,
        "created_date": "2017-03-09T13:22:38-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 7005,
        "mfr_code": "LIL08",
        "name": "ELI LILLY CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 900",
        "street_name": "EXCHANGE TOWER, 130 KING STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5X 1B1",
        "post_office_box": "PO BOX 73",
        "contact_information": "Lilly Canada’s Customer Response Centre 1-888-545-5972."
      },
      "drug_ingredients": [
        {
          "id": 8342611,
          "ingredient": {
            "id": 3196,
            "ingredient_code": 13584,
            "en_name": "ATOMOXETINE",
            "fr_name": "Atomoxétine (Chlorhydrate d'atomoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02279355",
      "brand_name": "STRATTERA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150434007"
    },
    "created_date": "2022-10-11T21:34:46-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02279355",
    "company_name": "ELI LILLY CANADA INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "discontinuation_date": "2023-06-01T00:00:00-04:00",
    "anticipated_discontinuation_date": "2023-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).",
    "fr_discontinuation_comments": "Pour toutes questions, communiquez avec le Centre de relations avec la clientèle au 1-888-545-5972 (du lundi au vendredi, de 9 h à 17 h, heure de l’Est, sauf les jours fériés).",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-06-02T19:25:27-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "STRATTERA",
    "en_drug_common_name": "atomoxetine capsules",
    "fr_drug_brand_name": "STRATTERA",
    "fr_drug_common_name": "capsules d’atomoxétine",
    "en_ingredients": "ATOMOXETINE",
    "fr_ingredients": "Atomoxétine",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Blister package of 28 capsules",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171501,
    "drug": {
      "current_status": "MARKETED",
      "id": 25780,
      "drug_code": 88165,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259302,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259301,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396610",
      "brand_name": "FREYA 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2022-10-11T22:06:14-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396610",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2022-10-12T00:00:00-04:00",
    "estimated_end_date": "2022-10-26T00:00:00-04:00",
    "actual_start_date": "2022-09-28T00:00:00-04:00",
    "actual_end_date": "2022-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-10-31T11:12:10-04:00",
    "status": "resolved",
    "en_comments": "Quality Hold",
    "fr_comments": "Quality Hold",
    "en_drug_brand_name": "FREYA 28",
    "en_drug_common_name": "DESOGESTREL ETHINYL ESTRADIOL",
    "fr_drug_brand_name": "FREYA 28",
    "fr_drug_common_name": "DESOGESTREL ETHINYL ESTRADIOL",
    "en_ingredients": "DESOGESTREL\r\nETHINYL ESTRADIOL",
    "fr_ingredients": "Désogestrel\r\nÉthinylestradiol",
    "drug_strength": "0.15MG\r\n0.03MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28 BL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171506,
    "drug": {
      "current_status": "MARKETED",
      "id": 25764,
      "drug_code": 88154,
      "updated_date": "2025-05-15T02:33:43-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259294,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259293,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02396491",
      "brand_name": "FREYA 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2022-10-11T22:09:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02396491",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-10-24T00:00:00-04:00",
    "actual_start_date": "2022-09-19T00:00:00-04:00",
    "actual_end_date": "2022-10-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-10-31T11:11:33-04:00",
    "status": "resolved",
    "en_comments": "Quality Hold",
    "fr_comments": "Quality Hold",
    "en_drug_brand_name": "FREYA 21",
    "en_drug_common_name": "ETHINYL ESTRADIOL DESOGESTREL",
    "fr_drug_brand_name": "FREYA 21",
    "fr_drug_common_name": "ETHINYL ESTRADIOL DESOGESTREL",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nDESOGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nDésogestrel",
    "drug_strength": "0.03MG\r\n0.15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21 BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171537,
    "drug": {
      "current_status": "MARKETED",
      "id": 10990,
      "drug_code": 66965,
      "updated_date": "2025-05-15T02:31:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254132,
          "ingredient": {
            "id": 1642,
            "ingredient_code": 10303,
            "en_name": "ACETYLCYSTEINE",
            "fr_name": "Acétylcystéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02243098",
      "brand_name": "ACETYLCYSTEINE SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100024001"
    },
    "created_date": "2022-10-12T14:04:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243098",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "R05CB",
    "atc_description": "EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",
    "estimated_end_date": "2023-02-10T00:00:00-05:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2023-02-08T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-02T15:06:22-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACETYLCYSTEINE SOLUTION",
    "en_drug_common_name": "ACETYLCYSTEINE",
    "fr_drug_brand_name": "ACETYLCYSTEINE SOLUTION",
    "fr_drug_common_name": "ACETYLCYSTEINE",
    "en_ingredients": "ACETYLCYSTEINE",
    "fr_ingredients": "Acétylcystéine",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVENOUS\r\nINHALATION\r\nORAL\r\nINTRAVENOUS\r\nINHALATION",
    "drug_route_fr": "Orale\r\nIntraveineuse\r\nInhalation\r\nOrale\r\nIntraveineuse\r\nInhalation",
    "drug_package_quantity": "30ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171540,
    "drug": {
      "current_status": "MARKETED",
      "id": 16532,
      "drug_code": 77349,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255877,
          "ingredient": {
            "id": 2950,
            "ingredient_code": 13353,
            "en_name": "ALENDRONIC ACID",
            "fr_name": "Acide alendronique (Alendronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "70",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02288109",
      "brand_name": "SANDOZ ALENDRONATE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150323002"
    },
    "created_date": "2022-10-12T14:18:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02288109",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-28T18:49:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ALENDRONATE",
    "en_drug_common_name": "ALENDRONATE",
    "fr_drug_brand_name": "SANDOZ ALENDRONATE",
    "fr_drug_common_name": "ALENDRONATE",
    "en_ingredients": "ALENDRONIC ACID",
    "fr_ingredients": "ALENDRONIC ACID",
    "drug_strength": "70MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "4TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171544,
    "drug": {
      "current_status": "MARKETED",
      "id": 20184,
      "drug_code": 81620,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257156,
          "ingredient": {
            "id": 782,
            "ingredient_code": 11344,
            "en_name": "AMLODIPINE",
            "fr_name": "Amlodipine (Bésylate d'amlodipine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02330474",
      "brand_name": "SANDOZ AMLODIPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131437003"
    },
    "created_date": "2022-10-12T14:21:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02330474",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C08CA",
    "atc_description": "SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF.",
    "estimated_end_date": "2022-11-18T00:00:00-05:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-28T14:25:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AMLODIPINE",
    "en_drug_common_name": "AMLODIPINE",
    "fr_drug_brand_name": "SANDOZ AMLODIPINE",
    "fr_drug_common_name": "AMLODIPINE",
    "en_ingredients": "AMLODIPINE",
    "fr_ingredients": "AMLODIPINE",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171547,
    "drug": {
      "current_status": "MARKETED",
      "id": 20302,
      "drug_code": 81804,
      "updated_date": "2025-05-15T02:32:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257193,
          "ingredient": {
            "id": 2130,
            "ingredient_code": 424,
            "en_name": "AZITHROMYCIN",
            "fr_name": "Azithromycine (Monohydrate d'azithromycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02332388",
      "brand_name": "SANDOZ AZITHROMYCIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0126072002"
    },
    "created_date": "2022-10-12T14:29:29-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02332388",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01FA",
    "atc_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-11-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-11-26T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ AZITHROMYCIN",
    "en_drug_common_name": "AZITHROMYCIN",
    "fr_drug_brand_name": "SANDOZ AZITHROMYCIN",
    "fr_drug_common_name": "AZITHROMYCIN",
    "en_ingredients": "AZITHROMYCIN",
    "fr_ingredients": "Azithromycine",
    "drug_strength": "100MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100MG/5ML 15ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171551,
    "drug": {
      "current_status": "MARKETED",
      "id": 14450,
      "drug_code": 74714,
      "updated_date": "2025-05-15T02:31:39-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8255207,
          "ingredient": {
            "id": 954,
            "ingredient_code": 1205,
            "en_name": "DICLOFENAC POTASSIUM",
            "fr_name": "Diclofénac potassique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02261774",
      "brand_name": "SANDOZ DICLOFENAC RAPIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122516001"
    },
    "created_date": "2022-10-12T14:31:33-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02261774",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-10-14T00:00:00-04:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ DICLOFENAC RAPIDE",
    "en_drug_common_name": "DICLOFENAC RAPIDE",
    "fr_drug_brand_name": "SANDOZ DICLOFENAC RAPIDE",
    "fr_drug_common_name": "DICLOFENAC RAPIDE",
    "en_ingredients": "DICLOFENAC POTASSIUM",
    "fr_ingredients": "Diclofénac potassique",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100SCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171554,
    "drug": {
      "current_status": "MARKETED",
      "id": 23924,
      "drug_code": 86585,
      "updated_date": "2025-05-15T02:33:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258611,
          "ingredient": {
            "id": 2882,
            "ingredient_code": 12126,
            "en_name": "ENTACAPONE",
            "fr_name": "Entacapone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02380005",
      "brand_name": "SANDOZ ENTACAPONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0143623001"
    },
    "created_date": "2022-10-12T14:37:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02380005",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N04BX",
    "atc_description": "DOPAMINERGIC AGENTS",
    "estimated_end_date": "2022-10-14T00:00:00-04:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ENTACAPONE",
    "en_drug_common_name": "ENTACAPONE",
    "fr_drug_brand_name": "SANDOZ ENTACAPONE",
    "fr_drug_common_name": "ENTACAPONE",
    "en_ingredients": "ENTACAPONE",
    "fr_ingredients": "Entacapone",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171557,
    "drug": {
      "current_status": "MARKETED",
      "id": 27930,
      "drug_code": 90134,
      "updated_date": "2025-05-15T02:34:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8260143,
          "ingredient": {
            "id": 3046,
            "ingredient_code": 12754,
            "en_name": "EZETIMIBE",
            "fr_name": "Ézétimibe"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02416778",
      "brand_name": "SANDOZ EZETIMIBE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149164001"
    },
    "created_date": "2022-10-12T14:41:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02416778",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AX",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-10-21T00:00:00-04:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ EZETIMIBE",
    "en_drug_common_name": "EZETIMIBE",
    "fr_drug_brand_name": "SANDOZ EZETIMIBE",
    "fr_drug_common_name": "EZETIMIBE",
    "en_ingredients": "EZETIMIBE",
    "fr_ingredients": "Ézétimibe",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100TAB",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171561,
    "drug": {
      "current_status": "MARKETED",
      "id": 1848,
      "drug_code": 13946,
      "updated_date": "2025-05-15T02:30:54-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251844,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "01916203",
      "brand_name": "SANDOZ PREDNISOLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75429",
      "number_of_ais": "1",
      "ai_group_no": "0106295001"
    },
    "created_date": "2022-10-12T14:43:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01916203",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2022-11-18T00:00:00-05:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-11-28T16:25:56-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ PREDNISOLONE",
    "en_drug_common_name": "PREDNISOLONE",
    "fr_drug_brand_name": "SANDOZ PREDNISOLONE",
    "fr_drug_common_name": "PREDNISOLONE",
    "en_ingredients": "PREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de prednisolone",
    "drug_strength": "1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171572,
    "drug": {
      "current_status": "MARKETED",
      "id": 9256,
      "drug_code": 62269,
      "updated_date": "2025-05-15T02:31:06-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253614,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253613,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "28.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02238831",
      "brand_name": "CLAVULIN 200",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720006"
    },
    "created_date": "2022-10-12T16:18:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02238831",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-06-15T00:00:00-04:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2023-06-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:42:58-05:00",
    "status": "resolved",
    "en_comments": "For emergency supply, contact GSK Customer Service 1-800-387-7374.",
    "fr_comments": "Pour l’approvisionnement d’urgence, communiquez avec le service à la clientèle de GSK au 1-800-387-7374.",
    "en_drug_brand_name": "CLAVULIN 200",
    "en_drug_common_name": "amoxicillin / clavulanate potassium for oral suspension",
    "fr_drug_brand_name": "CLAVULIN 200",
    "fr_drug_common_name": "amoxicilline et clavulanate de potassium pour suspension orale",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Acide clavulanique (Clavulanate de potassium); Amoxicilline (Trihydrate d'amoxicilline)",
    "drug_strength": "28.5MG\r\n200MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "70ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171577,
    "drug": {
      "current_status": "MARKETED",
      "id": 4766,
      "drug_code": 2568,
      "updated_date": "2025-12-03T00:30:20-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250428,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00382825",
      "brand_name": "RIVOTRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50354",
      "number_of_ais": "1",
      "ai_group_no": "0111558001"
    },
    "created_date": "2022-10-12T17:29:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00382825",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "N03AE",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_end_date": "2023-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVOTRIL",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "RIVOTRIL",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "0.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171580,
    "drug": {
      "current_status": "MARKETED",
      "id": 4768,
      "drug_code": 2569,
      "updated_date": "2025-12-03T00:30:20-05:00",
      "company": {
        "id": 430,
        "created_date": "2017-03-09T13:22:46-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15812,
        "mfr_code": "",
        "name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ZIEGELHOF 24",
        "province": "MECKLENBURG - WEST POMERANIA",
        "country": "GERMANY",
        "city": "GREIFSWALD",
        "postal_code": "17489",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250429,
          "ingredient": {
            "id": 1096,
            "ingredient_code": 2192,
            "en_name": "CLONAZEPAM",
            "fr_name": "Clonazépam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00382841",
      "brand_name": "RIVOTRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "50355",
      "number_of_ais": "1",
      "ai_group_no": "0111558002"
    },
    "created_date": "2022-10-12T17:33:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00382841",
    "company_name": "CHEPLAPHARM ARZNEIMITTEL GMBH",
    "atc_number": "N03AE",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_end_date": "2023-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-01T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "RIVOTRIL",
    "en_drug_common_name": "CLONAZEPAM",
    "fr_drug_brand_name": "RIVOTRIL",
    "fr_drug_common_name": "CLONAZEPAM",
    "en_ingredients": "CLONAZEPAM",
    "fr_ingredients": "Clonazépam",
    "drug_strength": "2MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottles of 100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171597,
    "drug": {
      "current_status": "MARKETED",
      "id": 6036,
      "drug_code": 4230,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8250611,
          "ingredient": {
            "id": 14,
            "ingredient_code": 51,
            "en_name": "CALCIUM CHLORIDE",
            "fr_name": "Chlorure de calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00294748",
      "brand_name": "CALCIUM CHLORIDE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57029",
      "number_of_ais": "1",
      "ai_group_no": "0108565001"
    },
    "created_date": "2022-10-12T19:33:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00294748",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2023-03-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-03T18:45:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "en_drug_common_name": "CALCIUM CHLORIDE INJECTION USP",
    "fr_drug_brand_name": "CALCIUM CHLORIDE INJECTION USP",
    "fr_drug_common_name": "CALCIUM CHLORIDE INJECTION USP",
    "en_ingredients": "CALCIUM CHLORIDE",
    "fr_ingredients": "Chlorure de calcium",
    "drug_strength": "100MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10mL LifeShield syringe",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171608,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 1688,
      "drug_code": 13628,
      "updated_date": "2025-05-15T03:39:52-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8291848,
          "ingredient": {
            "id": 176,
            "ingredient_code": 8452,
            "en_name": "TRIMETHOPRIM",
            "fr_name": "Triméthoprime"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        },
        {
          "id": 8291847,
          "ingredient": {
            "id": 52,
            "ingredient_code": 8520,
            "en_name": "POLYMYXIN B",
            "fr_name": "Polymyxine B (Sulfate de polymyxine b)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02011956",
      "brand_name": "POLYTRIM OPHTHALMIC SOLUTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "75056",
      "number_of_ais": "2",
      "ai_group_no": "0233101001"
    },
    "created_date": "2022-10-12T21:17:03-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02011956",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01AA",
    "atc_description": "ANTIINFECTIVES",
    "discontinuation_date": "2022-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-10-17T02:37:09-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "POLYTRIM OPHTHALMIC SOLUTION",
    "en_drug_common_name": "Polytrim",
    "fr_drug_brand_name": "Polytrim",
    "fr_drug_common_name": "Triméthoprime Polymyxine B",
    "en_ingredients": "TRIMETHOPRIM\r\nPOLYMYXIN B",
    "fr_ingredients": "Triméthoprime\r\nPolymyxine B",
    "drug_strength": "1MG\r\n10000UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10mL",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171637,
    "drug": {
      "current_status": "MARKETED",
      "id": 25010,
      "drug_code": 87519,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259050,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389703",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2022-10-13T15:26:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389703",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-12-19T00:00:00-05:00",
    "actual_start_date": "2022-09-26T00:00:00-04:00",
    "actual_end_date": "2023-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T14:53:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171640,
    "drug": {
      "current_status": "MARKETED",
      "id": 25010,
      "drug_code": 87519,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259050,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389703",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563001"
    },
    "created_date": "2022-10-13T15:28:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389703",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-12-19T00:00:00-05:00",
    "actual_start_date": "2022-07-27T00:00:00-04:00",
    "actual_end_date": "2023-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T14:53:53-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171643,
    "drug": {
      "current_status": "MARKETED",
      "id": 25012,
      "drug_code": 87521,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259051,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389738",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2022-10-13T15:32:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389738",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-12-19T00:00:00-05:00",
    "actual_start_date": "2022-09-26T00:00:00-04:00",
    "actual_end_date": "2023-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T14:54:17-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171646,
    "drug": {
      "current_status": "MARKETED",
      "id": 25012,
      "drug_code": 87521,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259051,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389738",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563002"
    },
    "created_date": "2022-10-13T15:34:04-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389738",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-12-19T00:00:00-05:00",
    "actual_start_date": "2022-07-27T00:00:00-04:00",
    "actual_end_date": "2023-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T14:54:37-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171649,
    "drug": {
      "current_status": "MARKETED",
      "id": 25014,
      "drug_code": 87522,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259052,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389746",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2022-10-13T15:35:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389746",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-12-19T00:00:00-05:00",
    "actual_start_date": "2022-09-26T00:00:00-04:00",
    "actual_end_date": "2023-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171652,
    "drug": {
      "current_status": "MARKETED",
      "id": 25014,
      "drug_code": 87522,
      "updated_date": "2025-05-15T02:33:36-04:00",
      "company": {
        "id": 772,
        "created_date": "2017-03-09T13:23:16-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 15130,
        "mfr_code": "",
        "name": "SIVEM PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4705 DOBRIN STREET",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4R 2P7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259052,
          "ingredient": {
            "id": 318,
            "ingredient_code": 1201,
            "en_name": "PRAVASTATIN SODIUM",
            "fr_name": "Pravastatine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02389746",
      "brand_name": "PRAVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0122563003"
    },
    "created_date": "2022-10-13T15:36:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02389746",
    "company_name": "SIVEM PHARMACEUTICALS ULC",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2022-12-19T00:00:00-05:00",
    "actual_start_date": "2022-07-27T00:00:00-04:00",
    "actual_end_date": "2023-01-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-10T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PRAVASTATIN",
    "en_drug_common_name": "Pravastatin",
    "fr_drug_brand_name": "PRAVASTATIN",
    "fr_drug_common_name": "Pravastatin",
    "en_ingredients": "PRAVASTATIN SODIUM",
    "fr_ingredients": "Pravastatine sodique",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171699,
    "drug": {
      "current_status": "MARKETED",
      "id": 14186,
      "drug_code": 74247,
      "updated_date": "2025-05-15T02:31:38-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8255126,
          "ingredient": {
            "id": 3164,
            "ingredient_code": 12056,
            "en_name": "GATIFLOXACIN",
            "fr_name": "Gatifloxacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.3",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02257270",
      "brand_name": "ZYMAR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0142621005"
    },
    "created_date": "2022-10-13T21:11:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02257270",
    "company_name": "ABBVIE CORPORATION",
    "atc_number": "S01AE",
    "atc_description": "ANTIINFECTIVES",
    "anticipated_start_date": "2022-10-13T00:00:00-04:00",
    "estimated_end_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-10-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-10-28T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ZYMAR",
    "en_drug_common_name": "Gatifloxacin Ophthalmic solution 0.3%",
    "fr_drug_brand_name": "ZYMAR",
    "fr_drug_common_name": "Gatifloxacin Ophthalmic solution 0.3%",
    "en_ingredients": "GATIFLOXACIN",
    "fr_ingredients": "Gatifloxacine",
    "drug_strength": "0.3%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171702,
    "drug": {
      "current_status": "MARKETED",
      "id": 5888,
      "drug_code": 4114,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 1930,
        "created_date": "2017-03-09T13:26:25-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16088,
        "mfr_code": "",
        "name": "LUPIN PHARMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "550-1111 RUE ST-CHARLES OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LONGUEUIL",
        "postal_code": "J4K 5G4",
        "post_office_box": "",
        "contact_information": "lupin@lsu3pl.ca (Customer service / Service à la clientèle)"
      },
      "drug_ingredients": [
        {
          "id": 8250594,
          "ingredient": {
            "id": 966,
            "ingredient_code": 11447,
            "en_name": "CROMOLYN SODIUM",
            "fr_name": "Cromolyne sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00500895",
      "brand_name": "NALCROM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56686",
      "number_of_ais": "1",
      "ai_group_no": "0108810001"
    },
    "created_date": "2022-10-13T21:27:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00500895",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A07EB",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2023-06-30T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-01T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Replenishment supply is available to market. Intermittent supply constraints. Allocations are for protective measures.",
    "fr_comments": "Réapprovisionnement de stock est disponible pour le marché. Restrictions intermittentes de stock. Les allocations sont pour des mesures protectrices.",
    "en_drug_brand_name": "NALCROM",
    "en_drug_common_name": "NALCROM",
    "fr_drug_brand_name": "NALCROM",
    "fr_drug_common_name": "NALCROM",
    "en_ingredients": "CROMOLYN SODIUM",
    "fr_ingredients": "Cromolyne sodique",
    "drug_strength": "100MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 100 capsules",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171705,
    "drug": {
      "current_status": "MARKETED",
      "id": 29460,
      "drug_code": 91484,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8260692,
          "ingredient": {
            "id": 4002,
            "ingredient_code": 22511,
            "en_name": "ANTIHEMOPHILIC FACTOR",
            "fr_name": "Facteur Antihémophilique (Recombiné BDD), Protéine Hybride FC"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02430355",
      "brand_name": "ELOCTATE",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL (POWDER), PRE-FILLED SYRINGE (DILUENT)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0155970007"
    },
    "created_date": "2022-10-13T21:35:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430355",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B02BD",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "estimated_end_date": "2022-12-02T00:00:00-05:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2022-12-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-06T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ELOCTATE",
    "en_drug_common_name": "ELOCTATE 3000",
    "fr_drug_brand_name": "ELOCTATE",
    "fr_drug_common_name": "ELOCTATE 3000",
    "en_ingredients": "ANTIHEMOPHILIC FACTOR",
    "fr_ingredients": "ANTIHEMOPHILIC FACTOR",
    "drug_strength": "3000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "3000 IU/vial",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171718,
    "drug": {
      "current_status": "MARKETED",
      "id": 2306,
      "drug_code": 15208,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252018,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "31.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8252017,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01916882",
      "brand_name": "CLAVULIN 125 F ORAL SUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76889",
      "number_of_ais": "2",
      "ai_group_no": "0234720010"
    },
    "created_date": "2022-10-14T14:16:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01916882",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-07-07T00:00:00-04:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2023-06-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:42:58-05:00",
    "status": "resolved",
    "en_comments": "For emergency supply, contact GSK Customer Service 1-800-387-7374.",
    "fr_comments": "Pour l’approvisionnement d’urgence, communiquez avec le service à la clientèle de GSK au 1-800-387-7374.",
    "en_drug_brand_name": "CLAVULIN 125 F ORAL SUS",
    "en_drug_common_name": "amoxicillin / clavulanate potassium for oral suspension",
    "fr_drug_brand_name": "CLAVULIN 125 F",
    "fr_drug_common_name": "amoxicilline et clavulanate de potassium pour suspension orale",
    "en_ingredients": "AMOXICILLIN\r\nCLAVULANIC ACID",
    "fr_ingredients": "Amoxicilline (Trihydrate d'amoxicilline); Acide clavulanique (Clavulanate de potassium)",
    "drug_strength": "125MG\r\n31.25MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171733,
    "drug": {
      "current_status": "MARKETED",
      "id": 8528,
      "drug_code": 59976,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 6,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3699,
        "mfr_code": "BAX08",
        "name": "BAXTER CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7125 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 0C2",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253447,
          "ingredient": {
            "id": 10,
            "ingredient_code": 42,
            "en_name": "DEXTROSE",
            "fr_name": "Dextrose"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "100",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00060364",
      "brand_name": "10% DEXTROSE INJECTION, USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "70438",
      "number_of_ais": "1",
      "ai_group_no": "0102181002"
    },
    "created_date": "2022-10-14T15:31:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00060364",
    "company_name": "BAXTER CORPORATION",
    "atc_number": "B05BA",
    "atc_description": "I.V. SOLUTIONS",
    "anticipated_start_date": "2022-10-14T00:00:00-04:00",
    "estimated_end_date": "2022-10-25T00:00:00-04:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2022-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-26T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "10% DEXTROSE INJECTION, USP",
    "en_drug_common_name": "10% Dextrose Injection",
    "fr_drug_brand_name": "10% Dextrose Injection, USP",
    "fr_drug_common_name": "10% Dextrose Injection",
    "en_ingredients": "DEXTROSE",
    "fr_ingredients": "Dextrose",
    "drug_strength": "10G",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "500 mL (JB0163)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171756,
    "drug": {
      "current_status": "MARKETED",
      "id": 32218,
      "drug_code": 9973,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251251,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00792667",
      "brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69548",
      "number_of_ais": "1",
      "ai_group_no": "0105858002"
    },
    "created_date": "2022-10-14T16:07:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00792667",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07AA",
    "atc_description": "INTESTINALANTIINFECTIVES",
    "estimated_end_date": "2022-11-07T00:00:00-05:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2022-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-03T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "en_drug_common_name": "NYSTATIN",
    "fr_drug_brand_name": "pms-NYSTATIN",
    "fr_drug_common_name": "NYSTATIN",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "100000UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171759,
    "drug": {
      "current_status": "MARKETED",
      "id": 32218,
      "drug_code": 9973,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251251,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00792667",
      "brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69548",
      "number_of_ais": "1",
      "ai_group_no": "0105858002"
    },
    "created_date": "2022-10-14T16:09:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00792667",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "A07AA",
    "atc_description": "INTESTINALANTIINFECTIVES",
    "estimated_end_date": "2023-02-24T00:00:00-05:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2023-02-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-24T14:51:26-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-NYSTATIN SUSPENSION 100000 UNIT/ML",
    "en_drug_common_name": "NYSTATIN",
    "fr_drug_brand_name": "pms-NYSTATIN",
    "fr_drug_common_name": "NYSTATIN",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "100000UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500 ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171762,
    "drug": {
      "current_status": "DORMANT",
      "id": 12476,
      "drug_code": 71125,
      "updated_date": "2025-12-03T02:32:20-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367605,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246898",
      "brand_name": "PMS-LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134001"
    },
    "created_date": "2022-10-14T16:13:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246898",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2022-10-17T00:00:00-04:00",
    "estimated_end_date": "2023-01-04T00:00:00-05:00",
    "actual_end_date": "2023-01-04T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T16:38:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "pms-LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171765,
    "drug": {
      "current_status": "DORMANT",
      "id": 12478,
      "drug_code": 71126,
      "updated_date": "2025-12-03T02:32:20-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8367606,
          "ingredient": {
            "id": 1318,
            "ingredient_code": 238,
            "en_name": "LAMOTRIGINE",
            "fr_name": "Lamotrigine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "150",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02246899",
      "brand_name": "PMS-LAMOTRIGINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127134006"
    },
    "created_date": "2022-10-14T16:16:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246899",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N03AX",
    "atc_description": "ANTIEPILEPTICS",
    "estimated_end_date": "2022-11-29T00:00:00-05:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2022-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-01T18:19:19-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-LAMOTRIGINE",
    "en_drug_common_name": "LAMOTRIGINE",
    "fr_drug_brand_name": "pms-LAMOTRIGINE",
    "fr_drug_common_name": "LAMOTRIGINE",
    "en_ingredients": "LAMOTRIGINE",
    "fr_ingredients": "Lamotrigine",
    "drug_strength": "150MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171785,
    "drug": {
      "current_status": "MARKETED",
      "id": 60486,
      "drug_code": 2780,
      "updated_date": "2025-05-15T02:30:28-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250441,
          "ingredient": {
            "id": 672,
            "ingredient_code": 11107,
            "en_name": "DOXEPIN",
            "fr_name": "Doxépine (Chlorhydrate de doxépine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00400750",
      "brand_name": "SINEQUAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "51301",
      "number_of_ais": "1",
      "ai_group_no": "0107703003"
    },
    "created_date": "2022-10-14T17:30:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00400750",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2022-10-07T00:00:00-04:00",
    "estimated_end_date": "2022-11-28T00:00:00-05:00",
    "actual_end_date": "2022-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-29T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SINEQUAN",
    "en_drug_common_name": "Sinequan",
    "fr_drug_brand_name": "Sinequan",
    "fr_drug_common_name": "Sinequan",
    "en_ingredients": "DOXEPIN",
    "fr_ingredients": "Doxepin",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171788,
    "drug": {
      "current_status": "MARKETED",
      "id": 31946,
      "drug_code": 945,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250222,
          "ingredient": {
            "id": 672,
            "ingredient_code": 11107,
            "en_name": "DOXEPIN",
            "fr_name": "Doxépine (Chlorhydrate de doxépine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00024333",
      "brand_name": "SINEQUAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "32892",
      "number_of_ais": "1",
      "ai_group_no": "0107703001"
    },
    "created_date": "2022-10-14T17:40:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00024333",
    "company_name": "AA PHARMA INC",
    "atc_number": "N06AA",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2022-11-07T00:00:00-05:00",
    "estimated_end_date": "2022-11-24T00:00:00-05:00",
    "actual_end_date": "2022-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-29T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SINEQUAN",
    "en_drug_common_name": "Sinequan",
    "fr_drug_brand_name": "Sinequan",
    "fr_drug_common_name": "Sinequan",
    "en_ingredients": "DOXEPIN",
    "fr_ingredients": "Doxepin",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171792,
    "drug": {
      "current_status": "MARKETED",
      "id": 10604,
      "drug_code": 66190,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254017,
          "ingredient": {
            "id": 970,
            "ingredient_code": 2155,
            "en_name": "DESMOPRESSIN ACETATE",
            "fr_name": "Acétate de desmopressine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02242465",
      "brand_name": "DESMOPRESSIN SPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0112050001"
    },
    "created_date": "2022-10-14T17:42:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242465",
    "company_name": "AA PHARMA INC",
    "atc_number": "H01BA",
    "atc_description": "POSTERIOR PITUITARY LOBE HORMONES",
    "anticipated_start_date": "2022-10-19T00:00:00-04:00",
    "estimated_end_date": "2022-12-07T00:00:00-05:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DESMOPRESSIN SPRAY",
    "en_drug_common_name": "Desmopressin Spray",
    "fr_drug_brand_name": "Desmopressin Nasal Spray",
    "fr_drug_common_name": "Desmopressin",
    "en_ingredients": "DESMOPRESSIN ACETATE",
    "fr_ingredients": "Acétate de desmopressine",
    "drug_strength": "10MCG",
    "drug_dosage_form": "SPRAY, METERED DOSE",
    "drug_dosage_form_fr": "Pulvérisation, à dose mesurée",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171795,
    "drug": {
      "current_status": "MARKETED",
      "id": 4572,
      "drug_code": 228,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250134,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037834",
      "brand_name": "SODIUM CHLORIDE IRRIGATION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "08228",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2022-10-14T18:54:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037834",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T16:13:39-05:00",
    "status": "active_confirmed",
    "en_comments": "0.9% Sodium Chloride Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "fr_comments": "0.9% Sodium Chloride Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "en_drug_brand_name": "SODIUM CHLORIDE IRRIGATION USP",
    "en_drug_common_name": "Sodium Chloride Irrigation USP",
    "fr_drug_brand_name": "Chlorure de sodium à irrigation USP",
    "fr_drug_common_name": "Chlorure de sodium à irrigation USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL\r\nTOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL",
    "drug_route_fr": "Topique\r\nIrrigation\r\nIntrapéritonéale\r\nTopique\r\nIrrigation\r\nIntrapéritonéale",
    "drug_package_quantity": "500 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171833,
    "drug": {
      "current_status": "MARKETED",
      "id": 101851,
      "drug_code": 98324,
      "updated_date": "2023-10-26T00:04:16-04:00",
      "company": {
        "id": 4,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14412,
        "mfr_code": "",
        "name": "AA PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 1",
        "street_name": "1165 CREDITSTONE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "VAUGHAN",
        "postal_code": "L4K 4N7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264523,
          "ingredient": {
            "id": 2640,
            "ingredient_code": 11819,
            "en_name": "RISEDRONATE SODIUM",
            "fr_name": "Risédronate sodique (Hémipentahydrate de risédronate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "35",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02493268",
      "brand_name": "AA-RISEDRONATE DR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135301003"
    },
    "created_date": "2022-10-14T20:41:19-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02493268",
    "company_name": "APOTEX INC",
    "atc_number": "M05BA",
    "atc_description": "DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION",
    "estimated_end_date": "2023-01-06T00:00:00-05:00",
    "actual_start_date": "2022-10-12T00:00:00-04:00",
    "actual_end_date": "2023-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T20:25:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-RISEDRONATE DR",
    "en_drug_common_name": "RISEDRONATE DR",
    "fr_drug_brand_name": "APO-RISEDRONATE DR",
    "fr_drug_common_name": "RISEDRONATE DR",
    "en_ingredients": "RISEDRONATE SODIUM",
    "fr_ingredients": "Risédronate sodique",
    "drug_strength": "35MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "30 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171836,
    "drug": {
      "current_status": "MARKETED",
      "id": 62328,
      "drug_code": 93082,
      "updated_date": "2025-12-03T00:32:55-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261430,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02445549",
      "brand_name": "APO-AMPHETAMINE XR",
      "brand_name_fr": "APO-AMPHÉTAMINE XR",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310006"
    },
    "created_date": "2022-10-14T20:44:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02445549",
    "company_name": "APOTEX INC",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-11-11T00:00:00-05:00",
    "estimated_end_date": "2023-04-07T00:00:00-04:00",
    "actual_start_date": "2022-11-01T00:00:00-04:00",
    "actual_end_date": "2023-04-05T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-04-06T11:09:50-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMPHETAMINE XR",
    "en_drug_common_name": "AMPHETAMINE XR",
    "fr_drug_brand_name": "APO-AMPHETAMINE XR",
    "fr_drug_common_name": "AMPHETAMINE XR",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "MIXED SALTS AMPHETAMINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171841,
    "drug": {
      "current_status": "MARKETED",
      "id": 5268,
      "drug_code": 3394,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250507,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "mEq",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402206",
      "brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
      "brand_name_fr": "CHLORURE DE POTASSIUM POUR INJECTION - CONCENTRÉ",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54169",
      "number_of_ais": "1",
      "ai_group_no": "0100273003"
    },
    "created_date": "2022-10-14T21:07:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402206",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-11-07T00:00:00-05:00",
    "actual_end_date": "2022-10-20T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-10-20T16:15:31-04:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
    "en_drug_common_name": "Potassium Chloride for Injection Concentrate",
    "fr_drug_brand_name": "Chlorure de potassium pour injection concentré",
    "fr_drug_common_name": "Chlorure de potassium pour injection concentré",
    "en_ingredients": "POTASSIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium",
    "drug_strength": "20mEq",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10mL vial / fiole",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171844,
    "drug": {
      "current_status": "MARKETED",
      "id": 17240,
      "drug_code": 78289,
      "updated_date": "2025-05-15T02:31:58-04:00",
      "company": {
        "id": 678,
        "created_date": "2017-03-09T13:23:04-05:00",
        "updated_date": "2025-05-15T02:30:18-04:00",
        "company_code": 14108,
        "mfr_code": "",
        "name": "TAKEDA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "3800",
        "street_name": "22 ADELAIDE STREET WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5H 4E3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256082,
          "ingredient": {
            "id": 1086,
            "ingredient_code": 14088,
            "en_name": "MESALAZINE",
            "fr_name": "Mésalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02297558",
      "brand_name": "MEZAVANT",
      "brand_name_fr": "",
      "descriptor": "ALSO KNOWN AS MESALAMINE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116808011"
    },
    "created_date": "2022-10-14T22:31:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02297558",
    "company_name": "TAKEDA CANADA INC",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2022-10-14T00:00:00-04:00",
    "estimated_end_date": "2022-11-04T00:00:00-04:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2022-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MEZAVANT",
    "en_drug_common_name": "Mesalamine delayed- and extended-release tablets",
    "fr_drug_brand_name": "MEZAVANT",
    "fr_drug_common_name": "Mesalamine delayed- and extended-release tablets",
    "en_ingredients": "MESALAZINE",
    "fr_ingredients": "Mésalazine",
    "drug_strength": "1.2G",
    "drug_dosage_form": "TABLET (DELAYED AND EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée et prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "120 tablets / bottle",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171877,
    "drug": {
      "current_status": "MARKETED",
      "id": 63995,
      "drug_code": 81328,
      "updated_date": "2025-05-15T02:32:26-04:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257038,
          "ingredient": {
            "id": 14565,
            "ingredient_code": 8044,
            "en_name": "GALLIUM CITRATE GA 67",
            "fr_name": "Citrate de gallium 67 GA"
          },
          "ingredient_supplied_ind": "I",
          "strength": "74",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02327813",
      "brand_name": "GALLIUM (GA67) CITRATE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152589005"
    },
    "created_date": "2022-10-17T13:16:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02327813",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "V09HX",
    "anticipated_start_date": "2022-10-07T00:00:00-04:00",
    "estimated_end_date": "2022-11-13T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2022-11-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-11-17T14:19:26-05:00",
    "status": "resolved",
    "en_comments": "Following the discontinuation of Lantheus product, Curium is unable to cover Lantheus market. \r\nDue to a cyclotron mechanical issue, Curium was unable to execute production of Ga-67 raw material. As a consequence, Gallium Citrate Ga 67 Injection will not be available for shipment Nov 6-10, 2022.",
    "fr_comments": "Suite à la discontinuation du produit Lantheus, Curium n'est pas en mesure de couvrir le marché de Lantheus. En raison d'un problème mécanique du Cyclotron, nous n'avons pas pu exécuter la production de matière première Ga-67. En conséquence, l'injection de Citrate de Gallium Ga 67 ne sera pas disponible à l'expédition du 6 au 10 novembre 2022.",
    "en_drug_brand_name": "GALLIUM (GA67) CITRATE INJECTION",
    "en_drug_common_name": "gallium Ga-67 citrate injection",
    "fr_drug_brand_name": "citrate de gallium ga67 injectable",
    "fr_drug_common_name": "citrate de gallium ga67 injectable",
    "en_ingredients": "GALLIUM CITRATE GA 67",
    "fr_ingredients": "citrate de gallium",
    "drug_strength": "74MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "6 & 12 mCi",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171882,
    "drug": {
      "current_status": "DORMANT",
      "id": 66071,
      "drug_code": 81459,
      "updated_date": "2025-12-03T02:32:25-05:00",
      "company": {
        "id": 12493,
        "created_date": "2019-06-14T02:15:03-04:00",
        "updated_date": "2025-05-15T02:30:21-04:00",
        "company_code": 17542,
        "mfr_code": "",
        "name": "CURIUM CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "217 & 220",
        "street_name": "2572 BOUL. DANIEL-JOHNSON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7T 2R3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368328,
          "ingredient": {
            "id": 14561,
            "ingredient_code": 8045,
            "en_name": "THALLIUM CHLORIDE",
            "fr_name": "Chlorure de thallium (TI 201)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "37",
          "strength_unit": "MBq",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "Not Applicable/non applicable",
      "brand_name": "THALLOUS CHLORIDE TI-201 INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152598004"
    },
    "created_date": "2022-10-17T13:21:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02328925",
    "company_name": "CURIUM CANADA INC",
    "atc_number": "V09GX",
    "anticipated_start_date": "2022-10-07T00:00:00-04:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2025-10-06T14:09:32-04:00",
    "status": "active_confirmed",
    "en_comments": "Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. \r\n\r\nPlease also note that as of 28OCT20222, Curium will require maintenance on one of its cyclotron resulting in suspension of production for Curium Thallous Chloride injection during that period.\r\n\r\nThe product was rendered dormant as of 18JUN2025",
    "fr_comments": "Suite à la discontinuation du produit Lantheus, Curium n'est pas en mesure de couvrir le marché de Lantheus.\r\nVeuillez également noter qu'à partir du 28OCT20222, Curium nécessitera une maintenance sur l'un de ses cyclotrons, ce qui entraînera la suspension de la production d'injection de chlorure de thallium durant cette période.\r\n\r\nLe produit est dormant depuis le 18juin2025",
    "en_drug_brand_name": "THALLOUS CHLORIDE TI-201 INJECTION",
    "en_drug_common_name": "thallous chloride Tl201 injection",
    "fr_drug_brand_name": "chlorure de thallium Tl201 injectable",
    "fr_drug_common_name": "chlorure de thallium Tl201 injectable",
    "en_ingredients": "THALLIUM CHLORIDE",
    "fr_ingredients": "chlorure de thallium",
    "drug_strength": "37MBq",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2.8 to 9.9 mCi",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171886,
    "drug": {
      "current_status": "MARKETED",
      "id": 15966,
      "drug_code": 76747,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255702,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281813",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783004"
    },
    "created_date": "2022-10-17T13:34:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281813",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-10-14T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-05T13:07:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "7.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 171889,
    "drug": {
      "current_status": "MARKETED",
      "id": 55784,
      "drug_code": 77466,
      "updated_date": "2025-05-15T02:31:51-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255889,
          "ingredient": {
            "id": 1286,
            "ingredient_code": 232,
            "en_name": "PERINDOPRIL ERBUMINE",
            "fr_name": "Périndopril erbumine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02289288",
      "brand_name": "APO-PERINDOPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0127178002"
    },
    "created_date": "2022-10-17T13:36:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02289288",
    "company_name": "APOTEX INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2022-11-25T00:00:00-05:00",
    "actual_start_date": "2022-10-13T00:00:00-04:00",
    "actual_end_date": "2022-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-21T00:18:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-PERINDOPRIL",
    "en_drug_common_name": "PERINDOPRIL",
    "fr_drug_brand_name": "APO-PERINDOPRIL",
    "fr_drug_common_name": "PERINDOPRIL",
    "en_ingredients": "PERINDOPRIL ERBUMINE",
    "fr_ingredients": "Périndopril erbumine",
    "drug_strength": "4MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172010,
    "drug": {
      "current_status": "MARKETED",
      "id": 5900,
      "drug_code": 4129,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250596,
          "ingredient": {
            "id": 910,
            "ingredient_code": 10126,
            "en_name": "INDOMETHACIN",
            "fr_name": "Indométhacine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337420",
      "brand_name": "TEVA-INDOMETHACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56714",
      "number_of_ais": "1",
      "ai_group_no": "0101832001"
    },
    "created_date": "2022-10-17T15:16:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337420",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AB",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2023-05-20T00:00:00-04:00",
    "actual_start_date": "2022-10-17T00:00:00-04:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:07-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-INDOMETHACIN",
    "en_drug_common_name": "TEVA-INDOMETHACIN 25MG",
    "fr_drug_brand_name": "TEVA-INDOMETHACIN 25MG",
    "fr_drug_common_name": "TEVA-INDOMETHACIN 25MG",
    "en_ingredients": "INDOMETHACIN",
    "fr_ingredients": "Indométhacine",
    "drug_strength": "25MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172013,
    "drug": {
      "current_status": "MARKETED",
      "id": 18386,
      "drug_code": 79654,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256442,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310929",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055004"
    },
    "created_date": "2022-10-17T15:16:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310929",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2023-02-10T00:00:00-05:00",
    "actual_start_date": "2022-10-17T00:00:00-04:00",
    "actual_end_date": "2023-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-12T15:54:06-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "TEVA-ATORVASTATIN 80MG",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN 80MG",
    "fr_drug_common_name": "TEVA-ATORVASTATIN 80MG",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "TEVA-ATORVASTATIN 80MG",
    "drug_strength": "80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30, 90's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172018,
    "drug": {
      "current_status": "MARKETED",
      "id": 4610,
      "drug_code": 2333,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250400,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00337730",
      "brand_name": "TEVA-FUROSEMIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "48891",
      "number_of_ais": "1",
      "ai_group_no": "0101944002"
    },
    "created_date": "2022-10-17T15:17:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00337730",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "estimated_end_date": "2023-06-30T00:00:00-04:00",
    "actual_start_date": "2022-10-17T00:00:00-04:00",
    "actual_end_date": "2023-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-12T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FUROSEMIDE",
    "en_drug_common_name": "TEVA-FUROSEMIDE",
    "fr_drug_brand_name": "TEVA-FUROSEMIDE",
    "fr_drug_common_name": "TEVA-FUROSEMIDE",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172021,
    "drug": {
      "current_status": "MARKETED",
      "id": 30462,
      "drug_code": 92500,
      "updated_date": "2025-05-15T02:34:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261122,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440628",
      "brand_name": "TEVA-PANTOPRAZOLE MAGNESIUM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2022-10-17T15:18:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440628",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2022-10-17T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-08T18:00:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PANTOPRAZOLE MAGNESIUM",
    "en_drug_common_name": "TEVA-PANTOPRAZOLE MAGNESIUM",
    "fr_drug_brand_name": "TEVA-PANTOPRAZOLE MAGNESIUM",
    "fr_drug_common_name": "TEVA-PANTOPRAZOLE MAGNESIUM",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "TEVA-PANTOPRAZOLE MAGNESIUM",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172024,
    "drug": {
      "current_status": "MARKETED",
      "id": 11464,
      "drug_code": 6812,
      "updated_date": "2025-05-15T02:30:37-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250950,
          "ingredient": {
            "id": 2866,
            "ingredient_code": 1996,
            "en_name": "PIROXICAM",
            "fr_name": "Piroxicam"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00695696",
      "brand_name": "TEVA-PIROXICAM",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64131",
      "number_of_ais": "1",
      "ai_group_no": "0114612001"
    },
    "created_date": "2022-10-17T15:18:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00695696",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "M01AC",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2023-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-17T00:00:00-04:00",
    "actual_end_date": "2023-10-18T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-19T16:31:58-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PIROXICAM",
    "en_drug_common_name": "TEVA-PIROXICAM",
    "fr_drug_brand_name": "TEVA-PIROXICAM",
    "fr_drug_common_name": "TEVA-PIROXICAM",
    "en_ingredients": "PIROXICAM",
    "fr_ingredients": "Piroxicam",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172027,
    "drug": {
      "current_status": "MARKETED",
      "id": 30310,
      "drug_code": 92363,
      "updated_date": "2025-12-03T00:32:46-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8261072,
          "ingredient": {
            "id": 20953,
            "ingredient_code": 23170,
            "en_name": "MIXED SALTS AMPHETAMINE",
            "fr_name": "Sels mixtes d'amphétamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02439247",
      "brand_name": "TEVA-AMPHETAMINE XR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0161310002"
    },
    "created_date": "2022-10-17T15:25:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02439247",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "estimated_end_date": "2023-07-30T00:00:00-04:00",
    "actual_start_date": "2022-10-17T00:00:00-04:00",
    "actual_end_date": "2023-07-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-07-28T05:00:04-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMPHETAMINE XR",
    "en_drug_common_name": "TEVA-AMPHETAMINE XR",
    "fr_drug_brand_name": "TEVA-AMPHETAMINE XR",
    "fr_drug_common_name": "TEVA-AMPHETAMINE XR",
    "en_ingredients": "MIXED SALTS AMPHETAMINE",
    "fr_ingredients": "TEVA-AMPHETAMINE XR",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172030,
    "drug": {
      "current_status": "MARKETED",
      "id": 12226,
      "drug_code": 7042,
      "updated_date": "2025-05-15T02:30:38-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250975,
          "ingredient": {
            "id": 70,
            "ingredient_code": 7617,
            "en_name": "PREDNISOLONE ACETATE",
            "fr_name": "Acétate de prednisolone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00700401",
      "brand_name": "TEVA-PREDNISOLONE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "64527",
      "number_of_ais": "1",
      "ai_group_no": "0106295001"
    },
    "created_date": "2022-10-17T15:30:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00700401",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "S01BA",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "estimated_end_date": "2023-05-30T00:00:00-04:00",
    "actual_start_date": "2022-10-17T00:00:00-04:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:08-04:00",
    "status": "resolved",
    "en_comments": "5ml is OOS, 10ml is under allocations",
    "en_drug_brand_name": "TEVA-PREDNISOLONE",
    "en_drug_common_name": "TEVA-PREDNISOLONE",
    "fr_drug_brand_name": "TEVA-PREDNISOLONE",
    "fr_drug_common_name": "TEVA-PREDNISOLONE",
    "en_ingredients": "PREDNISOLONE ACETATE",
    "fr_ingredients": "Acétate de prednisolone",
    "drug_strength": "1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172087,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 7504,
      "drug_code": 50160,
      "updated_date": "2025-05-15T03:51:19-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8315745,
          "ingredient": {
            "id": 2380,
            "ingredient_code": 11381,
            "en_name": "FORMOTEROL FUMARATE",
            "fr_name": "Fumarate de formotérol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230898",
      "brand_name": "FORADIL DRY POWDER CAPSULES FOR INHALATION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131817001"
    },
    "created_date": "2022-10-18T20:10:22-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02230898",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "R03AC",
    "atc_description": "ADRENERGICS, INHALANTS",
    "discontinuation_date": "2023-01-03T00:00:00-05:00",
    "anticipated_discontinuation_date": "2022-12-31T00:00:00-05:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2023-01-25T21:12:36-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "FORADIL DRY POWDER CAPSULES FOR INHALATION",
    "en_drug_common_name": "FORADIL 12UG  CAPS",
    "fr_drug_brand_name": "FORADIL DRY POWDER CAPSULES FOR INHALATION",
    "fr_drug_common_name": "FORADIL 12UG CAPS",
    "en_ingredients": "FORMOTEROL FUMARATE",
    "fr_ingredients": "Fumarate de formotérol",
    "drug_strength": "12MCG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "INHALATION\r\nINHALATION",
    "drug_route_fr": "Inhalation\r\nInhalation",
    "drug_package_quantity": "6 X 10",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172090,
    "drug": {
      "current_status": "MARKETED",
      "id": 30566,
      "drug_code": 92621,
      "updated_date": "2025-05-15T02:34:48-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8261216,
          "ingredient": {
            "id": 2970,
            "ingredient_code": 12724,
            "en_name": "INSULIN GLARGINE",
            "fr_name": "Insuline glargine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "300",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02441829",
      "brand_name": "TOUJEO SOLOSTAR",
      "brand_name_fr": "",
      "descriptor": "1.5ML (450 IU) PREFILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147062002"
    },
    "created_date": "2022-10-18T20:10:57-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02441829",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AE",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2022-10-25T00:00:00-04:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-10-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-10-20T05:00:05-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai en approvisionnement. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "TOUJEO SOLOSTAR",
    "en_drug_common_name": "TOUJEO SOLOSTAR",
    "fr_drug_brand_name": "TOUJEO SOLOSTAR",
    "fr_drug_common_name": "TOUJEO SOLOSTAR",
    "en_ingredients": "INSULIN GLARGINE",
    "fr_ingredients": "Insuline glargine",
    "drug_strength": "300UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172094,
    "drug": {
      "current_status": "MARKETED",
      "id": 12596,
      "drug_code": 71343,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254616,
          "ingredient": {
            "id": 24,
            "ingredient_code": 8642,
            "en_name": "DOXYCYCLINE",
            "fr_name": "Doxycycline (Hyclate de doxycycline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247104",
      "brand_name": "PMS-DOXYCYCLINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105569005"
    },
    "created_date": "2022-10-18T20:18:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247104",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "A01AB",
    "atc_description": "STOMATOLOGICAL PREPARATIONS",
    "estimated_end_date": "2022-12-16T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-19T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PERIOSTAT",
    "en_drug_common_name": "PERIOSTAT",
    "fr_drug_brand_name": "PERIOSTAT",
    "fr_drug_common_name": "PERIOSTAT",
    "en_ingredients": "DOXYCYCLINE",
    "fr_ingredients": "Doxycycline",
    "drug_strength": "20MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172103,
    "drug": {
      "current_status": "MARKETED",
      "id": 15774,
      "drug_code": 76507,
      "updated_date": "2025-05-15T02:31:44-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8255646,
          "ingredient": {
            "id": 3290,
            "ingredient_code": 18938,
            "en_name": "INSULIN GLULISINE",
            "fr_name": "Insuline glulisine (source: ADN recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02279479",
      "brand_name": "APIDRA",
      "brand_name_fr": "",
      "descriptor": "3ML CARTRIDGE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151630001"
    },
    "created_date": "2022-10-18T20:49:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02279479",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2023-07-31T00:00:00-04:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2023-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-12T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard d'approvisionnement. La pénurie peut être intermittente, car Sanofi peut recevoir des expéditions partielles, d'ici jusqu'à la résolution complète prévue à la « date estimée de fin ».La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "APIDRA",
    "en_drug_common_name": "APIDRA CARTRIDGE",
    "fr_drug_brand_name": "APIDRA",
    "fr_drug_common_name": "APIDRA CARTRIDGE",
    "en_ingredients": "INSULIN GLULISINE",
    "fr_ingredients": "INSULIN GLULISINE",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "5 cartridges/box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172106,
    "drug": {
      "current_status": "MARKETED",
      "id": 32178,
      "drug_code": 9892,
      "updated_date": "2025-05-15T02:30:49-04:00",
      "company": {
        "id": 17054,
        "created_date": "2021-04-08T04:00:05-04:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17859,
        "mfr_code": "",
        "name": "ORGANON CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "300",
        "street_name": "16766 ROUTE TRANSCANADIENNE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9H 4M7",
        "post_office_box": "",
        "contact_information": "1-844-820-5468\r\ndpoc.canada@organon.com"
      },
      "drug_ingredients": [
        {
          "id": 8251241,
          "ingredient": {
            "id": 568,
            "ingredient_code": 253,
            "en_name": "AMYLASE",
            "fr_name": "Amylase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251240,
          "ingredient": {
            "id": 570,
            "ingredient_code": 648,
            "en_name": "PROTEASE",
            "fr_name": "Protéase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8251239,
          "ingredient": {
            "id": 572,
            "ingredient_code": 649,
            "en_name": "LIPASE",
            "fr_name": "Lipase"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00821373",
      "brand_name": "COTAZYM ECS 20",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "69249",
      "number_of_ais": "3",
      "ai_group_no": "0302964026"
    },
    "created_date": "2022-10-18T22:16:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00821373",
    "company_name": "ORGANON CANADA INC.",
    "atc_number": "A09AA",
    "atc_description": "DIGESTIVES, INCL ENZYMES",
    "estimated_end_date": "2022-12-23T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-12-20T06:00:02-05:00",
    "status": "resolved",
    "en_comments": "Orders partially released Dec 2nd,2022",
    "fr_comments": "Les commandes en souffrance ont été partiellement libérées le 2 Decembre 2022",
    "en_drug_brand_name": "COTAZYM ECS 20",
    "en_drug_common_name": "PANCRELIPASE DELAYED-RELEASE CAPSULES",
    "fr_drug_brand_name": "COTAZYM E.C.S.",
    "fr_drug_common_name": "CAPSULES DE PANCRÉLIPASE À LIBÉRATION RETARDÉE",
    "en_ingredients": "PROTEASE\r\nAMYLASE\r\nLIPASE",
    "fr_ingredients": "Protéase\r\nAmylase\r\nLipase",
    "drug_strength": "100000UNIT\r\n100000UNIT\r\n25000UNIT",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172122,
    "drug": {
      "current_status": "MARKETED",
      "id": 5656,
      "drug_code": 37375,
      "updated_date": "2025-05-15T02:31:01-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252905,
          "ingredient": {
            "id": 564,
            "ingredient_code": 10091,
            "en_name": "FUROSEMIDE",
            "fr_name": "Furosémide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02224755",
      "brand_name": "LASIX SPECIAL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H4906",
      "number_of_ais": "1",
      "ai_group_no": "0101944006"
    },
    "created_date": "2022-10-19T13:37:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02224755",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "C03CA",
    "atc_description": "HIGH-CEILING DIURETICS",
    "anticipated_start_date": "2022-10-21T00:00:00-04:00",
    "estimated_end_date": "2023-01-31T00:00:00-05:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2023-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-01-19T16:26:49-05:00",
    "status": "resolved",
    "en_comments": "Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Délai en approvisionnement. La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "LASIX SPECIAL",
    "en_drug_common_name": "LASIX SPECIAL",
    "fr_drug_brand_name": "LASIX SPECIAL",
    "fr_drug_common_name": "LASIX SPECIAL",
    "en_ingredients": "FUROSEMIDE",
    "fr_ingredients": "Furosémide",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 20 tablets",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172125,
    "drug": {
      "current_status": "MARKETED",
      "id": 25590,
      "drug_code": 88000,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 100,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4901,
        "mfr_code": "PDL07",
        "name": "PRO DOC LIMITEE",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2925 BOULEVARD INDUSTRIEL",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7L 3W9",
        "post_office_box": "",
        "contact_information": "2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9"
      },
      "drug_ingredients": [
        {
          "id": 8259247,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02394847",
      "brand_name": "ESOMEPRAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0145162002"
    },
    "created_date": "2022-10-19T14:20:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02394847",
    "company_name": "PRO DOC LIMITEE",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-12-22T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-23T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ESOMEPRAZOLE",
    "en_drug_common_name": "ESOMEPRAZOLE",
    "fr_drug_brand_name": "ESOMEPRAZOLE",
    "fr_drug_common_name": "ESOMEPRAZOLE",
    "en_ingredients": "ESOMEPRAZOLE",
    "fr_ingredients": "ESOMEPRAZOLE",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30,500",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172164,
    "drug": {
      "current_status": "MARKETED",
      "id": 10560,
      "drug_code": 66036,
      "updated_date": "2025-12-03T00:30:45-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254008,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242325",
      "brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593002"
    },
    "created_date": "2022-10-19T16:19:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242325",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2022-12-23T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-29T18:02:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "AMIODARONE",
    "fr_drug_brand_name": "AMIODARONE HYDROCHLORIDE INJECTION",
    "fr_drug_common_name": "AMIODARONE",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "50MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "18ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172169,
    "drug": {
      "current_status": "MARKETED",
      "id": 18662,
      "drug_code": 79937,
      "updated_date": "2025-05-15T02:32:13-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256534,
          "ingredient": {
            "id": 1570,
            "ingredient_code": 118,
            "en_name": "MYCOPHENOLATE MOFETIL",
            "fr_name": "Mofétilmycophénolate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02313855",
      "brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128158002"
    },
    "created_date": "2022-10-19T17:10:47-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02313855",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "L04AA",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-10-28T00:00:00-04:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 3,
      "en_reason": "Requirements related to complying with good manufacturing practices.",
      "fr_reason": "Exigences liées au respect des bonnes pratiques de fabrication",
      "active": true
    },
    "updated_date": "2022-10-27T02:40:57-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
    "en_drug_common_name": "MYCOPHENOLATE",
    "fr_drug_brand_name": "SANDOZ MYCOPHENOLATE MOFETIL",
    "fr_drug_common_name": "MYCOPHENOLATE",
    "en_ingredients": "MYCOPHENOLATE MOFETIL",
    "fr_ingredients": "Mofétilmycophénolate",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172174,
    "drug": {
      "current_status": "MARKETED",
      "id": 3146,
      "drug_code": 18024,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252240,
          "ingredient": {
            "id": 1364,
            "ingredient_code": 2474,
            "en_name": "NALOXONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de naloxone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02148714",
      "brand_name": "NALOXONE HCL INJECTION - 1MG/ML USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "80236",
      "number_of_ais": "1",
      "ai_group_no": "0108981001"
    },
    "created_date": "2022-10-19T17:16:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148714",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2023-01-13T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-12-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-29T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "NALOXONE HCL INJECTION - 1MG/ML USP",
    "en_drug_common_name": "NALOXONE HCL",
    "fr_drug_brand_name": "SANDOZ NALOXONE HCL INJECTION",
    "fr_drug_common_name": "NALOXONE HCL",
    "en_ingredients": "NALOXONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de naloxone",
    "drug_strength": "1MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172178,
    "drug": {
      "current_status": "MARKETED",
      "id": 18048,
      "drug_code": 79242,
      "updated_date": "2025-05-15T02:32:07-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256348,
          "ingredient": {
            "id": 2294,
            "ingredient_code": 11086,
            "en_name": "PANTOPRAZOLE",
            "fr_name": "Pantoprazole (Pantoprazole sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02306727",
      "brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133229001"
    },
    "created_date": "2022-10-19T17:22:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02306727",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A02BC",
    "atc_description": "DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)",
    "estimated_end_date": "2022-12-21T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-28T21:03:38-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PANTOPRAZOLE SODIUM FOR INJECTION",
    "en_drug_common_name": "PANTOPRAZOLE SODIUM",
    "fr_drug_brand_name": "PANTOPRAZOLE SODIUM POUR INJECTION",
    "fr_drug_common_name": "PANTOPRAZOLE SODIUM",
    "en_ingredients": "PANTOPRAZOLE",
    "fr_ingredients": "PANTOPRAZOLE SODIUM",
    "drug_strength": "40MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10LYVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172182,
    "drug": {
      "current_status": "MARKETED",
      "id": 100255,
      "drug_code": 98612,
      "updated_date": "2020-04-03T06:54:33-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8264818,
          "ingredient": {
            "id": 3374,
            "ingredient_code": 20127,
            "en_name": "POSACONAZOLE",
            "fr_name": "Posaconazole"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02496259",
      "brand_name": "SANDOZ POSACONAZOLE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152201002"
    },
    "created_date": "2022-10-19T17:27:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496259",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J02AC",
    "atc_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-11-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-17T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ POSACONAZOLE",
    "en_drug_common_name": "POSACONAZOLE",
    "fr_drug_brand_name": "SANDOZ POSACONAZOLE",
    "fr_drug_common_name": "POSACONAZOLE",
    "en_ingredients": "POSACONAZOLE",
    "fr_ingredients": "Posaconazole",
    "drug_strength": "100MG",
    "drug_dosage_form": "TABLET (DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération retardée)",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "60GRT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172186,
    "drug": {
      "current_status": "MARKETED",
      "id": 49642,
      "drug_code": 92813,
      "updated_date": "2025-05-15T02:34:58-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8261324,
          "ingredient": {
            "id": 2926,
            "ingredient_code": 12371,
            "en_name": "ESOMEPRAZOLE",
            "fr_name": "Ésoméprazole (Ésoméprazole magnésien dihydraté)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8261323,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02443449",
      "brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
      "brand_name_fr": "",
      "descriptor": "MODIFIED-RELEASE TABLETS",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0252870002"
    },
    "created_date": "2022-10-19T17:35:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02443449",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2022-10-13T00:00:00-04:00",
    "actual_end_date": "2022-12-22T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2023-01-10T16:07:10-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NAPROXEN/ESOMEPRAZOLE MR",
    "en_drug_common_name": "ESOMEPRAZOLE NAPROXEN",
    "fr_drug_brand_name": "MYLAN-ESOMEPRAZOLE NAPROXEN",
    "fr_drug_common_name": "ESOMEPRAZOLE NAPROXEN",
    "en_ingredients": "ESOMEPRAZOLE\r\nNAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "20MG\r\n500MG",
    "drug_dosage_form": "TABLET (IMMEDIATE AND DELAYED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération immédiate et retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60BT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172191,
    "drug": {
      "current_status": "MARKETED",
      "id": 3766,
      "drug_code": 19252,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252467,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02166712",
      "brand_name": "SANDOZ TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81543",
      "number_of_ais": "1",
      "ai_group_no": "0131275001"
    },
    "created_date": "2022-10-19T17:40:07-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02166712",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-11-18T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-28T14:29:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TIMOLOL",
    "en_drug_common_name": "TIMOLOL",
    "fr_drug_brand_name": "SANDOZ TIMOLOL",
    "fr_drug_common_name": "TIMOLOL",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "TIMOLOL",
    "drug_strength": "0.25%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172194,
    "drug": {
      "current_status": "MARKETED",
      "id": 3754,
      "drug_code": 19242,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252466,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02166720",
      "brand_name": "SANDOZ TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81533",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2022-10-19T17:42:41-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02166720",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-10-28T00:00:00-04:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-10-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-10-27T02:46:12-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TIMOLOL",
    "en_drug_common_name": "TIMOLOL",
    "fr_drug_brand_name": "SANDOZ TIMOLOL",
    "fr_drug_common_name": "TIMOLOL",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "TIMOLOL",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172199,
    "drug": {
      "current_status": "MARKETED",
      "id": 3754,
      "drug_code": 19242,
      "updated_date": "2025-05-15T02:30:58-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8252466,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02166720",
      "brand_name": "SANDOZ TIMOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81533",
      "number_of_ais": "1",
      "ai_group_no": "0131275002"
    },
    "created_date": "2022-10-19T17:45:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02166720",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "estimated_end_date": "2022-11-18T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-11-02T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-03T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TIMOLOL",
    "en_drug_common_name": "TIMOLOL",
    "fr_drug_brand_name": "SANDOZ TIMOLOL",
    "fr_drug_common_name": "TIMOLOL",
    "en_ingredients": "TIMOLOL",
    "fr_ingredients": "TIMOLOL",
    "drug_strength": "0.5%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172202,
    "drug": {
      "current_status": "MARKETED",
      "id": 22410,
      "drug_code": 84796,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258040,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362988",
      "brand_name": "SANDOZ ZOLMITRIPTAN",
      "brand_name_fr": "",
      "descriptor": "FILM-COATED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2022-10-19T17:48:21-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362988",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-12-02T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-11-29T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ZOLMITRIPTAN",
    "en_drug_common_name": "ZOLMITRIPTAN",
    "fr_drug_brand_name": "SANDOZ ZOLMITRIPTAN",
    "fr_drug_common_name": "ZOLMITRIPTAN",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "3FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172209,
    "drug": {
      "current_status": "MARKETED",
      "id": 60198,
      "drug_code": 95785,
      "updated_date": "2025-05-15T02:36:07-04:00",
      "company": {
        "id": 1930,
        "created_date": "2017-03-09T13:26:25-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 16088,
        "mfr_code": "",
        "name": "LUPIN PHARMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "550-1111 RUE ST-CHARLES OUEST",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LONGUEUIL",
        "postal_code": "J4K 5G4",
        "post_office_box": "",
        "contact_information": "lupin@lsu3pl.ca (Customer service / Service à la clientèle)"
      },
      "drug_ingredients": [
        {
          "id": 8262816,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02469189",
      "brand_name": "LUPIN-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0105911002"
    },
    "created_date": "2022-10-19T20:10:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469189",
    "company_name": "LUPIN PHARMA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-02-28T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2023-01-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:46:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "LUPIN-CEPHALEXIN",
    "en_drug_common_name": "Lupin-CEPHALEXIN",
    "fr_drug_brand_name": "Lupin-CEPHALEXIN",
    "fr_drug_common_name": "Lupin-CEPHALEXIN",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 ml and 150 ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172253,
    "drug": {
      "current_status": "MARKETED",
      "id": 24734,
      "drug_code": 87302,
      "updated_date": "2025-12-03T00:32:00-05:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8258929,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.02",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258928,
          "ingredient": {
            "id": 3794,
            "ingredient_code": 21354,
            "en_name": "LEVOMEFOLATE CALCIUM",
            "fr_name": "Levomefolate Calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.451",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258927,
          "ingredient": {
            "id": 3190,
            "ingredient_code": 13375,
            "en_name": "DROSPIRENONE",
            "fr_name": "Drospirénone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.00",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8258926,
          "ingredient": {
            "id": 3794,
            "ingredient_code": 21354,
            "en_name": "LEVOMEFOLATE CALCIUM",
            "fr_name": "Levomefolate Calcium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.451",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02387433",
      "brand_name": "YAZ PLUS",
      "brand_name_fr": "",
      "descriptor": "PINK TAB CONTAINS DROSPIRENONE, ETHINYL ESTRADIOL AND LEVOMEFOLATE CALCIUM AND LIGHT ORANGE TAB CONTAINS LEVOMEFOLATE CALCIUM",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "4",
      "ai_group_no": "0453183001"
    },
    "created_date": "2022-10-20T13:51:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02387433",
    "company_name": "BAYER INC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "anticipated_start_date": "2022-11-14T00:00:00-05:00",
    "estimated_end_date": "2023-01-27T00:00:00-05:00",
    "actual_start_date": "2022-11-21T00:00:00-05:00",
    "actual_end_date": "2023-01-30T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-01-31T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Supply delay",
    "fr_comments": "Retard d’approvisionnement",
    "en_drug_brand_name": "YAZ PLUS",
    "en_drug_common_name": "Drospirenone/Ethinyl Estradiol/Levomefolate Calcium",
    "fr_drug_brand_name": "Yaz Plus",
    "fr_drug_common_name": "Éthinyl estradiol / Drospirénone",
    "en_ingredients": "LEVOMEFOLATE CALCIUM\r\nLEVOMEFOLATE CALCIUM\r\nETHINYL ESTRADIOL\r\nDROSPIRENONE",
    "fr_ingredients": "Éthinylestradiol\r\nDrospirénone",
    "drug_strength": "0.451MG\r\n0.451MG\r\n0.02MG\r\n3.00MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "28's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172256,
    "drug": {
      "current_status": "MARKETED",
      "id": 6584,
      "drug_code": 43537,
      "updated_date": "2025-05-15T02:31:03-04:00",
      "company": {
        "id": 70,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 11656,
        "mfr_code": "",
        "name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253105,
          "ingredient": {
            "id": 1932,
            "ingredient_code": 7512,
            "en_name": "DESONIDE",
            "fr_name": "Désonide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.05",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/W",
          "base": false
        }
      ],
      "din": "02229323",
      "brand_name": "PDP-DESONIDE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9878",
      "number_of_ais": "1",
      "ai_group_no": "0106367001"
    },
    "created_date": "2022-10-20T14:04:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02229323",
    "company_name": "PENDOPHARM DIVISION OF PHARMASCIENCE INC",
    "atc_number": "D07AB",
    "atc_description": "CORTICOSTEROIDS, PLAIN",
    "anticipated_start_date": "2022-10-19T00:00:00-04:00",
    "estimated_end_date": "2022-12-07T00:00:00-05:00",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Note that 60g cream format is available",
    "fr_comments": "Le format 60g crème est disponible",
    "en_drug_brand_name": "PDP-DESONIDE",
    "en_drug_common_name": "PDP-DESONIDE",
    "fr_drug_brand_name": "PDP-DESONIDE",
    "fr_drug_common_name": "PDP-DESONIDE",
    "en_ingredients": "DESONIDE",
    "fr_ingredients": "Désonide",
    "drug_strength": "0.05%",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172263,
    "drug": {
      "current_status": "MARKETED",
      "id": 2874,
      "drug_code": 16954,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252178,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01934163",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "SUGAR REDUCED",
      "pediatric_flag": false,
      "accession_number": "79068",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2022-10-20T16:22:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01934163",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-07-10T00:00:00-04:00",
    "actual_start_date": "2022-08-20T00:00:00-04:00",
    "actual_end_date": "2023-07-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:44:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "NOVAMOXIN",
    "fr_drug_brand_name": "NOVAMOXIN",
    "fr_drug_common_name": "NOVAMOXIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172266,
    "drug": {
      "current_status": "MARKETED",
      "id": 21414,
      "drug_code": 83801,
      "updated_date": "2025-12-03T00:31:37-05:00",
      "company": {
        "id": 1260,
        "created_date": "2017-03-09T13:24:02-05:00",
        "updated_date": "2025-05-15T02:30:20-04:00",
        "company_code": 14236,
        "mfr_code": "",
        "name": "SANIS HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1 PRESIDENTS CHOICE CIRCLE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "BRAMPTON",
        "postal_code": "L6Y 5S5",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257651,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02352753",
      "brand_name": "AMOXICILLIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131314003"
    },
    "created_date": "2022-10-20T16:25:54-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02352753",
    "company_name": "SANIS HEALTH INC",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-07-16T00:00:00-04:00",
    "actual_start_date": "2022-10-20T00:00:00-04:00",
    "actual_end_date": "2023-07-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:44:12-05:00",
    "status": "resolved",
    "en_drug_brand_name": "AMOXICILLIN",
    "en_drug_common_name": "AMOXICILLIN",
    "fr_drug_brand_name": "AMOXICILLINE",
    "fr_drug_common_name": "AMOXICILLINE",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172290,
    "drug": {
      "current_status": "MARKETED",
      "id": 22364,
      "drug_code": 84760,
      "updated_date": "2025-12-03T00:31:44-05:00",
      "company": {
        "id": 17393,
        "created_date": "2025-12-03T00:30:14-05:00",
        "updated_date": "2025-12-03T00:30:14-05:00",
        "company_code": 22004,
        "mfr_code": "",
        "name": "JUNO PHARMA CANADA INC.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258008,
          "ingredient": {
            "id": 1166,
            "ingredient_code": 1076,
            "en_name": "POTASSIUM ACETATE",
            "fr_name": "Acétate de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "39.2",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02362597",
      "brand_name": "POTASSIUM ACETATE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "POTASSIUM 4MMOL/ML. 50ML SINGLE USE VIALS.",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107304002"
    },
    "created_date": "2022-10-20T20:01:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362597",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2022-11-01T00:00:00-04:00",
    "actual_end_date": "2022-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-11-02T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "POTASSIUM ACETATE INJECTION USP",
    "en_drug_common_name": "Potassium Acetate Injection",
    "fr_drug_brand_name": "Potassium Acetate Injection",
    "fr_drug_common_name": "Acétate de potassium injection",
    "en_ingredients": "POTASSIUM ACETATE",
    "fr_ingredients": "Acétate de potassium",
    "drug_strength": "39.2%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 50mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172313,
    "drug": {
      "current_status": "MARKETED",
      "id": 15592,
      "drug_code": 76281,
      "updated_date": "2025-05-15T02:31:43-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255590,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02277166",
      "brand_name": "BIPHENTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548001"
    },
    "created_date": "2022-10-20T20:13:34-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02277166",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-10-21T00:00:00-04:00",
    "estimated_end_date": "2022-11-04T00:00:00-04:00",
    "actual_start_date": "2022-10-21T00:00:00-04:00",
    "actual_end_date": "2022-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-07T18:28:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BIPHENTIN",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "BIPHENTIN",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "10MG",
    "drug_dosage_form": "CAPSULE (EXTENDED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172316,
    "drug": {
      "current_status": "MARKETED",
      "id": 54634,
      "drug_code": 95930,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262890,
          "ingredient": {
            "id": 130,
            "ingredient_code": 6186,
            "en_name": "METHYLPHENIDATE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de méthylphénidate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "55",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470322",
      "brand_name": "FOQUEST",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0107548006"
    },
    "created_date": "2022-10-20T20:15:30-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470322",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "N06BA",
    "atc_description": "PSYCHOSTIMULANTS AND NOOTROPICS",
    "anticipated_start_date": "2022-10-21T00:00:00-04:00",
    "estimated_end_date": "2022-11-04T00:00:00-04:00",
    "actual_start_date": "2022-10-22T00:00:00-04:00",
    "actual_end_date": "2022-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-07T18:29:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FOQUEST",
    "en_drug_common_name": "methylphenidate hydrochloride Controlled Release Capsules",
    "fr_drug_brand_name": "FOQUEST",
    "fr_drug_common_name": "chlorhydrate de méthylphénidate Capsules à libération contrôlée",
    "en_ingredients": "METHYLPHENIDATE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de méthylphénidate",
    "drug_strength": "55MG",
    "drug_dosage_form": "CAPSULE (CONTROLLED RELEASE)",
    "drug_dosage_form_fr": "Capsule à libération contrôlée",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172321,
    "drug": {
      "current_status": "MARKETED",
      "id": 101185,
      "drug_code": 99196,
      "updated_date": "2023-06-19T22:04:45-04:00",
      "company": {
        "id": 17271,
        "created_date": "2023-06-19T22:00:15-04:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 18848,
        "mfr_code": "",
        "name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 35/36",
        "street_name": "GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13",
        "province": "--",
        "country": "IRELAND",
        "city": "DUBLIN",
        "postal_code": "D13R20R",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265419,
          "ingredient": {
            "id": 3168,
            "ingredient_code": 13356,
            "en_name": "ADALIMUMAB",
            "fr_name": "Adalimumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.4",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02502380",
      "brand_name": "HULIO",
      "brand_name_fr": "",
      "descriptor": "SINGLE-DOSE PREFILLED SYRINGES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150364003"
    },
    "created_date": "2022-10-20T20:26:27-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502380",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "L04AB",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-12-06T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-08T12:28:31-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HULIO",
    "en_drug_common_name": "ADALIMUMAB",
    "fr_drug_brand_name": "HULIO",
    "fr_drug_common_name": "ADALIMUMAB",
    "en_ingredients": "ADALIMUMAB",
    "fr_ingredients": "Adalimumab",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2 x 0.4mL sterile solution (50mg/mL) subcutaneous injection (pre-filled syringe)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172335,
    "drug": {
      "current_status": "MARKETED",
      "id": 6262,
      "drug_code": 43089,
      "updated_date": "2025-12-03T00:30:37-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253029,
          "ingredient": {
            "id": 2134,
            "ingredient_code": 11118,
            "en_name": "CEFUROXIME",
            "fr_name": "Céfuroxime (Céfuroxime sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02212307",
      "brand_name": "CEFTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "P9381",
      "number_of_ais": "1",
      "ai_group_no": "0122448005"
    },
    "created_date": "2022-10-21T13:41:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02212307",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J01DC",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "actual_start_date": "2022-10-19T00:00:00-04:00",
    "actual_end_date": "2022-10-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-11-04T16:17:41-04:00",
    "status": "resolved",
    "en_comments": "This product has been divested.",
    "fr_comments": "Ce produit a été abandonné.",
    "en_drug_brand_name": "CEFTIN",
    "en_drug_common_name": "cefuroxime axetil for oral suspension",
    "fr_drug_brand_name": "CEFTIN",
    "fr_drug_common_name": "céfuroxime axétil pour suspension orale",
    "en_ingredients": "CEFUROXIME",
    "fr_ingredients": "Céfuroxime",
    "drug_strength": "125MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "70ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172342,
    "drug": {
      "current_status": "MARKETED",
      "id": 7374,
      "drug_code": 4980,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8250699,
          "ingredient": {
            "id": 1090,
            "ingredient_code": 2414,
            "en_name": "NAPROXEN",
            "fr_name": "Naproxène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00522651",
      "brand_name": "APO-NAPROXEN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59282",
      "number_of_ais": "1",
      "ai_group_no": "0109634001"
    },
    "created_date": "2022-10-21T13:56:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00522651",
    "company_name": "APOTEX INC",
    "atc_number": "M01AE",
    "atc_description": "ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-11T16:47:15-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-NAPROXEN",
    "en_drug_common_name": "NAPROXEN",
    "fr_drug_brand_name": "APO-NAPROXEN",
    "fr_drug_common_name": "NAPROXEN",
    "en_ingredients": "NAPROXEN",
    "fr_ingredients": "Naproxène",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172345,
    "drug": {
      "current_status": "MARKETED",
      "id": 4294,
      "drug_code": 20256,
      "updated_date": "2025-12-03T00:30:34-05:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8252691,
          "ingredient": {
            "id": 36161,
            "ingredient_code": 23888,
            "en_name": "HEPATITIS A VIRUS, INACTIVATED",
            "fr_name": "Virus inactivé contre l'hépatite a, inactivé"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1440",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02187078",
      "brand_name": "HAVRIX 1440",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE PREFILLED SYRINGE",
      "pediatric_flag": false,
      "accession_number": "82560",
      "number_of_ais": "1",
      "ai_group_no": "0165325001"
    },
    "created_date": "2022-10-21T13:56:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02187078",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "J07BC",
    "atc_description": "VIRAL VACCINES",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-10-20T00:00:00-04:00",
    "actual_end_date": "2022-11-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-30T18:03:38-05:00",
    "status": "resolved",
    "en_comments": "Supply available for public programs. Supply unavailable in the private market.",
    "fr_comments": "Approvisionnement possible pour les programmes publics. Approvisionnement impossible pour le marché privé",
    "en_drug_brand_name": "HAVRIX - SUS IM 1440 ELISA UNITS/ML",
    "en_drug_common_name": "hepatitis A vaccine, inactivated",
    "fr_drug_brand_name": "HAVRIX 1440",
    "fr_drug_common_name": "vaccin contre l’hépatite A, inactivé",
    "en_ingredients": "HEPATITIS A VACCINE, INACTIVATED",
    "fr_ingredients": "Vaccin contre l'hépatite a, inactivé",
    "drug_strength": "1440UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "1's (prefilled syringe / seringue préremplie)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172347,
    "drug": {
      "current_status": "MARKETED",
      "id": 9640,
      "drug_code": 63385,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8253725,
          "ingredient": {
            "id": 1002,
            "ingredient_code": 11385,
            "en_name": "TERBINAFINE",
            "fr_name": "Terbinafine (Chlorhydrate de terbinafine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02239893",
      "brand_name": "APO-TERBINAFINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0132855002"
    },
    "created_date": "2022-10-21T13:57:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02239893",
    "company_name": "APOTEX INC",
    "atc_number": "D01BA",
    "atc_description": "ANTIFUNGALS FOR SYSTEMIC USE",
    "estimated_end_date": "2023-01-06T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2023-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T20:35:39-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-TERBINAFINE",
    "en_drug_common_name": "TERBINAFINE",
    "fr_drug_brand_name": "APO-TERBINAFINE",
    "fr_drug_common_name": "TERBINAFINE",
    "en_ingredients": "TERBINAFINE",
    "fr_ingredients": "Terbinafine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172351,
    "drug": {
      "current_status": "MARKETED",
      "id": 30436,
      "drug_code": 92479,
      "updated_date": "2025-05-15T02:34:45-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8261116,
          "ingredient": {
            "id": 3432,
            "ingredient_code": 20171,
            "en_name": "DULOXETINE",
            "fr_name": "Duloxétine (Chlorhydrate de duloxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "30",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02440423",
      "brand_name": "APO-DULOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152350001"
    },
    "created_date": "2022-10-21T13:58:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02440423",
    "company_name": "APOTEX INC",
    "atc_number": "N06AX",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2023-04-14T00:00:00-04:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2023-03-15T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2023-03-16T11:57:54-04:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DULOXETINE",
    "en_drug_common_name": "DULOXETINE",
    "fr_drug_brand_name": "APO-DULOXETINE",
    "fr_drug_common_name": "DULOXETINE",
    "en_ingredients": "DULOXETINE",
    "fr_ingredients": "DULOXETINE",
    "drug_strength": "30MG",
    "drug_dosage_form": "CAPSULE (DELAYED RELEASE)",
    "drug_dosage_form_fr": "Capsule (à libération retardée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL and 500 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172355,
    "drug": {
      "current_status": "MARKETED",
      "id": 27234,
      "drug_code": 89490,
      "updated_date": "2025-05-15T02:34:00-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259838,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": true
        },
        {
          "id": 8259837,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.0300",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "TAB",
          "base": true
        }
      ],
      "din": "02410249",
      "brand_name": "MIRVALA 21",
      "brand_name_fr": "",
      "descriptor": "ORAL CONTRACEPTIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2022-10-21T14:00:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02410249",
    "company_name": "APOTEX INC",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-07T13:15:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MIRVALA 21",
    "en_drug_common_name": "MIRVALA",
    "fr_drug_brand_name": "MIRVALA",
    "fr_drug_common_name": "MIRVALA",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nDESOGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nDésogestrel",
    "drug_strength": "0.0300MG\r\n0.1500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172360,
    "drug": {
      "current_status": "MARKETED",
      "id": 66416,
      "drug_code": 95972,
      "updated_date": "2025-05-15T02:36:12-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8262928,
          "ingredient": {
            "id": 3370,
            "ingredient_code": 20122,
            "en_name": "DASATINIB",
            "fr_name": "Dasatinib (Monohydrate de dasatinib)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02470713",
      "brand_name": "APO-DASATINIB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152198002"
    },
    "created_date": "2022-10-21T14:01:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02470713",
    "company_name": "APOTEX INC",
    "atc_number": "L01EA",
    "estimated_end_date": "2022-12-17T00:00:00-05:00",
    "actual_start_date": "2022-10-18T00:00:00-04:00",
    "actual_end_date": "2022-12-16T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-17T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-DASATINIB",
    "en_drug_common_name": "DASATINIB",
    "fr_drug_brand_name": "APO-DASATINIB",
    "fr_drug_common_name": "DASATINIB",
    "en_ingredients": "DASATINIB",
    "fr_ingredients": "DASATINIB",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30 BLS",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172363,
    "drug": {
      "current_status": "MARKETED",
      "id": 20658,
      "drug_code": 82422,
      "updated_date": "2025-05-15T02:32:32-04:00",
      "company": {
        "id": 202,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 4225,
        "mfr_code": "GAC08",
        "name": "GALDERMA CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "SUITE 400",
        "street_name": "55 COMMERCE VALLEY DRIVE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "THORNHILL",
        "postal_code": "L3T 7V9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257303,
          "ingredient": {
            "id": 1938,
            "ingredient_code": 4893,
            "en_name": "CALCITRIOL",
            "fr_name": "Calcitriol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "02338572",
      "brand_name": "SILKIS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0113628006"
    },
    "created_date": "2022-10-21T14:02:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338572",
    "company_name": "GALDERMA CANADA INC",
    "atc_number": "D05AX",
    "atc_description": "ANTIPSORIATICS FOR TOPICAL USE",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-08-16T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 5,
      "en_reason": "Shortage of an active ingredient.",
      "fr_reason": "Pénurie d’un ingrédient actif",
      "active": true
    },
    "updated_date": "2022-12-08T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SILKIS",
    "en_drug_common_name": "Calcitriol",
    "fr_drug_brand_name": "Silkis",
    "fr_drug_common_name": "Calcitriol",
    "en_ingredients": "CALCITRIOL",
    "fr_ingredients": "Calcitriol",
    "drug_strength": "3MCG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "60 g",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172389,
    "drug": {
      "current_status": "MARKETED",
      "id": 16312,
      "drug_code": 771,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 510,
        "created_date": "2017-03-09T13:22:50-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 16647,
        "mfr_code": "",
        "name": "SEARCHLIGHT PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1600 RUE NOTRE DAME OUEST, SUITE 312",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3J 1M1",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250182,
          "ingredient": {
            "id": 3106,
            "ingredient_code": 6363,
            "en_name": "ETHOSUXIMIDE",
            "fr_name": "Éthosuximide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00022799",
      "brand_name": "ZARONTIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "29524",
      "number_of_ais": "1",
      "ai_group_no": "0107470002"
    },
    "created_date": "2022-10-21T15:09:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00022799",
    "company_name": "ERFA CANADA 2012 INC",
    "atc_number": "N03AD",
    "atc_description": "ANTIEPILEPTICS",
    "anticipated_start_date": "2022-10-06T00:00:00-04:00",
    "estimated_end_date": "2023-02-15T00:00:00-05:00",
    "actual_start_date": "2022-10-07T00:00:00-04:00",
    "actual_end_date": "2023-02-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-02T17:05:20-05:00",
    "status": "resolved",
    "en_comments": "RESOLVED",
    "en_drug_brand_name": "ZARONTIN CAP 250MG",
    "en_drug_common_name": "ZARONTIN CAP",
    "fr_drug_brand_name": "ZARONTIN CAPS 250MG",
    "fr_drug_common_name": "ZARONTIN CAP",
    "en_ingredients": "ETHOSUXIMIDE",
    "fr_ingredients": "Éthosuximide",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "BOTTLE 100'S",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172396,
    "drug": {
      "current_status": "MARKETED",
      "id": 3006,
      "drug_code": 17417,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252207,
          "ingredient": {
            "id": 1328,
            "ingredient_code": 8138,
            "en_name": "SULFASALAZINE",
            "fr_name": "Sulfasalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02064472",
      "brand_name": "SALAZOPYRIN EN-TABS 500 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79570",
      "number_of_ais": "1",
      "ai_group_no": "0106101001"
    },
    "created_date": "2022-10-21T16:50:43-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02064472",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2022-10-24T00:00:00-04:00",
    "actual_end_date": "2023-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-16T14:00:25-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SALAZOPYRIN EN-TABS 500 MG",
    "en_drug_common_name": "SALAZOPYRIN",
    "fr_drug_brand_name": "SALAZOPYRIN EN 500MG",
    "fr_drug_common_name": "SALAZOPYRIN",
    "en_ingredients": "SULFASALAZINE",
    "fr_ingredients": "Sulfasalazine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100'S",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172399,
    "drug": {
      "current_status": "MARKETED",
      "id": 3006,
      "drug_code": 17417,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252207,
          "ingredient": {
            "id": 1328,
            "ingredient_code": 8138,
            "en_name": "SULFASALAZINE",
            "fr_name": "Sulfasalazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02064472",
      "brand_name": "SALAZOPYRIN EN-TABS 500 MG",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79570",
      "number_of_ais": "1",
      "ai_group_no": "0106101001"
    },
    "created_date": "2022-10-21T16:52:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02064472",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "A07EC",
    "atc_description": "INTESTINALANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2023-03-31T00:00:00-04:00",
    "actual_start_date": "2022-10-24T00:00:00-04:00",
    "actual_end_date": "2023-04-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-05T15:29:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "SALAZOPYRIN EN-TABS 500 MG",
    "en_drug_common_name": "SALAZOPYRIN",
    "fr_drug_brand_name": "SALAZOPYRIN EN-TABS 500 MG",
    "fr_drug_common_name": "SALAZOPYRIN",
    "en_ingredients": "SULFASALAZINE",
    "fr_ingredients": "Sulfasalazine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET (ENTERIC-COATED)",
    "drug_dosage_form_fr": "Comprimé (entérosoluble)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "300's",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172409,
    "drug": {
      "current_status": "MARKETED",
      "id": 55369,
      "drug_code": 94721,
      "updated_date": "2025-05-15T02:35:43-04:00",
      "company": {
        "id": 16976,
        "created_date": "2020-10-02T23:51:29-04:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 17602,
        "mfr_code": "",
        "name": "HIKMA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "55 STANDISH COURT, SUITE 1050",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 0G3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262243,
          "ingredient": {
            "id": 1642,
            "ingredient_code": 10303,
            "en_name": "ACETYLCYSTEINE",
            "fr_name": "Acétylcystéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02459906",
      "brand_name": "ACETYLCYSTEINE SOLUTION USP",
      "brand_name_fr": "SOLUTION D'ACÉTYLCYSTÉINE USP",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0100024001"
    },
    "created_date": "2022-10-21T19:16:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02459906",
    "company_name": "HIKMA CANADA LIMITED",
    "atc_number": "R05CB",
    "atc_description": "EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR.",
    "anticipated_start_date": "2022-11-30T00:00:00-05:00",
    "estimated_end_date": "2023-06-09T00:00:00-04:00",
    "actual_start_date": "2022-11-03T00:00:00-04:00",
    "actual_end_date": "2022-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-06-14T13:12:13-04:00",
    "status": "avoided_shortage",
    "en_comments": "Inventory available in 30mL vial format - Hikma product code 0015AI02.",
    "fr_comments": "Inventaire disponible en format de fiole de 30 ml - Code produit Hikma 0015AI02.",
    "en_drug_brand_name": "ACETYLCYSTEINE SOLUTION USP",
    "en_drug_common_name": "ACETYLCYSTEINE SOLUTION USP",
    "fr_drug_brand_name": "ACETYLCYSTEINE SOLUTION USP",
    "fr_drug_common_name": "ACETYLCYSTEINE SOLUTION USP",
    "en_ingredients": "ACETYLCYSTEINE",
    "fr_ingredients": "Acétylcystéine",
    "drug_strength": "200MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVENOUS\r\nINHALATION\r\nORAL\r\nINTRAVENOUS\r\nINHALATION",
    "drug_route_fr": "Orale\r\nIntraveineuse\r\nInhalation\r\nOrale\r\nIntraveineuse\r\nInhalation",
    "drug_package_quantity": "10ML",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172459,
    "drug": {
      "current_status": "MARKETED",
      "id": 13364,
      "drug_code": 72996,
      "updated_date": "2025-05-15T02:31:32-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8254847,
          "ingredient": {
            "id": 1584,
            "ingredient_code": 1255,
            "en_name": "OCTREOTIDE",
            "fr_name": "Octréotide (Acétate d'octréotide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02248639",
      "brand_name": "OCTREOTIDE ACETATE OMEGA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121548004"
    },
    "created_date": "2022-10-24T15:28:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02248639",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "H01CB",
    "atc_description": "HYPOTHALAMIC HORMONES",
    "actual_start_date": "2022-10-24T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "OCTREOTIDE ACETATE OMEGA",
    "en_drug_common_name": "Octreotide Acetate Injection 50 MCG/ML",
    "fr_drug_brand_name": "OCTREOTIDE ACETATE OMEGA",
    "fr_drug_common_name": "Acétate d'octréotide injectable 50 MCG/ML",
    "en_ingredients": "OCTREOTIDE",
    "fr_ingredients": "Octréotide",
    "drug_strength": "50MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nSUBCUTANEOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nSous-cutanée\r\nIntraveineuse",
    "drug_package_quantity": "5 x 1mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172500,
    "drug": {
      "current_status": "MARKETED",
      "id": 29458,
      "drug_code": 91483,
      "updated_date": "2025-05-15T02:34:31-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8260691,
          "ingredient": {
            "id": 4002,
            "ingredient_code": 22511,
            "en_name": "ANTIHEMOPHILIC FACTOR",
            "fr_name": "Facteur Antihémophilique (Recombiné BDD), Protéine Hybride FC"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02430347",
      "brand_name": "ELOCTATE",
      "brand_name_fr": "",
      "descriptor": "SINGLE-USE VIAL (POWDER), PRE-FILLED SYRINGE (DILUENT)",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0155970006"
    },
    "created_date": "2022-10-24T20:59:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02430347",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "B02BD",
    "atc_description": "VITAMIN K AND OTHER HEMOSTATICS",
    "anticipated_start_date": "2022-11-14T00:00:00-05:00",
    "estimated_end_date": "2023-01-27T00:00:00-05:00",
    "actual_end_date": "2023-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-01-27T19:04:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "ELOCTATE",
    "en_drug_common_name": "ELOCTATE 2000",
    "fr_drug_brand_name": "ELOCTATE",
    "fr_drug_common_name": "ELOCTATE 2000",
    "en_ingredients": "ANTIHEMOPHILIC FACTOR",
    "drug_strength": "2000UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION\r\nKIT",
    "drug_dosage_form_fr": "Poudre pour solution\r\nTrousse",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "2000 IU/vial",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172505,
    "drug": {
      "current_status": "MARKETED",
      "id": 100297,
      "drug_code": 98662,
      "updated_date": "2020-04-03T06:54:35-04:00",
      "company": {
        "id": 860,
        "created_date": "2017-03-09T13:23:23-05:00",
        "updated_date": "2025-05-15T02:30:19-04:00",
        "company_code": 9126,
        "mfr_code": "",
        "name": "CHIESI FARMACEUTICI S.P.A.",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "26/A VIA PALERMO",
        "province": "--",
        "country": "ITALY",
        "city": "PARMA",
        "postal_code": "43122",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8264855,
          "ingredient": {
            "id": 852,
            "ingredient_code": 9357,
            "en_name": "CAFFEINE CITRATE",
            "fr_name": "Citrate de caféine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02496771",
      "brand_name": "PEYONA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0162054001"
    },
    "created_date": "2022-10-24T22:49:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02496771",
    "company_name": "CHIESI FARMACEUTICI S.P.A.",
    "atc_number": "N06BC",
    "anticipated_start_date": "2022-10-25T00:00:00-04:00",
    "estimated_end_date": "2022-12-12T00:00:00-05:00",
    "actual_end_date": "2023-01-03T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-20T14:48:30-05:00",
    "status": "resolved",
    "en_comments": "Shortage end date provided.",
    "en_drug_brand_name": "PEYONA",
    "en_drug_common_name": "Caffeine Citrate",
    "fr_drug_brand_name": "Peyona",
    "fr_drug_common_name": "Citrate de caffeine",
    "en_ingredients": "CAFFEINE CITRATE",
    "fr_ingredients": "Citrate de caféine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "ORAL\r\nINTRAVENOUS",
    "drug_route_fr": "Orale\r\nIntraveineuse",
    "drug_package_quantity": "1mL x 10 ampoules",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172526,
    "drug": {
      "current_status": "MARKETED",
      "id": 1540,
      "drug_code": 13340,
      "updated_date": "2025-05-15T02:30:53-04:00",
      "company": {
        "id": 80,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4489,
        "mfr_code": "LEO08",
        "name": "LEO PHARMA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "6 ADELAIDE STREET EAST, SUITE 200",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M5C 1H6",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251752,
          "ingredient": {
            "id": 856,
            "ingredient_code": 894,
            "en_name": "CALCIPOTRIOL",
            "fr_name": "Calcipotriol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "G",
          "base": false
        }
      ],
      "din": "01976133",
      "brand_name": "DOVONEX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74692",
      "number_of_ais": "1",
      "ai_group_no": "0123661001"
    },
    "created_date": "2022-10-25T14:09:42-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01976133",
    "company_name": "LEO PHARMA INC",
    "atc_number": "D05AX",
    "atc_description": "ANTIPSORIATICS FOR TOPICAL USE",
    "anticipated_start_date": "2022-10-25T00:00:00-04:00",
    "estimated_end_date": "2022-10-31T00:00:00-04:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2022-11-01T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-02T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "DOVONEX",
    "en_drug_common_name": "Calcipotrial 0.5mg/g",
    "fr_drug_brand_name": "Dovonex Ointment",
    "fr_drug_common_name": "Calcipotriol 0.5mg/g",
    "en_ingredients": "CALCIPOTRIOL",
    "fr_ingredients": "Calcipotriol",
    "drug_strength": "50MCG",
    "drug_dosage_form": "OINTMENT",
    "drug_dosage_form_fr": "Pommade",
    "drug_route": "TOPICAL\r\nTOPICAL",
    "drug_route_fr": "Topique\r\nTopique",
    "drug_package_quantity": "120g",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172533,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 11178,
      "drug_code": 67506,
      "updated_date": "2025-05-15T04:03:09-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8333934,
          "ingredient": {
            "id": 62,
            "ingredient_code": 9412,
            "en_name": "NITROGLYCERIN",
            "fr_name": "Nitroglycérine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02243588",
      "brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0103615009"
    },
    "created_date": "2022-10-25T17:17:00-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02243588",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "C01DA",
    "atc_description": "VASODILATORS USED IN CARDIAC DISEASES",
    "anticipated_start_date": "2022-11-01T00:00:00-04:00",
    "actual_start_date": "2022-10-13T00:00:00-04:00",
    "actual_end_date": "2022-11-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-22T15:32:01-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
    "en_drug_common_name": "NITROGLYCERIN",
    "fr_drug_brand_name": "MYLAN-NITRO SUBLINGUAL SPRAY",
    "fr_drug_common_name": "Nitroglycérine",
    "en_ingredients": "NITROGLYCERIN",
    "fr_ingredients": "Nitroglycérine",
    "drug_strength": "0.4MG",
    "drug_dosage_form": "METERED-DOSE AEROSOL",
    "drug_dosage_form_fr": "Aérosol à dose mesurée",
    "drug_route": "SUBLINGUAL\r\nSUBLINGUAL",
    "drug_route_fr": "Sublinguale\r\nSublinguale",
    "drug_package_quantity": "1BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172537,
    "drug": {
      "current_status": "MARKETED",
      "id": 26354,
      "drug_code": 88703,
      "updated_date": "2025-05-15T02:33:49-04:00",
      "company": {
        "id": 338,
        "created_date": "2017-03-09T13:22:41-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 13930,
        "mfr_code": "",
        "name": "MYLAN PHARMACEUTICALS ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "85 ADVANCE ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "ETOBICOKE",
        "postal_code": "M8Z 2S6",
        "post_office_box": "",
        "contact_information": "Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6"
      },
      "drug_ingredients": [
        {
          "id": 8259520,
          "ingredient": {
            "id": 2578,
            "ingredient_code": 11782,
            "en_name": "PROGUANIL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de proguanil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259519,
          "ingredient": {
            "id": 2152,
            "ingredient_code": 8317,
            "en_name": "ATOVAQUONE",
            "fr_name": "Atovaquone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02402165",
      "brand_name": "MYLAN-ATOVAQUONE/PROGUANIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0250721002"
    },
    "created_date": "2022-10-25T17:19:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02402165",
    "company_name": "MYLAN PHARMACEUTICALS ULC",
    "atc_number": "P01BB",
    "atc_description": "ANTIMALARIALS",
    "anticipated_start_date": "2022-11-09T00:00:00-05:00",
    "estimated_end_date": "2023-01-17T00:00:00-05:00",
    "actual_start_date": "2022-11-07T00:00:00-05:00",
    "actual_end_date": "2023-01-12T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-17T17:59:24-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MYLAN-ATOVAQUONE/PROGUANIL",
    "en_drug_common_name": "PROGUANIL HYDROCHLORIDE ATOVAQUONE",
    "fr_drug_brand_name": "MYLAN-ATOVAQUONE/PROGUANIL",
    "fr_drug_common_name": "PROGUANIL HYDROCHLORIDE ATOVAQUONE",
    "en_ingredients": "PROGUANIL HYDROCHLORIDE\r\nATOVAQUONE",
    "fr_ingredients": "Chlorhydrate de proguanil\r\nAtovaquone",
    "drug_strength": "100MG\r\n250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100BT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172544,
    "drug": {
      "current_status": "MARKETED",
      "id": 17348,
      "drug_code": 78395,
      "updated_date": "2025-12-03T00:31:14-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256114,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298635",
      "brand_name": "SANDOZ LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663003"
    },
    "created_date": "2022-10-25T17:29:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298635",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2023-02-24T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-03-06T16:06:36-05:00",
    "status": "resolved",
    "en_comments": "Limited inventory has been allocated.",
    "fr_comments": "L'inventaire limité a été alloué.",
    "en_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172547,
    "drug": {
      "current_status": "MARKETED",
      "id": 17350,
      "drug_code": 78396,
      "updated_date": "2025-12-03T00:31:14-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256115,
          "ingredient": {
            "id": 3084,
            "ingredient_code": 11705,
            "en_name": "LEVOFLOXACIN",
            "fr_name": "Lévofloxacine (Hémihydrate de lévofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02298643",
      "brand_name": "SANDOZ LEVOFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131663004"
    },
    "created_date": "2022-10-25T17:37:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02298643",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2023-02-03T00:00:00-05:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2023-02-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-02-15T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Limited inventory has been allocated.",
    "fr_comments": "L'inventaire limité a été alloué.",
    "en_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "en_drug_common_name": "LEVOFLOXACIN",
    "fr_drug_brand_name": "SANDOZ LEVOFLOXACIN",
    "fr_drug_common_name": "LEVOFLOXACIN",
    "en_ingredients": "LEVOFLOXACIN",
    "fr_ingredients": "Lévofloxacine",
    "drug_strength": "500MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172552,
    "drug": {
      "current_status": "MARKETED",
      "id": 1582,
      "drug_code": 13416,
      "updated_date": "2025-12-03T00:30:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251763,
          "ingredient": {
            "id": 880,
            "ingredient_code": 331,
            "en_name": "ZINC",
            "fr_name": "Zinc (Oxyde de zinc, Sulfate de zinc)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "00787000",
      "brand_name": "MICRO ZN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "74799",
      "number_of_ais": "1",
      "ai_group_no": "0109299013"
    },
    "created_date": "2022-10-25T18:45:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00787000",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "A12CB",
    "atc_description": "OTHER MINERAL SUPPLEMENTS",
    "estimated_end_date": "2023-03-10T00:00:00-05:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2023-03-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-14T05:00:03-04:00",
    "status": "resolved",
    "en_comments": "Baxter item : 9410\r\nProduct is available on allocation based on 100% of historical volumes",
    "fr_comments": "Baxter item : 9410\r\nLe produit est disponible sous allocation, basé sur 100% du volume historique.",
    "en_drug_brand_name": "MICRO ZN",
    "en_drug_common_name": "MICRO ZN",
    "fr_drug_brand_name": "MICRO ZN",
    "fr_drug_common_name": "MICRO ZN",
    "en_ingredients": "ZINC",
    "fr_ingredients": "Zinc",
    "drug_strength": "5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10ML 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172557,
    "drug": {
      "current_status": "MARKETED",
      "id": 10660,
      "drug_code": 66277,
      "updated_date": "2025-05-15T02:31:10-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254041,
          "ingredient": {
            "id": 108,
            "ingredient_code": 4991,
            "en_name": "FOLIC ACID",
            "fr_name": "Acide folique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "140",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254040,
          "ingredient": {
            "id": 638,
            "ingredient_code": 5015,
            "en_name": "NICOTINAMIDE",
            "fr_name": "Nicotinamide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "17",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254039,
          "ingredient": {
            "id": 634,
            "ingredient_code": 4993,
            "en_name": "DEXPANTHENOL",
            "fr_name": "Dexpanthénol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254038,
          "ingredient": {
            "id": 632,
            "ingredient_code": 4962,
            "en_name": "BIOTIN",
            "fr_name": "Biotine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254037,
          "ingredient": {
            "id": 754,
            "ingredient_code": 11171,
            "en_name": "VITAMIN B2",
            "fr_name": "Vitanine B2 (Riboflavine 5'-phosphate sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.4",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254036,
          "ingredient": {
            "id": 752,
            "ingredient_code": 11170,
            "en_name": "VITAMIN B1",
            "fr_name": "Vitamine B1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254035,
          "ingredient": {
            "id": 644,
            "ingredient_code": 781,
            "en_name": "VITAMIN B12",
            "fr_name": "Vitamine B12"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254034,
          "ingredient": {
            "id": 760,
            "ingredient_code": 701,
            "en_name": "VITAMIN E",
            "fr_name": "Vitamine E"
          },
          "ingredient_supplied_ind": "I",
          "strength": "7",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254033,
          "ingredient": {
            "id": 32869,
            "ingredient_code": 645,
            "en_name": "ASCORBIC ACID",
            "fr_name": "Acide ascorbique (Acide ascorbique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254032,
          "ingredient": {
            "id": 636,
            "ingredient_code": 5008,
            "en_name": "PYRIDOXINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de pyridoxine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254031,
          "ingredient": {
            "id": 738,
            "ingredient_code": 4918,
            "en_name": "VITAMIN K1",
            "fr_name": "Vitamine K1"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.2",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254030,
          "ingredient": {
            "id": 424,
            "ingredient_code": 703,
            "en_name": "VITAMIN D",
            "fr_name": "Vitamine D"
          },
          "ingredient_supplied_ind": "I",
          "strength": "400",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        },
        {
          "id": 8254029,
          "ingredient": {
            "id": 426,
            "ingredient_code": 704,
            "en_name": "VITAMIN A",
            "fr_name": "Vitamine A"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2300",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": true
        }
      ],
      "din": "02242529",
      "brand_name": "MULTI-12/K1 PEDIATRIC",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "13",
      "ai_group_no": "1341461001"
    },
    "created_date": "2022-10-25T18:49:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242529",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B05XC",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "estimated_end_date": "2023-05-26T00:00:00-04:00",
    "actual_start_date": "2022-11-28T00:00:00-05:00",
    "actual_end_date": "2023-05-19T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-30T18:45:59-04:00",
    "status": "resolved",
    "en_comments": "Baxter item : 6461",
    "fr_comments": "Baxter item : 6461",
    "en_drug_brand_name": "MULTI-12/K1 PEDIATRIC",
    "en_drug_common_name": "MULTI-12/K1 PED",
    "fr_drug_brand_name": "MULTI-12/K1 PEDIATRIC",
    "fr_drug_common_name": "MULTI-12/K1 PED",
    "en_ingredients": "VITAMIN D\r\nVITAMIN A\r\nASCORBIC ACID\r\nVITAMIN B12\r\nFOLIC ACID\r\nBIOTIN\r\nVITAMIN K1\r\nVITAMIN E\r\nDEXPANTHENOL\r\nNICOTINAMIDE\r\nPYRIDOXINE HYDROCHLORIDE\r\nVITAMIN B2\r\nVITAMIN B1",
    "fr_ingredients": "Vitamine D\r\nVitamine A\r\nVitamine B12\r\nAcide folique\r\nBiotine\r\nVitamine K1\r\nVitamine E\r\nDexpanthénol\r\nNicotinamide\r\nChlorhydrate de pyridoxine\r\nVitanine B2\r\nVitamine B1",
    "drug_strength": "400UNIT\r\n2300UNIT\r\n80MG\r\n1MCG\r\n140MCG\r\n20MCG\r\n0.2MG\r\n7UNIT\r\n5MG\r\n17MG\r\n1MG\r\n1.4MG\r\n1.2MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "SINGLE DOSE 10LIVI",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172560,
    "drug": {
      "current_status": "MARKETED",
      "id": 4786,
      "drug_code": 259,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 26,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 7277,
        "mfr_code": "NVR07",
        "name": "NOVARTIS PHARMACEUTICALS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "700 RUE SAINT-HUBERT",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H2Y 0C1",
        "post_office_box": "",
        "contact_information": "customer.relations@novartis.com"
      },
      "drug_ingredients": [
        {
          "id": 8250139,
          "ingredient": {
            "id": 106,
            "ingredient_code": 8519,
            "en_name": "POLYMYXIN B SULFATE",
            "fr_name": "Sulfate de polymyxine b"
          },
          "ingredient_supplied_ind": "I",
          "strength": "6000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250138,
          "ingredient": {
            "id": 56,
            "ingredient_code": 8638,
            "en_name": "NEOMYCIN",
            "fr_name": "Néomycine (Sulfate de néomycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8250137,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.1",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "00042676",
      "brand_name": "MAXITROL",
      "brand_name_fr": "",
      "descriptor": "SUSPENSION",
      "pediatric_flag": false,
      "accession_number": "09947",
      "number_of_ais": "3",
      "ai_group_no": "0305643001"
    },
    "created_date": "2022-10-25T19:30:39-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00042676",
    "company_name": "NOVARTIS PHARMACEUTICALS CANADA INC",
    "atc_number": "S01CA",
    "atc_description": "ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMB",
    "anticipated_start_date": "2022-11-09T00:00:00-05:00",
    "estimated_end_date": "2022-12-02T00:00:00-05:00",
    "actual_end_date": "2023-01-13T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-25T20:59:43-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MAXITROL",
    "en_drug_common_name": "MAXITROL SUSPENSION",
    "fr_drug_brand_name": "MAXITROL",
    "fr_drug_common_name": "MAXITROL SUSPENSION",
    "en_ingredients": "POLYMYXIN B SULFATE\r\nNEOMYCIN\r\nDEXAMETHASONE",
    "fr_ingredients": "Sulfate de polymyxine b\r\nNéomycine\r\nDexaméthasone",
    "drug_strength": "6000UNIT\r\n3.5MG\r\n0.1%",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "5ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172563,
    "drug": {
      "current_status": "MARKETED",
      "id": 10560,
      "drug_code": 66036,
      "updated_date": "2025-12-03T00:30:45-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8254008,
          "ingredient": {
            "id": 2674,
            "ingredient_code": 1400,
            "en_name": "AMIODARONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'amiodarone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02242325",
      "brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0118593002"
    },
    "created_date": "2022-10-25T19:42:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02242325",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C01BD",
    "atc_description": "ANTIARRHYTHMICS, CLASS I AND III",
    "estimated_end_date": "2022-12-23T00:00:00-05:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2022-12-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-03-29T18:02:20-04:00",
    "status": "resolved",
    "en_drug_brand_name": "AMIODARONE HYDROCHLORIDE FOR INJECTION",
    "en_drug_common_name": "AMIODARONE HYDROCHLORIDE",
    "fr_drug_brand_name": "SANDOZ AMIODARONE HYDROCHLORIDE",
    "fr_drug_common_name": "AMIODARONE HYDROCHLORIDE",
    "en_ingredients": "AMIODARONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'amiodarone",
    "drug_strength": "50MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "9ML",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172587,
    "drug": {
      "current_status": "MARKETED",
      "id": 16070,
      "drug_code": 76872,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 318,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 4174,
        "mfr_code": "FEI08",
        "name": "FERRING INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "500",
        "street_name": "200 YORKLAND BLVD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2J 5C1",
        "post_office_box": "",
        "contact_information": "1-800-263-4057"
      },
      "drug_ingredients": [
        {
          "id": 8255737,
          "ingredient": {
            "id": 3062,
            "ingredient_code": 7369,
            "en_name": "MENOTROPINS",
            "fr_name": "Ménotropines"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02283093",
      "brand_name": "MENOPUR",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0149345001"
    },
    "created_date": "2022-10-26T14:01:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02283093",
    "company_name": "FERRING INC",
    "atc_number": "G03GA",
    "atc_description": "GONADOTROPHINS AND OTHER OVULATION STIMULANTS",
    "anticipated_start_date": "2022-10-26T00:00:00-04:00",
    "estimated_end_date": "2022-12-21T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2022-12-29T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-30T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MENOPUR",
    "en_drug_common_name": "Menotropins for injection",
    "fr_drug_brand_name": "MENOPUR",
    "fr_drug_common_name": "Menotropins for injection",
    "en_ingredients": "MENOTROPINS",
    "fr_ingredients": "Ménotropines",
    "drug_strength": "75UNIT",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "5 vials Menopur 75 IU",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172596,
    "drug": {
      "current_status": "MARKETED",
      "id": 12542,
      "drug_code": 71256,
      "updated_date": "2025-05-15T02:31:24-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8254608,
          "ingredient": {
            "id": 908,
            "ingredient_code": 2446,
            "en_name": "DEFEROXAMINE MESYLATE",
            "fr_name": "Mésylate de déféroxamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "G",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02247022",
      "brand_name": "DEFEROXAMINE MESYLATE FOR INJECTION",
      "brand_name_fr": "MÉSILATE DE DÉFÉROXAMINE POUR INJECTION",
      "descriptor": "SINGLE-USE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0109208001"
    },
    "created_date": "2022-10-26T15:27:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247022",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "V03AC",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2023-01-03T00:00:00-05:00",
    "actual_end_date": "2022-12-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-05T14:34:05-05:00",
    "status": "avoided_shortage",
    "en_drug_brand_name": "DEFEROXAMINE MESYLATE FOR INJECTION",
    "en_drug_common_name": "DEFEROXAMINE MESYLATE FOR INJECTION",
    "fr_drug_brand_name": "Mésilate de déféroxamine pour injection",
    "fr_drug_common_name": "Mésilate de déféroxamine pour injection",
    "en_ingredients": "DEFEROXAMINE MESYLATE",
    "fr_ingredients": "Mésylate de déféroxamine",
    "drug_strength": "2G",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAPERITONEAL\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntrapéritonéale\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntrapéritonéale\r\nIntramusculaire",
    "drug_package_quantity": "2g vial",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172620,
    "drug": {
      "current_status": "MARKETED",
      "id": 2944,
      "drug_code": 17227,
      "updated_date": "2025-05-15T02:30:57-04:00",
      "company": {
        "id": 54,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 4908,
        "mfr_code": "PFI07",
        "name": "PFIZER CANADA ULC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "17300 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "KIRKLAND",
        "postal_code": "H9J 2M5",
        "post_office_box": "",
        "contact_information": "Customer Service / service à la clientèle : 1-888-999-8750\r\nEmail / courriel: PharmaCustomerServiceDept@pfizer.com"
      },
      "drug_ingredients": [
        {
          "id": 8252194,
          "ingredient": {
            "id": 170,
            "ingredient_code": 9060,
            "en_name": "HEPARIN SODIUM",
            "fr_name": "Héparine sodique"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "01990748",
      "brand_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "79380",
      "number_of_ais": "1",
      "ai_group_no": "0104596011"
    },
    "created_date": "2022-10-26T18:45:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "01990748",
    "company_name": "PFIZER CANADA ULC",
    "atc_number": "B01AB",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-09-06T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-09-07T05:00:03-04:00",
    "status": "resolved",
    "en_drug_brand_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
    "en_drug_common_name": "HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE INJECTION",
    "fr_drug_brand_name": "Heparin Sodium in Sodium Chloride Injection",
    "fr_drug_common_name": "Heparin Sodium in Sodium Chloride Injection",
    "en_ingredients": "HEPARIN SODIUM",
    "fr_ingredients": "Héparine sodique",
    "drug_strength": "2UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "12 x 1L bag",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172625,
    "drug": {
      "current_status": "MARKETED",
      "id": 22898,
      "drug_code": 85428,
      "updated_date": "2025-05-15T02:32:58-04:00",
      "company": {
        "id": 52,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15353,
        "mfr_code": "",
        "name": "ABBVIE CORPORATION",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "8401 TRANS-CANADA HIGHWAY",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-LAURENT",
        "postal_code": "H4S 1Z1",
        "post_office_box": "",
        "contact_information": "Should you require any additional information, please contact our Customer Service Department at 1-888-704-8270."
      },
      "drug_ingredients": [
        {
          "id": 8258291,
          "ingredient": {
            "id": 814,
            "ingredient_code": 1241,
            "en_name": "KETOROLAC TROMETHAMINE",
            "fr_name": "Kétorolac trométhamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.45",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02369362",
      "brand_name": "ACUVAIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0121995006"
    },
    "created_date": "2022-10-26T19:22:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02369362",
    "company_name": "ALLERGAN INC",
    "atc_number": "S01BC",
    "atc_description": "ANTIINFLAMMATORY AGENTS",
    "anticipated_start_date": "2022-10-28T00:00:00-04:00",
    "estimated_end_date": "2023-04-28T00:00:00-04:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-04-28T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-04-29T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACUVAIL",
    "en_drug_common_name": "Acuvail Ketolorac Tromethamine, 0.45%",
    "fr_drug_brand_name": "Acuvail",
    "fr_drug_common_name": "Acuvail Kétorolac trométhamine",
    "en_ingredients": "KETOROLAC TROMETHAMINE",
    "fr_ingredients": "Kétorolac trométhamine",
    "drug_strength": "0.45%",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "30s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172631,
    "drug": {
      "current_status": "CANCELLED POST MARKET",
      "id": 14014,
      "drug_code": 73990,
      "updated_date": "2025-05-15T04:08:51-04:00",
      "company": {
        "id": 30,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 3574,
        "mfr_code": "ALL07",
        "name": "ALLERGAN INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "300",
        "street_name": "1380 RODICK ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MARKHAM",
        "postal_code": "L3R 4G5",
        "post_office_box": "",
        "contact_information": "Company contact information;\r\nTelephone number: 800-668-6424\r\nEmail address: MR-GENERAL_INQUIRY@allergan.com\r\nWebsite address: allergan.ca\r\nPostal address:  500-85 Enterprise Blvd, Markham, Ontario, L6G 0B5"
      },
      "drug_ingredients": [
        {
          "id": 8340115,
          "ingredient": {
            "id": 3142,
            "ingredient_code": 13333,
            "en_name": "OXYBUTYNIN",
            "fr_name": "Oxybutynine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "3.9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "24",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02254735",
      "brand_name": "OXYTROL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150161002"
    },
    "created_date": "2022-10-26T21:23:18-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02254735",
    "company_name": "ALLERGAN INC",
    "atc_number": "G04BD",
    "atc_description": "OTHER UROLOGICALS, INCL ANTISPASMODICS",
    "discontinuation_date": "2022-10-25T00:00:00-04:00",
    "anticipated_discontinuation_date": "2022-10-25T00:00:00-04:00",
    "decision_reversal": false,
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-11-14T15:24:56-05:00",
    "status": "discontinued",
    "en_drug_brand_name": "OXYTROL",
    "en_drug_common_name": "OXYBUTYNIN TRANSDERMAL SYSTEM",
    "fr_drug_brand_name": "Oxytrol",
    "fr_drug_common_name": "OXYTROL(système transdermique d’oxybutynine)",
    "en_ingredients": "OXYBUTYNIN",
    "fr_ingredients": "Oxybutynine",
    "drug_strength": "3.9MG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "8s",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172683,
    "drug": {
      "current_status": "MARKETED",
      "id": 930,
      "drug_code": 12208,
      "updated_date": "2025-05-15T02:30:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8251600,
          "ingredient": {
            "id": 290,
            "ingredient_code": 7600,
            "en_name": "DEXAMETHASONE",
            "fr_name": "Dexaméthasone (Phosphate de dexaméthasone sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "1",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00874582",
      "brand_name": "DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "73251",
      "number_of_ais": "1",
      "ai_group_no": "0106303005"
    },
    "created_date": "2022-10-27T03:52:05-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00874582",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "H02AB",
    "atc_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
    "estimated_end_date": "2023-01-20T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-01-18T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-19T14:48:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP",
    "en_drug_common_name": "DEXAMETHASONE",
    "fr_drug_brand_name": "DEXAMETHASONE SOD PHOSPH INJ 10MG/ML USP",
    "fr_drug_common_name": "DEXAMETHASONE",
    "en_ingredients": "DEXAMETHASONE",
    "fr_ingredients": "Dexaméthasone",
    "drug_strength": "10MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRASYNOVIAL\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRASYNOVIAL\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntrasynoviale\r\nIntramusculaire\r\nIntraveineuse\r\nIntrasynoviale\r\nIntramusculaire",
    "drug_package_quantity": "1ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172686,
    "drug": {
      "current_status": "MARKETED",
      "id": 20680,
      "drug_code": 82440,
      "updated_date": "2025-12-03T00:31:31-05:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8257317,
          "ingredient": {
            "id": 3022,
            "ingredient_code": 13123,
            "en_name": "ROSUVASTATIN",
            "fr_name": "Rosuvastatine (Rosuvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02338750",
      "brand_name": "SANDOZ ROSUVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0148963003"
    },
    "created_date": "2022-10-27T03:54:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02338750",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2023-01-27T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-01-31T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-02-01T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "en_drug_common_name": "ROSUVASTATIN",
    "fr_drug_brand_name": "SANDOZ ROSUVASTATIN",
    "fr_drug_common_name": "ROSUVASTATIN",
    "en_ingredients": "ROSUVASTATIN",
    "fr_ingredients": "ROSUVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172689,
    "drug": {
      "current_status": "MARKETED",
      "id": 25436,
      "drug_code": 87878,
      "updated_date": "2025-05-15T02:33:40-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8259219,
          "ingredient": {
            "id": 2730,
            "ingredient_code": 11907,
            "en_name": "TELMISARTAN",
            "fr_name": "Telmisartan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "80",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259218,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02393565",
      "brand_name": "SANDOZ TELMISARTAN HCT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244783002"
    },
    "created_date": "2022-10-27T03:56:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02393565",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2022-11-25T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2022-11-23T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-28T14:28:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ TELMISARTAN HCT",
    "en_drug_common_name": "TELMISARTAN HCT",
    "fr_drug_brand_name": "SANDOZ TELMISARTAN HCT",
    "fr_drug_common_name": "TELMISARTAN HCT",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nTELMISARTAN",
    "fr_ingredients": "Hydrochlorothiazide\r\nTelmisartan",
    "drug_strength": "25MG\r\n80MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100FCT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172692,
    "drug": {
      "current_status": "MARKETED",
      "id": 10114,
      "drug_code": 64815,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8253842,
          "ingredient": {
            "id": 292,
            "ingredient_code": 8565,
            "en_name": "TOBRAMYCIN",
            "fr_name": "Tobramycine (Sulfate de tobramycine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": true
        }
      ],
      "din": "02241209",
      "brand_name": "TOBRAMYCIN INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0110230002"
    },
    "created_date": "2022-10-27T03:57:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241209",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "J01GB",
    "atc_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
    "estimated_end_date": "2023-01-27T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-01-25T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-27T16:38:48-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TOBRAMYCIN INJECTION USP",
    "en_drug_common_name": "TOBRAMYCIN",
    "fr_drug_brand_name": "SANDOZ TOBRAMYCIN INJECTION USP",
    "fr_drug_common_name": "TOBRAMYCIN INJECTION USP",
    "en_ingredients": "TOBRAMYCIN",
    "fr_ingredients": "Tobramycine",
    "drug_strength": "10MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "INTRAVENOUS\r\nINTRAMUSCULAR\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intraveineuse\r\nIntramusculaire\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "2ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172695,
    "drug": {
      "current_status": "MARKETED",
      "id": 22412,
      "drug_code": 84797,
      "updated_date": "2025-05-15T02:32:52-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8258041,
          "ingredient": {
            "id": 2614,
            "ingredient_code": 11793,
            "en_name": "ZOLMITRIPTAN",
            "fr_name": "Zolmitriptan"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02362996",
      "brand_name": "SANDOZ ZOLMITRIPTAN ODT",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0134381001"
    },
    "created_date": "2022-10-27T03:58:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02362996",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-12-02T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2022-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-29T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ ZOLMITRIPTAN ODT",
    "en_drug_common_name": "ZOLMITRIPTAN ODT",
    "fr_drug_brand_name": "SANDOZ ZOLMITRIPTAN ODT",
    "fr_drug_common_name": "ZOLMITRIPTAN ODT",
    "en_ingredients": "ZOLMITRIPTAN",
    "fr_ingredients": "Zolmitriptan",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET (ORALLY DISINTEGRATING)",
    "drug_dosage_form_fr": "Comprimé (à désintégration orale)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "2ODT",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172698,
    "drug": {
      "current_status": "MARKETED",
      "id": 6798,
      "drug_code": 4432,
      "updated_date": "2025-05-15T02:30:31-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8250634,
          "ingredient": {
            "id": 644,
            "ingredient_code": 781,
            "en_name": "VITAMIN B12",
            "fr_name": "Vitamine B12"
          },
          "ingredient_supplied_ind": "I",
          "strength": "1000",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00521515",
      "brand_name": "VITAMIN B12",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "57597",
      "number_of_ais": "1",
      "ai_group_no": "0108437002"
    },
    "created_date": "2022-10-27T03:59:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00521515",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "B03BA",
    "atc_description": "VITAMIN B12 AND FOLIC ACID",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2022-11-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-16T16:23:08-05:00",
    "status": "resolved",
    "en_drug_brand_name": "VITAMIN B12",
    "en_drug_common_name": "VITAMIN B12",
    "fr_drug_brand_name": "VITAMIN B12",
    "fr_drug_common_name": "VITAMIN B12",
    "en_ingredients": "VITAMIN B12",
    "fr_ingredients": "Vitamine B12",
    "drug_strength": "1000MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntramusculaire\r\nSous-cutanée\r\nIntramusculaire",
    "drug_package_quantity": "10ML",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172701,
    "drug": {
      "current_status": "MARKETED",
      "id": 19910,
      "drug_code": 81230,
      "updated_date": "2025-05-15T02:32:25-04:00",
      "company": {
        "id": 10,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 12027,
        "mfr_code": "",
        "name": "SANDOZ CANADA INCORPORATED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "4600 RUE ARMAND-FRAPPIER",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT-HUBERT",
        "postal_code": "J3Z 1G5",
        "post_office_box": "",
        "contact_information": "1 800-361-3062"
      },
      "drug_ingredients": [
        {
          "id": 8256959,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "16",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02326973",
      "brand_name": "SANDOZ CANDESARTAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0135220003"
    },
    "created_date": "2022-10-27T04:10:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02326973",
    "company_name": "SANDOZ CANADA INCORPORATED",
    "atc_number": "C09CA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, PLAIN",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-28T19:09:34-05:00",
    "status": "resolved",
    "en_drug_brand_name": "SANDOZ CANDESARTAN",
    "en_drug_common_name": "CANDESARTAN",
    "fr_drug_brand_name": "SANDOZ CANDESARTAN",
    "fr_drug_common_name": "CANDESARTAN",
    "en_ingredients": "CANDESARTAN CILEXETIL",
    "fr_ingredients": "Candésartan cilexétil",
    "drug_strength": "16MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500TAB",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172715,
    "drug": {
      "current_status": "MARKETED",
      "id": 101186,
      "drug_code": 99197,
      "updated_date": "2023-06-19T22:04:45-04:00",
      "company": {
        "id": 17271,
        "created_date": "2023-06-19T22:00:15-04:00",
        "updated_date": "2025-05-15T02:30:24-04:00",
        "company_code": 18848,
        "mfr_code": "",
        "name": "BIOSIMILAR COLLABORATIONS IRELAND LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "UNIT 35/36",
        "street_name": "GRANGE PARADE, BALDOYLE INDUSTRIAL ESTATE, DUBLIN 13",
        "province": "--",
        "country": "IRELAND",
        "city": "DUBLIN",
        "postal_code": "D13R20R",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8265420,
          "ingredient": {
            "id": 3168,
            "ingredient_code": 13356,
            "en_name": "ADALIMUMAB",
            "fr_name": "Adalimumab"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "0.8",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02502399",
      "brand_name": "HULIO",
      "brand_name_fr": "",
      "descriptor": "SINGLE- DOSE PREFILLED SYRINGES",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150364003"
    },
    "created_date": "2022-10-27T11:28:32-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02502399",
    "company_name": "BGP PHARMA ULC",
    "atc_number": "L04AB",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-11-09T00:00:00-05:00",
    "actual_start_date": "2022-10-24T00:00:00-04:00",
    "actual_end_date": "2022-11-09T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-18T14:16:41-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HULIO",
    "en_drug_common_name": "ADALIMUMAB",
    "fr_drug_brand_name": "HULIO",
    "fr_drug_common_name": "ADALIMUMAB",
    "en_ingredients": "ADALIMUMAB",
    "fr_ingredients": "Adalimumab",
    "drug_strength": "40MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2 x 0.8mL sterile solution (50mg/mL) subcutaneous injection (pre-filled syringe)",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172732,
    "drug": {
      "current_status": "MARKETED",
      "id": 10200,
      "drug_code": 65111,
      "updated_date": "2025-05-15T02:31:08-04:00",
      "company": {
        "id": 316,
        "created_date": "2017-03-09T13:22:40-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4328,
        "mfr_code": "HLR07",
        "name": "HOFFMANN-LA ROCHE LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "7070 MISSISSAUGA ROAD",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5N 5M8",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253866,
          "ingredient": {
            "id": 2766,
            "ingredient_code": 11956,
            "en_name": "OSELTAMIVIR",
            "fr_name": "Oséltamivir (Phosphate d'oseltamivir)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02241472",
      "brand_name": "TAMIFLU",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0139501001"
    },
    "created_date": "2022-10-27T18:37:35-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02241472",
    "company_name": "HOFFMANN-LA ROCHE LIMITED",
    "atc_number": "J05AH",
    "atc_description": "DIRECT ACTING ANTIVIRALS",
    "estimated_end_date": "2022-12-16T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T06:00:03-05:00",
    "status": "resolved",
    "en_comments": "Please note Tamiflu 30mg and Tamiflu 45mg are currently available for order with no supply disruptions.",
    "fr_comments": "Veuillez noter que le Tamiflu 30 mg et le Tamiflu 45 mg sont actuellement disponibles à la commande sans rupture d'approvisionnement.",
    "en_drug_brand_name": "TAMIFLU",
    "en_drug_common_name": "TAMIFLU",
    "fr_drug_brand_name": "TAMIFLU",
    "fr_drug_common_name": "TAMIFLU",
    "en_ingredients": "OSELTAMIVIR",
    "fr_ingredients": "OSELTAMIVIR",
    "drug_strength": "75MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "75MG 10 X 1 BLISTER",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172753,
    "drug": {
      "current_status": "MARKETED",
      "id": 9718,
      "drug_code": 63627,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 16952,
        "created_date": "2020-09-03T01:00:04-04:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 17643,
        "mfr_code": "",
        "name": "ELVIUM LIFE SCIENCES",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253737,
          "ingredient": {
            "id": 1624,
            "ingredient_code": 11213,
            "en_name": "DORZOLAMIDE",
            "fr_name": "Dorzolamide (Chlorhydrate de dorzolamide)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        },
        {
          "id": 8253736,
          "ingredient": {
            "id": 1476,
            "ingredient_code": 11163,
            "en_name": "TIMOLOL",
            "fr_name": "Timolol (Maléate de timolol)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02240113",
      "brand_name": "COSOPT",
      "brand_name_fr": "",
      "descriptor": "WITH PRESERVATIVE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0237301001"
    },
    "created_date": "2022-10-27T18:52:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240113",
    "company_name": "ELVIUM LIFE SCIENCES",
    "atc_number": "S01ED",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-10-27T00:00:00-04:00",
    "estimated_end_date": "2022-11-04T00:00:00-04:00",
    "actual_start_date": "2022-10-27T00:00:00-04:00",
    "actual_end_date": "2022-11-04T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-07T18:23:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "COSOPT",
    "en_drug_common_name": "Dorzolamide and Timolol Ophthalmic Solution",
    "fr_drug_brand_name": "Cosopt",
    "fr_drug_common_name": "Collyre de dorzolamide et de timolol",
    "en_ingredients": "DORZOLAMIDE\r\nTIMOLOL",
    "fr_ingredients": "Collyre de chlorhydrate de dorzolamide à 20 mg/mL et de maléate de timolol à 5 mg/mL,",
    "drug_strength": "20MG\r\n5MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "10ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172766,
    "drug": {
      "current_status": "MARKETED",
      "id": 22068,
      "drug_code": 84452,
      "updated_date": "2025-05-15T02:32:51-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8257903,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "4.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02359502",
      "brand_name": "HYDROMORPH CONTIN",
      "brand_name_fr": "",
      "descriptor": "CONTROLLED RELEASE CAPSULE",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0108698018"
    },
    "created_date": "2022-10-27T19:44:16-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02359502",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-10-27T00:00:00-04:00",
    "estimated_end_date": "2022-11-18T00:00:00-05:00",
    "actual_start_date": "2022-10-27T00:00:00-04:00",
    "actual_end_date": "2022-11-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-17T18:28:23-05:00",
    "status": "resolved",
    "en_drug_brand_name": "HYDROMORPH CONTIN",
    "en_drug_common_name": "Hydromorph Contin",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "Capsules de chlorhydrate d’HYDROmorphone* à libération contrôlée",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "4.5MG",
    "drug_dosage_form": "CAPSULE (SUSTAINED-RELEASE)",
    "drug_dosage_form_fr": "Capsule (à action soutenue)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172769,
    "drug": {
      "current_status": "MARKETED",
      "id": 32008,
      "drug_code": 9509,
      "updated_date": "2025-05-15T02:30:44-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251174,
          "ingredient": {
            "id": 74,
            "ingredient_code": 20280,
            "en_name": "HYDROMORPHONE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydromorphone"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00786543",
      "brand_name": "DILAUDID",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "68694",
      "number_of_ais": "1",
      "ai_group_no": "0108698005"
    },
    "created_date": "2022-10-27T19:47:03-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00786543",
    "company_name": "PURDUE PHARMA",
    "atc_number": "N02AA",
    "atc_description": "OPIOIDS",
    "anticipated_start_date": "2022-10-27T00:00:00-04:00",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-27T00:00:00-04:00",
    "actual_end_date": "2022-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "DILAUDID",
    "en_drug_common_name": "HYDROmorphone hydrochloride",
    "fr_drug_brand_name": "HYDROMORPH CONTIN",
    "fr_drug_common_name": "chlorhydrate d’HYDROmorphone",
    "en_ingredients": "HYDROMORPHONE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydromorphone",
    "drug_strength": "8MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172772,
    "drug": {
      "current_status": "MARKETED",
      "id": 7246,
      "drug_code": 49057,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 32,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 7054,
        "mfr_code": "PFR08",
        "name": "PURDUE PHARMA",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "310",
        "street_name": "3381 STEELES AVENUE EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2H 3S7",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253255,
          "ingredient": {
            "id": 1516,
            "ingredient_code": 6750,
            "en_name": "CODEINE",
            "fr_name": "Codéine (Phosphate de codéine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02230302",
      "brand_name": "CODEINE CONTIN 50MG CONTROLLED RELEASE TAB",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153086003"
    },
    "created_date": "2022-10-27T19:50:22-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230302",
    "company_name": "PURDUE PHARMA",
    "atc_number": "R05DA",
    "atc_description": "COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS",
    "anticipated_start_date": "2022-10-27T00:00:00-04:00",
    "estimated_end_date": "2023-01-13T00:00:00-05:00",
    "actual_start_date": "2022-10-27T00:00:00-04:00",
    "actual_end_date": "2023-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-12T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "CODEINE CONTIN 50MG CONTROLLED RELEASE TAB",
    "en_drug_common_name": "Codeine Controlled Release Tablets",
    "fr_drug_brand_name": "CODEINE CONTIN",
    "fr_drug_common_name": "Comprimés de codéine à libération contrôlée",
    "en_ingredients": "CODEINE",
    "fr_ingredients": "Codéine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "60",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172777,
    "drug": {
      "current_status": "MARKETED",
      "id": 101432,
      "drug_code": 99940,
      "updated_date": "2021-06-08T05:12:50-04:00",
      "company": {
        "id": 204,
        "created_date": "2017-03-09T13:22:37-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 10774,
        "mfr_code": "",
        "name": "BAYER INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2920 MATHESON BLVD EAST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L4W 5R6",
        "post_office_box": "",
        "contact_information": "1-800-265-7382"
      },
      "drug_ingredients": [
        {
          "id": 8265928,
          "ingredient": {
            "id": 3482,
            "ingredient_code": 20387,
            "en_name": "RIVAROXABAN",
            "fr_name": "Rivaroxaban"
          },
          "ingredient_supplied_ind": "I",
          "strength": "51.7",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "BOTTLE",
          "base": false
        }
      ],
      "din": "02510162",
      "brand_name": "XARELTO",
      "brand_name_fr": "",
      "descriptor": "1MG/ML WHEN RECONSTITUTED",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152487007"
    },
    "created_date": "2022-10-27T20:53:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02510162",
    "company_name": "BAYER INC",
    "atc_number": "B01AF",
    "atc_description": "ANTITHROMBOTIC AGENTS",
    "estimated_end_date": "2022-11-25T00:00:00-05:00",
    "actual_start_date": "2022-10-31T00:00:00-04:00",
    "actual_end_date": "2022-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-11-23T13:02:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "XARELTO",
    "en_drug_common_name": "Rivaroxaban",
    "fr_drug_brand_name": "XARELTO",
    "fr_drug_common_name": "Rivaroxaban",
    "en_ingredients": "RIVAROXABAN",
    "fr_ingredients": "Rivaroxaban",
    "drug_strength": "51.7MG",
    "drug_dosage_form": "GRANULES FOR SUSPENSION",
    "drug_dosage_form_fr": "Granules pour suspension",
    "drug_route": "ORAL",
    "drug_route_fr": "Orale",
    "drug_package_quantity": "100 mL",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172797,
    "drug": {
      "current_status": "MARKETED",
      "id": 7292,
      "drug_code": 49288,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 164,
        "created_date": "2017-03-09T13:22:36-05:00",
        "updated_date": "2025-05-15T02:30:17-04:00",
        "company_code": 9985,
        "mfr_code": "",
        "name": "GLAXOSMITHKLINE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "800",
        "street_name": "100 MILVERTON DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "MISSISSAUGA",
        "postal_code": "L5R 4H1",
        "post_office_box": "",
        "contact_information": "1-800-387-7374"
      },
      "drug_ingredients": [
        {
          "id": 8253267,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ACT",
          "base": false
        }
      ],
      "din": "02230418",
      "brand_name": "IMITREX",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238003"
    },
    "created_date": "2022-10-28T14:34:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230418",
    "company_name": "GLAXOSMITHKLINE INC",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2023-01-13T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-01-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-01-12T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "IMITREX",
    "en_drug_common_name": "Sumatriptan nasal spray",
    "fr_drug_brand_name": "IMITREX",
    "fr_drug_common_name": "Sumatriptan nasal spray",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "Sumatriptan",
    "drug_strength": "5MG",
    "drug_dosage_form": "SPRAY",
    "drug_dosage_form_fr": "Pulvérisation",
    "drug_route": "NASAL\r\nNASAL",
    "drug_route_fr": "Nasale\r\nNasale",
    "drug_package_quantity": "2s",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172804,
    "drug": {
      "current_status": "MARKETED",
      "id": 3530,
      "drug_code": 18860,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252392,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148447",
      "brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81140",
      "number_of_ais": "1",
      "ai_group_no": "0100662002"
    },
    "created_date": "2022-10-28T15:01:48-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148447",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "S01FB",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-10-24T00:00:00-04:00",
    "actual_end_date": "2022-12-15T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-12-19T20:04:21-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "2.5%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172807,
    "drug": {
      "current_status": "MARKETED",
      "id": 3476,
      "drug_code": 18759,
      "updated_date": "2025-12-03T00:30:33-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252376,
          "ingredient": {
            "id": 78,
            "ingredient_code": 10258,
            "en_name": "PHENYLEPHRINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de phényléphrine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "W/V",
          "base": false
        }
      ],
      "din": "02148455",
      "brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
      "brand_name_fr": "MINIMS CHLORHYDRATE DE PHÉNYLÉPHRINE",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "81033",
      "number_of_ais": "1",
      "ai_group_no": "0100662005"
    },
    "created_date": "2022-10-28T15:14:10-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02148455",
    "company_name": "BAUSCH HEALTH, CANADA INC.",
    "atc_number": "S01FB",
    "atc_description": "MYDRIATICSAND CYCLOPLEGICS",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-12-21T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_brand_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "fr_drug_common_name": "MINIMS PHENYLEPHRINE HYDROCHLORIDE",
    "en_ingredients": "PHENYLEPHRINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de phényléphrine",
    "drug_strength": "10%",
    "drug_dosage_form": "DROPS",
    "drug_dosage_form_fr": "Gouttes",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172816,
    "drug": {
      "current_status": "MARKETED",
      "id": 5110,
      "drug_code": 31096,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 412,
        "created_date": "2017-03-09T13:22:45-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 5661,
        "mfr_code": "BSH95",
        "name": "BAUSCH & LOMB INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "1400 N GOODMAN STREET",
        "province": "NEW YORK",
        "country": "UNITED STATES",
        "city": "ROCHESTER",
        "postal_code": "14609",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252785,
          "ingredient": {
            "id": 1900,
            "ingredient_code": 4957,
            "en_name": "ACETYLCHOLINE CHLORIDE",
            "fr_name": "Chlorure d'acétylcholine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02133326",
      "brand_name": "MIOCHOL-E",
      "brand_name_fr": "",
      "descriptor": "WITH DILUENT",
      "pediatric_flag": false,
      "accession_number": "F8164",
      "number_of_ais": "1",
      "ai_group_no": "0108463001"
    },
    "created_date": "2022-10-28T15:29:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02133326",
    "company_name": "BAUSCH & LOMB INC",
    "atc_number": "S01EB",
    "atc_description": "ANTIGLAUCOMA PREPARATIONS AND MIOTICS",
    "anticipated_start_date": "2022-10-31T00:00:00-04:00",
    "estimated_end_date": "2023-04-29T00:00:00-04:00",
    "actual_end_date": "2023-05-03T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-05-17T13:05:45-04:00",
    "status": "resolved",
    "en_drug_brand_name": "MIOCHOL-E",
    "en_drug_common_name": "MIOCHOL-E",
    "fr_drug_brand_name": "MIOCHOL-E",
    "fr_drug_common_name": "MIOCHOL-E",
    "en_ingredients": "ACETYLCHOLINE CHLORIDE",
    "fr_ingredients": "Chlorure d'acétylcholine",
    "drug_strength": "20MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "OPHTHALMIC\r\nOPHTHALMIC",
    "drug_route_fr": "Ophtalmique\r\nOphtalmique",
    "drug_package_quantity": "n/a",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172827,
    "drug": {
      "current_status": "DORMANT",
      "id": 20794,
      "drug_code": 82613,
      "updated_date": "2025-12-03T02:32:26-05:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8368405,
          "ingredient": {
            "id": 584,
            "ingredient_code": 11161,
            "en_name": "QUINAPRIL",
            "fr_name": "Quinapril (Chlorhydrate de quinapril)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02340550",
      "brand_name": "PMS-QUINAPRIL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123206001"
    },
    "created_date": "2022-10-28T16:36:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02340550",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "C09AA",
    "atc_description": "ACE INHIBITORS, PLAIN",
    "estimated_end_date": "2023-05-26T00:00:00-04:00",
    "actual_start_date": "2022-11-25T00:00:00-05:00",
    "actual_end_date": "2023-05-16T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-05-17T12:33:29-04:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-QUINAPRIL",
    "en_drug_common_name": "QUINAPRIL",
    "fr_drug_brand_name": "pms-QUINAPRIL",
    "fr_drug_common_name": "QUINAPRIL",
    "en_ingredients": "QUINAPRIL",
    "fr_ingredients": "QUINAPRIL",
    "drug_strength": "5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172840,
    "drug": {
      "current_status": "DORMANT",
      "id": 4576,
      "drug_code": 229,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365773,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038229",
      "brand_name": "STERILE WATER FOR IRRIGATION USP",
      "brand_name_fr": "EAU STÉRILE POUR IRRIGATION USP",
      "descriptor": "SINGLE-USE",
      "pediatric_flag": false,
      "accession_number": "08242",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2022-10-28T18:50:53-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038229",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2023-04-24T00:00:00-04:00",
    "actual_start_date": "2023-04-24T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T16:18:56-05:00",
    "status": "active_confirmed",
    "en_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "fr_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION USP",
    "en_drug_common_name": "Sterile Water for Irrigation USP",
    "fr_drug_brand_name": "Eau Stérile pour Irrigation USP",
    "fr_drug_common_name": "Eau Stérile pour Irrigation USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "TOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL\r\nTOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL",
    "drug_route_fr": "Topique\r\nIrrigation\r\nIntrapéritonéale\r\nTopique\r\nIrrigation\r\nIntrapéritonéale",
    "drug_package_quantity": "500 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172843,
    "drug": {
      "current_status": "DORMANT",
      "id": 4576,
      "drug_code": 229,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365773,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038229",
      "brand_name": "STERILE WATER FOR IRRIGATION USP",
      "brand_name_fr": "EAU STÉRILE POUR IRRIGATION USP",
      "descriptor": "SINGLE-USE",
      "pediatric_flag": false,
      "accession_number": "08242",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2022-10-28T18:54:08-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038229",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2023-06-26T00:00:00-04:00",
    "actual_start_date": "2023-06-26T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T16:21:14-05:00",
    "status": "active_confirmed",
    "en_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "fr_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION USP",
    "en_drug_common_name": "Sterile Water for Irrigation USP",
    "fr_drug_brand_name": "Eau Stérile pour Irrigation USP",
    "fr_drug_common_name": "Eau Stérile pour Irrigation USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "TOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL\r\nTOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL",
    "drug_route_fr": "Topique\r\nIrrigation\r\nIntrapéritonéale\r\nTopique\r\nIrrigation\r\nIntrapéritonéale",
    "drug_package_quantity": "250 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172846,
    "drug": {
      "current_status": "MARKETED",
      "id": 4572,
      "drug_code": 228,
      "updated_date": "2025-05-15T02:30:26-04:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250134,
          "ingredient": {
            "id": 16,
            "ingredient_code": 55,
            "en_name": "SODIUM CHLORIDE",
            "fr_name": "Chlorure de sodium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00037834",
      "brand_name": "SODIUM CHLORIDE IRRIGATION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "08228",
      "number_of_ais": "1",
      "ai_group_no": "0100053002"
    },
    "created_date": "2022-10-28T18:56:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00037834",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "B05CB",
    "atc_description": "IRRIGATING SOLUTIONS",
    "anticipated_start_date": "2023-07-01T00:00:00-04:00",
    "actual_start_date": "2023-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T16:14:56-05:00",
    "status": "active_confirmed",
    "en_comments": "0.9% Sodium Chloride Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "fr_comments": "0.9% Sodium Chloride Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "en_drug_brand_name": "SODIUM CHLORIDE IRRIGATION USP",
    "en_drug_common_name": "Sodium Chloride Irrigation USP",
    "fr_drug_brand_name": "Chlorure de sodium à irrigation USP",
    "fr_drug_common_name": "Chlorure de sodium à irrigation USP",
    "en_ingredients": "SODIUM CHLORIDE",
    "fr_ingredients": "Chlorure de sodium",
    "drug_strength": "9MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "TOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL\r\nTOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL",
    "drug_route_fr": "Topique\r\nIrrigation\r\nIntrapéritonéale\r\nTopique\r\nIrrigation\r\nIntrapéritonéale",
    "drug_package_quantity": "1500 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172849,
    "drug": {
      "current_status": "DORMANT",
      "id": 4576,
      "drug_code": 229,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365773,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038229",
      "brand_name": "STERILE WATER FOR IRRIGATION USP",
      "brand_name_fr": "EAU STÉRILE POUR IRRIGATION USP",
      "descriptor": "SINGLE-USE",
      "pediatric_flag": false,
      "accession_number": "08242",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2022-10-28T18:57:49-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038229",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2023-02-06T00:00:00-05:00",
    "actual_start_date": "2023-02-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T16:23:29-05:00",
    "status": "active_confirmed",
    "en_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "fr_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION USP",
    "en_drug_common_name": "Sterile Water for Irrigation USP",
    "fr_drug_brand_name": "Eau Stérile pour Irrigation USP",
    "fr_drug_common_name": "Eau Stérile pour Irrigation USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "TOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL\r\nTOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL",
    "drug_route_fr": "Topique\r\nIrrigation\r\nIntrapéritonéale\r\nTopique\r\nIrrigation\r\nIntrapéritonéale",
    "drug_package_quantity": "1000 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172852,
    "drug": {
      "current_status": "DORMANT",
      "id": 4576,
      "drug_code": 229,
      "updated_date": "2025-12-03T02:32:11-05:00",
      "company": {
        "id": 5980,
        "created_date": "2017-11-10T19:30:11-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 17241,
        "mfr_code": "",
        "name": "ICU MEDICAL CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2600 BOUL ALFRED-NOBEL, SUITE 100",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "SAINT LAURENT",
        "postal_code": "H4S 0A9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8365773,
          "ingredient": {
            "id": 482,
            "ingredient_code": 8826,
            "en_name": "WATER",
            "fr_name": "Eau"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "%",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00038229",
      "brand_name": "STERILE WATER FOR IRRIGATION USP",
      "brand_name_fr": "EAU STÉRILE POUR IRRIGATION USP",
      "descriptor": "SINGLE-USE",
      "pediatric_flag": false,
      "accession_number": "08242",
      "number_of_ais": "1",
      "ai_group_no": "0105143002"
    },
    "created_date": "2022-10-28T19:00:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00038229",
    "company_name": "ICU MEDICAL CANADA INC",
    "atc_number": "V07AB",
    "atc_description": "ALL OTHER NON-THERAPEUTIC PRODUCTS",
    "anticipated_start_date": "2023-04-17T00:00:00-04:00",
    "actual_start_date": "2023-04-17T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-12-20T16:25:26-05:00",
    "status": "active_confirmed",
    "en_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "fr_comments": "Sterile Water for Irrigation USP sourced by SteriCare Solutions is being offered as an alternative for this product during this supply interruption.",
    "en_drug_brand_name": "STERILE WATER FOR IRRIGATION USP",
    "en_drug_common_name": "Sterile Water for Irrigation USP",
    "fr_drug_brand_name": "Eau Stérile pour Irrigation USP",
    "fr_drug_common_name": "Eau Stérile pour Irrigation USP",
    "en_ingredients": "WATER",
    "fr_ingredients": "Eau",
    "drug_strength": "100%",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "TOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL\r\nTOPICAL\r\nIRRIGATION\r\nINTRAPERITONEAL",
    "drug_route_fr": "Topique\r\nIrrigation\r\nIntrapéritonéale\r\nTopique\r\nIrrigation\r\nIntrapéritonéale",
    "drug_package_quantity": "1500 mL",
    "resolved": false,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": true,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172865,
    "drug": {
      "current_status": "MARKETED",
      "id": 12122,
      "drug_code": 70142,
      "updated_date": "2025-05-15T02:31:19-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8254485,
          "ingredient": {
            "id": 2986,
            "ingredient_code": 12790,
            "en_name": "THYROTROPIN ALFA",
            "fr_name": "Thyrotropine alfa"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.9",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "VIAL",
          "base": false
        }
      ],
      "din": "02246016",
      "brand_name": "THYROGEN",
      "brand_name_fr": "",
      "descriptor": "SINGLE DOSE VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0147561001"
    },
    "created_date": "2022-10-28T19:38:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02246016",
    "company_name": "SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC",
    "atc_number": "V04CJ",
    "atc_description": "OTHER DIAGNOSTIC AGENTS",
    "estimated_end_date": "2023-02-17T00:00:00-05:00",
    "actual_start_date": "2022-10-24T00:00:00-04:00",
    "actual_end_date": "2023-01-27T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-01-28T06:00:04-05:00",
    "status": "resolved",
    "en_comments": "Transition between distribution centers.  Inventory is available at wholesaler level and orders are being carefully managed to avoid shortage at patient level.",
    "fr_comments": "Transfert entre les centres de distribution.  Les stocks sont disponibles au niveau des grossistes et les commandes sont gérées avec soin pour éviter les pénuries au niveau des patients",
    "en_drug_brand_name": "THYROGEN",
    "en_drug_common_name": "THYROGEN",
    "fr_drug_brand_name": "THYROGEN",
    "fr_drug_common_name": "THYROGEN",
    "en_ingredients": "THYROTROPIN ALFA",
    "fr_ingredients": "Thyrotropine alfa",
    "drug_strength": "0.9MG",
    "drug_dosage_form": "POWDER FOR SOLUTION",
    "drug_dosage_form_fr": "Poudre pour solution",
    "drug_route": "INTRAMUSCULAR\r\nINTRAMUSCULAR",
    "drug_route_fr": "Intramusculaire\r\nIntramusculaire",
    "drug_package_quantity": "2",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172882,
    "drug": {
      "current_status": "MARKETED",
      "id": 724,
      "drug_code": 11627,
      "updated_date": "2025-12-03T00:30:30-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8251558,
          "ingredient": {
            "id": 330,
            "ingredient_code": 6436,
            "en_name": "HYDRALAZINE HYDROCHLORIDE",
            "fr_name": "Chlorhydrate d'hydralazine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00441635",
      "brand_name": "APO-HYDRALAZINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "72442",
      "number_of_ais": "1",
      "ai_group_no": "0107444001"
    },
    "created_date": "2022-10-28T19:52:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00441635",
    "company_name": "APOTEX INC",
    "atc_number": "C02DB",
    "atc_description": "ARTERIOLARSMOOTH MUSCLE, AGENTS ACTING ON",
    "estimated_end_date": "2023-01-06T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-01-05T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-06T20:21:57-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-HYDRALAZINE",
    "en_drug_common_name": "HYDRALAZINE",
    "fr_drug_brand_name": "APO-HYDRALAZINE",
    "fr_drug_common_name": "HYDRALAZINE",
    "en_ingredients": "HYDRALAZINE HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate d'hydralazine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET\r\nTABLET",
    "drug_dosage_form_fr": "Comprimé\r\nComprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172901,
    "drug": {
      "current_status": "MARKETED",
      "id": 15962,
      "drug_code": 76745,
      "updated_date": "2025-12-03T00:31:07-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8255700,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02281791",
      "brand_name": "APO-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783001"
    },
    "created_date": "2022-10-28T19:56:11-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02281791",
    "company_name": "APOTEX INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "estimated_end_date": "2022-12-09T00:00:00-05:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-09T15:34:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "APO-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172942,
    "drug": {
      "current_status": "MARKETED",
      "id": 26328,
      "drug_code": 88684,
      "updated_date": "2025-12-03T00:32:13-05:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8259490,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259489,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259488,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.215",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259487,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259486,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.025",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259485,
          "ingredient": {
            "id": 792,
            "ingredient_code": 7492,
            "en_name": "NORGESTIMATE",
            "fr_name": "Norgestimate"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.18",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02401967",
      "brand_name": "TRI-CIRA LO 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "6",
      "ai_group_no": "0636783003"
    },
    "created_date": "2022-10-28T20:05:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02401967",
    "company_name": "APOTEX INC",
    "atc_number": "G03AB",
    "estimated_end_date": "2023-04-21T00:00:00-04:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-04-13T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2023-04-14T16:29:14-04:00",
    "status": "resolved",
    "en_comments": "28 pack format is available",
    "en_drug_brand_name": "TRI-CIRA LO 21",
    "en_drug_common_name": "TRICIRALO",
    "fr_drug_brand_name": "TRI-CIRA LO 21",
    "fr_drug_common_name": "TRICIRALO",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nNORGESTIMATE\r\nETHINYL ESTRADIOL\r\nNORGESTIMATE\r\nETHINYL ESTRADIOL\r\nNORGESTIMATE",
    "fr_ingredients": "Éthinylestradiol\r\nNorgestimate\r\nÉthinylestradiol\r\nNorgestimate\r\nÉthinylestradiol\r\nNorgestimate",
    "drug_strength": "0.025MG\r\n0.25MG\r\n0.025MG\r\n0.215MG\r\n0.025MG\r\n0.18MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "21",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 172960,
    "drug": {
      "current_status": "MARKETED",
      "id": 11906,
      "drug_code": 69723,
      "updated_date": "2025-05-15T02:31:18-04:00",
      "company": {
        "id": 20,
        "created_date": "2017-03-09T13:22:33-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3636,
        "mfr_code": "APX08",
        "name": "APOTEX INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "150 SIGNET DRIVE",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M9L 1T9",
        "post_office_box": "",
        "contact_information": "Apotex Customer Service   - 1-877-427-6839"
      },
      "drug_ingredients": [
        {
          "id": 8254417,
          "ingredient": {
            "id": 1116,
            "ingredient_code": 11247,
            "en_name": "CLAVULANIC ACID",
            "fr_name": "Acide clavulanique (Clavulinate potassique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8254416,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "875",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02245623",
      "brand_name": "APO-AMOXI CLAV",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0234720005"
    },
    "created_date": "2022-10-28T20:11:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02245623",
    "company_name": "APOTEX INC",
    "atc_number": "J01CR",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2022-11-11T00:00:00-05:00",
    "actual_start_date": "2022-10-25T00:00:00-04:00",
    "actual_end_date": "2022-11-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-11T16:41:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APO-AMOXI CLAV",
    "en_drug_common_name": "AMOXI-CLAV",
    "fr_drug_brand_name": "APO-AMOXI-CLAV",
    "fr_drug_common_name": "AMOXI-CLAV",
    "en_ingredients": "CLAVULANIC ACID\r\nAMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "125MG\r\n875MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100 BTL",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173000,
    "drug": {
      "current_status": "MARKETED",
      "id": 9882,
      "drug_code": 64054,
      "updated_date": "2025-05-15T02:31:07-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253776,
          "ingredient": {
            "id": 668,
            "ingredient_code": 11168,
            "en_name": "SERTRALINE",
            "fr_name": "Sertraline (Chlorhydrate de sertraline)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02240484",
      "brand_name": "TEVA-SERTRALINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123417001"
    },
    "created_date": "2022-10-28T20:20:24-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02240484",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-20T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-18T15:47:50-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SERTRALINE",
    "en_drug_common_name": "TEVA-SERTRALINE",
    "fr_drug_brand_name": "TEVA-SERTRALINE",
    "fr_drug_common_name": "TEVA-SERTRALINE",
    "en_ingredients": "SERTRALINE",
    "fr_ingredients": "TEVA-SERTRALINE",
    "drug_strength": "50MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "250",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173004,
    "drug": {
      "current_status": "MARKETED",
      "id": 99782,
      "drug_code": 97663,
      "updated_date": "2020-04-03T06:54:04-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8263951,
          "ingredient": {
            "id": 3140,
            "ingredient_code": 13330,
            "en_name": "TERIPARATIDE",
            "fr_name": "Tériparatide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02486423",
      "brand_name": "TEVA-TERIPARATIDE INJECTION",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0150152001"
    },
    "created_date": "2022-10-28T20:20:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02486423",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "H05AA",
    "atc_description": "PARATHYROID HORMONES AND ANALOGUES",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T16:08:45-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-TERIPARATIDE INJECTION",
    "en_drug_common_name": "TEVA-TERIPARATIDE INJECTION",
    "fr_drug_brand_name": "TEVA-TERIPARATIDE INJECTION",
    "fr_drug_common_name": "TEVA-TERIPARATIDE INJECTION",
    "en_ingredients": "TERIPARATIDE",
    "fr_ingredients": "Tériparatide",
    "drug_strength": "250MCG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée",
    "drug_package_quantity": "2.4",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173007,
    "drug": {
      "current_status": "MARKETED",
      "id": 5830,
      "drug_code": 3945,
      "updated_date": "2025-05-15T02:30:30-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250585,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00342084",
      "brand_name": "TEVA-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "56157",
      "number_of_ais": "1",
      "ai_group_no": "0105911004"
    },
    "created_date": "2022-10-28T20:22:02-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342084",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-09-10T00:00:00-04:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-09-27T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-03T18:07:15-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN",
    "en_drug_common_name": "TEVA-CEPHALEXIN",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN",
    "fr_drug_common_name": "TEVA-CEPHALEXIN",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173010,
    "drug": {
      "current_status": "MARKETED",
      "id": 8552,
      "drug_code": 60109,
      "updated_date": "2025-05-15T02:31:05-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8253450,
          "ingredient": {
            "id": 526,
            "ingredient_code": 10128,
            "en_name": "AZATHIOPRINE",
            "fr_name": "Azathioprine (Azathioprine sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02236819",
      "brand_name": "TEVA-AZATHIOPRINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0101830001"
    },
    "created_date": "2022-10-28T20:22:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02236819",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L04AX",
    "atc_description": "IMMUNOSUPPRESSANTS",
    "estimated_end_date": "2022-12-10T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-08T17:56:16-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AZATHIOPRINE",
    "en_drug_common_name": "TEVA-AZATHIOPRINE",
    "fr_drug_brand_name": "TEVA-AZATHIOPRINE",
    "fr_drug_common_name": "TEVA-AZATHIOPRINE",
    "en_ingredients": "AZATHIOPRINE",
    "fr_ingredients": "Azathioprine",
    "drug_strength": "50MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173013,
    "drug": {
      "current_status": "MARKETED",
      "id": 16064,
      "drug_code": 76859,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255735,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "75",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02282976",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302013"
    },
    "created_date": "2022-10-28T20:23:31-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282976",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "TEVA-FENTANYL",
    "fr_drug_brand_name": "TEVA-FENTANYL",
    "fr_drug_common_name": "TEVA-FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "75MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "20",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173016,
    "drug": {
      "current_status": "MARKETED",
      "id": 16062,
      "drug_code": 76858,
      "updated_date": "2025-12-03T00:31:08-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255734,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "50",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02282968",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302002"
    },
    "created_date": "2022-10-28T20:24:23-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282968",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "TEVA-FENTANYL",
    "fr_drug_brand_name": "TEVA-FENTANYL",
    "fr_drug_common_name": "TEVA-FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "50MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173019,
    "drug": {
      "current_status": "MARKETED",
      "id": 16060,
      "drug_code": 76857,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255733,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02282941",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302014"
    },
    "created_date": "2022-10-28T20:24:58-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282941",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "TEVA-FENTANYL",
    "fr_drug_brand_name": "TEVA-FENTANYL",
    "fr_drug_common_name": "TEVA-FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "25MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173022,
    "drug": {
      "current_status": "MARKETED",
      "id": 18474,
      "drug_code": 79746,
      "updated_date": "2025-05-15T02:32:11-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256466,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02311925",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302015"
    },
    "created_date": "2022-10-28T20:25:28-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02311925",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "TEVA-FENTANYL",
    "fr_drug_brand_name": "TEVA-FENTANYL",
    "fr_drug_common_name": "TEVA-FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "12MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173025,
    "drug": {
      "current_status": "MARKETED",
      "id": 16066,
      "drug_code": 76860,
      "updated_date": "2025-05-15T02:31:46-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255736,
          "ingredient": {
            "id": 670,
            "ingredient_code": 10075,
            "en_name": "FENTANYL",
            "fr_name": "Fentanyl (Citrate de fentanyl)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "MCG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "HOUR",
          "base": false
        }
      ],
      "din": "02282984",
      "brand_name": "TEVA-FENTANYL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123302012"
    },
    "created_date": "2022-10-28T20:26:06-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02282984",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02AB",
    "atc_description": "OPIOIDS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:05-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-FENTANYL",
    "en_drug_common_name": "TEVA-FENTANYL",
    "fr_drug_brand_name": "TEVA-FENTANYL",
    "fr_drug_common_name": "TEVA-FENTANYL",
    "en_ingredients": "FENTANYL",
    "fr_ingredients": "Fentanyl",
    "drug_strength": "100MCG",
    "drug_dosage_form": "PATCH",
    "drug_dosage_form_fr": "Timbre",
    "drug_route": "TRANSDERMAL\r\nTRANSDERMAL",
    "drug_route_fr": "Transdermique\r\nTransdermique",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173028,
    "drug": {
      "current_status": "MARKETED",
      "id": 16426,
      "drug_code": 77227,
      "updated_date": "2025-05-15T02:31:49-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8255859,
          "ingredient": {
            "id": 2132,
            "ingredient_code": 11323,
            "en_name": "SUMATRIPTAN",
            "fr_name": "Sumatriptan (Succinate de sumatriptan)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "25",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02286815",
      "brand_name": "TEVA-SUMATRIPTAN DF",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123238007"
    },
    "created_date": "2022-10-28T20:26:38-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02286815",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "N02CC",
    "atc_description": "ANTIMIGRAINE PREPARATIONS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-12T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-SUMATRIPTAN DF",
    "en_drug_common_name": "TEVA-SUMATRIPTAN DF",
    "fr_drug_brand_name": "TEVA-SUMATRIPTAN DF",
    "fr_drug_common_name": "TEVA-SUMATRIPTAN DF",
    "en_ingredients": "SUMATRIPTAN",
    "fr_ingredients": "TEVA-SUMATRIPTAN DF",
    "drug_strength": "25MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173031,
    "drug": {
      "current_status": "MARKETED",
      "id": 25664,
      "drug_code": 88064,
      "updated_date": "2025-05-15T02:33:42-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8259275,
          "ingredient": {
            "id": 2636,
            "ingredient_code": 11814,
            "en_name": "CANDESARTAN CILEXETIL",
            "fr_name": "Candésartan cilexétil"
          },
          "ingredient_supplied_ind": "I",
          "strength": "32",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8259274,
          "ingredient": {
            "id": 150,
            "ingredient_code": 10234,
            "en_name": "HYDROCHLOROTHIAZIDE",
            "fr_name": "Hydrochlorothiazide"
          },
          "ingredient_supplied_ind": "I",
          "strength": "12.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02395568",
      "brand_name": "TEVA-CANDESARTAN/HCTZ",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0244181002"
    },
    "created_date": "2022-10-28T20:27:13-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02395568",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C09DA",
    "atc_description": "ANGIOTENSIN II ANTAGONISTS, COMBINATIONS",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T16:05:29-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CANDESARTAN/HCTZ",
    "en_drug_common_name": "TEVA-CANDESARTAN/HCTZ",
    "fr_drug_brand_name": "TEVA-CANDESARTAN/HCTZ",
    "fr_drug_common_name": "TEVA-CANDESARTAN/HCTZ",
    "en_ingredients": "HYDROCHLOROTHIAZIDE\r\nCANDESARTAN CILEXETIL",
    "fr_ingredients": "Hydrochlorothiazide\r\nCandésartan cilexétil",
    "drug_strength": "12.5MG\r\n32MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173034,
    "drug": {
      "current_status": "MARKETED",
      "id": 572,
      "drug_code": 1124,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250233,
          "ingredient": {
            "id": 356,
            "ingredient_code": 8450,
            "en_name": "AMPICILLIN",
            "fr_name": "Ampicilline (Ampicilline sodique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "500",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00020885",
      "brand_name": "TEVA-AMPICILLIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "36116",
      "number_of_ais": "1",
      "ai_group_no": "0105872001"
    },
    "created_date": "2022-10-28T20:27:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00020885",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-11-11T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-12T06:00:04-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-AMPICILLIN",
    "en_drug_common_name": "TEVA-AMPICILLIN",
    "fr_drug_brand_name": "TEVA-AMPICILLIN",
    "fr_drug_common_name": "TEVA-AMPICILLIN",
    "en_ingredients": "AMPICILLIN",
    "fr_ingredients": "Ampicilline",
    "drug_strength": "500MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173037,
    "drug": {
      "current_status": "MARKETED",
      "id": 7722,
      "drug_code": 5073,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250705,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "125",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00342106",
      "brand_name": "TEVA-CEPHALEXIN 125",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59604",
      "number_of_ais": "1",
      "ai_group_no": "0105911001"
    },
    "created_date": "2022-10-28T20:28:44-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342106",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-06-10T00:00:00-04:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:46:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN 125",
    "en_drug_common_name": "TEVA-CEPHALEXIN 125",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN 125",
    "fr_drug_common_name": "TEVA-CEPHALEXIN 125",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "125MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "150",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173040,
    "drug": {
      "current_status": "MARKETED",
      "id": 12728,
      "drug_code": 71584,
      "updated_date": "2025-05-15T02:31:25-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8254654,
          "ingredient": {
            "id": 786,
            "ingredient_code": 93,
            "en_name": "CIPROFLOXACIN",
            "fr_name": "Ciprofloxacine (Chlorhydrate de ciprofloxacine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "750",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02247341",
      "brand_name": "ACT CIPROFLOXACIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0123207002"
    },
    "created_date": "2022-10-28T20:29:17-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02247341",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01MA",
    "atc_description": "QUINOLONE ANTIBACTERIALS",
    "estimated_end_date": "2023-05-20T00:00:00-04:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:02-04:00",
    "status": "resolved",
    "en_drug_brand_name": "ACT CIPROFLOXACIN",
    "en_drug_common_name": "ACT CIPROFLOXACIN",
    "fr_drug_brand_name": "ACT CIPROFLOXACIN",
    "fr_drug_common_name": "ACT CIPROFLOXACIN",
    "en_ingredients": "CIPROFLOXACIN",
    "fr_ingredients": "Ciprofloxacine",
    "drug_strength": "750MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "50",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173043,
    "drug": {
      "current_status": "MARKETED",
      "id": 7720,
      "drug_code": 5072,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250704,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "5",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00342092",
      "brand_name": "TEVA-CEPHALEXIN 250",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59603",
      "number_of_ais": "1",
      "ai_group_no": "0105911002"
    },
    "created_date": "2022-10-28T20:29:55-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00342092",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-05-30T00:00:00-04:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2024-02-14T20:46:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN 250",
    "en_drug_common_name": "TEVA-CEPHALEXIN 250",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN 250",
    "fr_drug_common_name": "TEVA-CEPHALEXIN 250",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "POWDER FOR SUSPENSION",
    "drug_dosage_form_fr": "Poudre pour suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100,150ml",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173046,
    "drug": {
      "current_status": "MARKETED",
      "id": 2126,
      "drug_code": 14506,
      "updated_date": "2025-12-03T00:30:32-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251973,
          "ingredient": {
            "id": 498,
            "ingredient_code": 11101,
            "en_name": "AMOXICILLIN",
            "fr_name": "Amoxicilline"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02036355",
      "brand_name": "NOVAMOXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "76140",
      "number_of_ais": "1",
      "ai_group_no": "0131314001"
    },
    "created_date": "2022-10-28T20:30:37-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02036355",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01CA",
    "atc_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
    "estimated_end_date": "2023-07-31T00:00:00-04:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-07-31T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-10-04T19:13:17-04:00",
    "status": "resolved",
    "en_drug_brand_name": "NOVAMOXIN",
    "en_drug_common_name": "NOVAMOXIN",
    "fr_drug_brand_name": "NOVAMOXIN",
    "fr_drug_common_name": "NOVAMOXIN",
    "en_ingredients": "AMOXICILLIN",
    "fr_ingredients": "Amoxicilline",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET (CHEWABLE)",
    "drug_dosage_form_fr": "Comprimé (à mâcher)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173049,
    "drug": {
      "current_status": "MARKETED",
      "id": 7970,
      "drug_code": 5181,
      "updated_date": "2025-05-15T02:30:32-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250710,
          "ingredient": {
            "id": 496,
            "ingredient_code": 8376,
            "en_name": "CEPHALEXIN",
            "fr_name": "Céphalexine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "250",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00583413",
      "brand_name": "TEVA-CEPHALEXIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "59856",
      "number_of_ais": "1",
      "ai_group_no": "0105911004"
    },
    "created_date": "2022-10-28T20:31:09-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00583413",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "J01DB",
    "atc_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
    "estimated_end_date": "2023-05-30T00:00:00-04:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-06-08T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-06-09T05:00:05-04:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-CEPHALEXIN",
    "en_drug_common_name": "TEVA-CEPHALEXIN",
    "fr_drug_brand_name": "TEVA-CEPHALEXIN",
    "fr_drug_common_name": "TEVA-CEPHALEXIN",
    "en_ingredients": "CEPHALEXIN",
    "fr_ingredients": "Céphalexine",
    "drug_strength": "250MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173052,
    "drug": {
      "current_status": "MARKETED",
      "id": 5436,
      "drug_code": 35798,
      "updated_date": "2025-12-03T00:30:35-05:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8252839,
          "ingredient": {
            "id": 136,
            "ingredient_code": 8508,
            "en_name": "NYSTATIN",
            "fr_name": "Nystatine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100000",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02194201",
      "brand_name": "TEVA-NYSTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "H3087",
      "number_of_ais": "1",
      "ai_group_no": "0105858002"
    },
    "created_date": "2022-10-28T20:31:52-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02194201",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "A07AA",
    "atc_description": "INTESTINALANTIINFECTIVES",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-14T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-15T16:02:27-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-NYSTATIN",
    "en_drug_common_name": "TEVA-NYSTATIN",
    "fr_drug_brand_name": "TEVA-NYSTATIN",
    "fr_drug_common_name": "TEVA-NYSTATIN",
    "en_ingredients": "NYSTATIN",
    "fr_ingredients": "Nystatine",
    "drug_strength": "100000UNIT",
    "drug_dosage_form": "SUSPENSION",
    "drug_dosage_form_fr": "Suspension",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173055,
    "drug": {
      "current_status": "MARKETED",
      "id": 13650,
      "drug_code": 7349,
      "updated_date": "2025-05-15T02:30:39-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8251011,
          "ingredient": {
            "id": 1222,
            "ingredient_code": 10127,
            "en_name": "PROPRANOLOL HYDROCHLORIDE",
            "fr_name": "Chlorhydrate de propranolol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "00740675",
      "brand_name": "TEVA-PROPRANOLOL",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "65238",
      "number_of_ais": "1",
      "ai_group_no": "0101831005"
    },
    "created_date": "2022-10-28T20:32:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00740675",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C07AA",
    "atc_description": "BETA BLOCKING AGENTS",
    "estimated_end_date": "2022-12-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-11T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-PROPRANOLOL",
    "en_drug_common_name": "TEVA-PROPRANOLOL",
    "fr_drug_brand_name": "TEVA-PROPRANOLOL",
    "fr_drug_common_name": "TEVA-PROPRANOLOL",
    "en_ingredients": "PROPRANOLOL HYDROCHLORIDE",
    "fr_ingredients": "Chlorhydrate de propanolol",
    "drug_strength": "20MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500,100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173058,
    "drug": {
      "current_status": "MARKETED",
      "id": 66087,
      "drug_code": 95113,
      "updated_date": "2025-05-15T02:35:51-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262461,
          "ingredient": {
            "id": 3624,
            "ingredient_code": 13238,
            "en_name": "EVEROLIMUS",
            "fr_name": "Évérolimus"
          },
          "ingredient_supplied_ind": "I",
          "strength": "2.5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02463229",
      "brand_name": "TEVA-EVEROLIMUS",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0152682003"
    },
    "created_date": "2022-10-28T20:33:26-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02463229",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "L01EG",
    "estimated_end_date": "2022-12-10T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-08T17:58:13-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-EVEROLIMUS",
    "en_drug_common_name": "TEVA-EVEROLIMUS",
    "fr_drug_brand_name": "TEVA-EVEROLIMUS",
    "fr_drug_common_name": "TEVA-EVEROLIMUS",
    "en_ingredients": "EVEROLIMUS",
    "fr_ingredients": "Évérolimus",
    "drug_strength": "2.5MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "30",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173061,
    "drug": {
      "current_status": "MARKETED",
      "id": 18384,
      "drug_code": 79653,
      "updated_date": "2025-05-15T02:32:10-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256441,
          "ingredient": {
            "id": 2368,
            "ingredient_code": 11366,
            "en_name": "ATORVASTATIN",
            "fr_name": "Atorvastatine (Atorvastatine calcique)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "40",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02310910",
      "brand_name": "TEVA-ATORVASTATIN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0133055003"
    },
    "created_date": "2022-10-28T20:34:12-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02310910",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "C10AA",
    "atc_description": "LIPID MODIFYING AGENTS, PLAIN",
    "estimated_end_date": "2023-01-10T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-01-10T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-12T15:53:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "TEVA-ATORVASTATIN",
    "en_drug_common_name": "TEVA-ATORVASTATIN",
    "fr_drug_brand_name": "TEVA-ATORVASTATIN",
    "fr_drug_common_name": "TEVA-ATORVASTATIN",
    "en_ingredients": "ATORVASTATIN",
    "fr_ingredients": "TEVA-ATORVASTATIN",
    "drug_strength": "40MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173064,
    "drug": {
      "current_status": "MARKETED",
      "id": 19004,
      "drug_code": 80272,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256654,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256653,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317206",
      "brand_name": "APRI 28",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2022-10-28T20:34:50-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317206",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APRI 28",
    "en_drug_common_name": "APRI 28",
    "fr_drug_brand_name": "APRI 28",
    "fr_drug_common_name": "APRI 28",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nDESOGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nDésogestrel",
    "drug_strength": "0.03MG\r\n0.15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173067,
    "drug": {
      "current_status": "MARKETED",
      "id": 19002,
      "drug_code": 80270,
      "updated_date": "2025-05-15T02:32:17-04:00",
      "company": {
        "id": 24,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 14318,
        "mfr_code": "",
        "name": "TEVA CANADA LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "30 NOVOPHARM COURT",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M1B 2K9",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256652,
          "ingredient": {
            "id": 1068,
            "ingredient_code": 660,
            "en_name": "DESOGESTREL",
            "fr_name": "Désogestrel"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.15",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8256651,
          "ingredient": {
            "id": 790,
            "ingredient_code": 7426,
            "en_name": "ETHINYL ESTRADIOL",
            "fr_name": "Éthinylestradiol"
          },
          "ingredient_supplied_ind": "I",
          "strength": "0.03",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02317192",
      "brand_name": "APRI 21",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "2",
      "ai_group_no": "0224591001"
    },
    "created_date": "2022-10-28T20:35:25-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02317192",
    "company_name": "TEVA CANADA LIMITED",
    "atc_number": "G03AA",
    "atc_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
    "estimated_end_date": "2022-11-20T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2022-12-01T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-12-02T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "APRI 21",
    "en_drug_common_name": "APRI 21",
    "fr_drug_brand_name": "APRI 21",
    "fr_drug_common_name": "APRI 21",
    "en_ingredients": "ETHINYL ESTRADIOL\r\nDESOGESTREL",
    "fr_ingredients": "Éthinylestradiol\r\nDésogestrel",
    "drug_strength": "0.03MG\r\n0.15MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "6",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173080,
    "drug": {
      "current_status": "MARKETED",
      "id": 2434,
      "drug_code": 15805,
      "updated_date": "2025-05-15T02:30:55-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8252059,
          "ingredient": {
            "id": 80,
            "ingredient_code": 270,
            "en_name": "ACETAMINOPHEN",
            "fr_name": "Acétaminophène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "325",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252058,
          "ingredient": {
            "id": 682,
            "ingredient_code": 10224,
            "en_name": "DOXYLAMINE SUCCINATE",
            "fr_name": "Succinate de doxylamine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "5",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        },
        {
          "id": 8252057,
          "ingredient": {
            "id": 98,
            "ingredient_code": 9131,
            "en_name": "CODEINE PHOSPHATE",
            "fr_name": "Phosphate de codéine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "8",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02047667",
      "brand_name": "MERSYNDOL WITH CODEINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": true,
      "accession_number": "77562",
      "number_of_ais": "3",
      "ai_group_no": "0315447001"
    },
    "created_date": "2022-10-28T21:08:40-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02047667",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "N02BE",
    "atc_description": "OTHER ANALGESICS AND ANTIPYRETICS",
    "estimated_end_date": "2022-11-30T00:00:00-05:00",
    "actual_start_date": "2022-10-24T00:00:00-04:00",
    "actual_end_date": "2022-11-28T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2022-11-30T21:47:13-05:00",
    "status": "resolved",
    "en_comments": "CANADA Office of Controlled Substance License Pending approval",
    "fr_comments": "Licence du Bureau canadien des substances contrôlées En attente d’approbation",
    "en_drug_brand_name": "MERSYNDOL WITH CODEINE",
    "en_drug_common_name": "MERSYNDOL WITH CODEINE",
    "fr_drug_brand_name": "MERSYNDOL WITH CODEINE",
    "fr_drug_common_name": "MERSYNDOL WITH CODEINE",
    "en_ingredients": "DOXYLAMINE SUCCINATE\r\nCODEINE PHOSPHATE\r\nACETAMINOPHEN",
    "fr_ingredients": "Succinate de doxylamine\r\nPhosphate de codéine\r\nAcétaminophène",
    "drug_strength": "5MG\r\n8MG\r\n325MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "Bottle of 100 tablets",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173085,
    "drug": {
      "current_status": "MARKETED",
      "id": 5268,
      "drug_code": 3394,
      "updated_date": "2025-05-15T02:30:29-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8250507,
          "ingredient": {
            "id": 44,
            "ingredient_code": 53,
            "en_name": "POTASSIUM CHLORIDE",
            "fr_name": "Chlorure de potassium"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "mEq",
          "strength_type": "",
          "dosage_value": "10",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00402206",
      "brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
      "brand_name_fr": "CHLORURE DE POTASSIUM POUR INJECTION - CONCENTRÉ",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "54169",
      "number_of_ais": "1",
      "ai_group_no": "0100273003"
    },
    "created_date": "2022-10-28T21:21:45-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00402206",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "B05XA",
    "atc_description": "I.V. SOLUTION ADDITIVES",
    "actual_start_date": "2022-11-17T00:00:00-05:00",
    "actual_end_date": "2022-12-07T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2022-12-08T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "POTASSIUM CHLORIDE FOR INJECTION CONCENTRATE",
    "en_drug_common_name": "Potassium Chloride for Injection Concentrate",
    "fr_drug_brand_name": "Chlorure de potassium pour injection concentré",
    "fr_drug_common_name": "Chlorure de potassium pour injection concentré",
    "en_ingredients": "POTASSIUM CHLORIDE",
    "fr_ingredients": "Chlorure de potassium",
    "drug_strength": "20mEq",
    "drug_dosage_form": "SOLUTION\r\nSOLUTION",
    "drug_dosage_form_fr": "Solution\r\nSolution",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 10mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173088,
    "drug": {
      "current_status": "MARKETED",
      "id": 7436,
      "drug_code": 50032,
      "updated_date": "2025-05-15T02:31:04-04:00",
      "company": {
        "id": 34,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 4852,
        "mfr_code": "OMG07",
        "name": "OMEGA LABORATORIES LIMITED",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "11177 HAMON",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H3M 3E4",
        "post_office_box": "",
        "contact_information": "info@omegalaboratory.com - 1-800-363-0584"
      },
      "drug_ingredients": [
        {
          "id": 8253311,
          "ingredient": {
            "id": 58,
            "ingredient_code": 7160,
            "en_name": "METHYLENE BLUE",
            "fr_name": "Bleu de méthylène"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02230770",
      "brand_name": "METHYLENE BLUE INJECTION USP",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0106816001"
    },
    "created_date": "2022-10-28T21:36:15-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02230770",
    "company_name": "OMEGA LABORATORIES LIMITED",
    "atc_number": "V03AB",
    "atc_description": "ALL OTHER THERAPEUTIC PRODUCTS",
    "estimated_end_date": "2023-02-03T00:00:00-05:00",
    "actual_start_date": "2022-10-28T00:00:00-04:00",
    "actual_end_date": "2023-01-26T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 9,
      "en_reason": "Demand increase for the drug.",
      "fr_reason": "Augmentation de la demande du médicament",
      "active": true
    },
    "updated_date": "2023-01-27T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "METHYLENE BLUE INJECTION USP",
    "en_drug_common_name": "Methylene Blue Injection",
    "fr_drug_brand_name": "Injection De Bleu De Méthylène USP",
    "fr_drug_common_name": "Injection De Bleu De Méthylène",
    "en_ingredients": "METHYLENE BLUE",
    "fr_ingredients": "Bleu de méthylène",
    "drug_strength": "10MG",
    "drug_dosage_form": "LIQUID",
    "drug_dosage_form_fr": "Liquide",
    "drug_route": "INTRAVENOUS\r\nINTRAVENOUS",
    "drug_route_fr": "Intraveineuse\r\nIntraveineuse",
    "drug_package_quantity": "10 x 5 mL vial / fiole",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173153,
    "drug": {
      "current_status": "MARKETED",
      "id": 4722,
      "drug_code": 2483,
      "updated_date": "2025-05-15T02:30:27-04:00",
      "company": {
        "id": 644,
        "created_date": "2017-03-09T13:23:00-05:00",
        "updated_date": "2025-05-15T02:30:14-04:00",
        "company_code": 15112,
        "mfr_code": "",
        "name": "SANOFI CONSUMER HEALTH INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "2905 PLACE LOUIS-R RENAUD",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "LAVAL",
        "postal_code": "H7V 0A3",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8250420,
          "ingredient": {
            "id": 1754,
            "ingredient_code": 9008,
            "en_name": "HYOSCINE BUTYLBROMIDE",
            "fr_name": "Butylbromure d'hyoscine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "20",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "00363839",
      "brand_name": "BUSCOPAN",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "49804",
      "number_of_ais": "1",
      "ai_group_no": "0104703002"
    },
    "created_date": "2022-10-31T15:10:20-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "00363839",
    "company_name": "SANOFI CONSUMER HEALTH INC",
    "atc_number": "A03BB",
    "atc_description": "BELLADONNAAND DERIVATIVES, PLAIN",
    "actual_start_date": "2022-09-23T00:00:00-04:00",
    "actual_end_date": "2022-11-21T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 8,
      "en_reason": "Delay in shipping of the drug.",
      "fr_reason": "Retard dans l’expédition du médicament",
      "active": true
    },
    "updated_date": "2022-11-22T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "BUSCOPAN",
    "en_drug_common_name": "BUSCOPAN AMP.",
    "fr_drug_brand_name": "BUSCOPAN",
    "fr_drug_common_name": "BUSCOPAN AMP.",
    "en_ingredients": "HYOSCINE BUTYLBROMIDE",
    "fr_ingredients": "Butylbromure d'hyoscine",
    "drug_strength": "20MG",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR\r\nSUBCUTANEOUS\r\nINTRAVENOUS\r\nINTRAMUSCULAR",
    "drug_route_fr": "Sous-cutanée\r\nIntraveineuse\r\nIntramusculaire\r\nSous-cutanée\r\nIntraveineuse\r\nIntramusculaire",
    "drug_package_quantity": "10",
    "resolved": true,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": true,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173164,
    "drug": {
      "current_status": "MARKETED",
      "id": 23916,
      "drug_code": 86577,
      "updated_date": "2025-12-03T00:31:54-05:00",
      "company": {
        "id": 17397,
        "created_date": "2025-12-03T00:30:15-05:00",
        "updated_date": "2025-12-03T00:30:15-05:00",
        "company_code": 22124,
        "mfr_code": "",
        "name": "MERZ THERAPEUTICS GMBH",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "",
        "street_name": "ECKENHEIMER LANDSTRASSE 100",
        "province": "",
        "country": "GERMANY",
        "city": "FRANKFURT AM MAIN",
        "postal_code": "60318",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8258610,
          "ingredient": {
            "id": 3776,
            "ingredient_code": 21173,
            "en_name": "FAMPRIDINE",
            "fr_name": "Fampridine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02379910",
      "brand_name": "FAMPYRA",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0153090001"
    },
    "created_date": "2022-10-31T17:42:51-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02379910",
    "company_name": "BIOGEN CANADA INC",
    "atc_number": "N07XX",
    "atc_description": "OTHER NERVOUS SYSTEM DRUGS",
    "anticipated_start_date": "2022-11-07T00:00:00-05:00",
    "estimated_end_date": "2022-11-17T00:00:00-05:00",
    "actual_end_date": "2022-11-17T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2022-11-18T06:00:02-05:00",
    "status": "resolved",
    "en_drug_brand_name": "FAMPYRA",
    "en_drug_common_name": "fampridine",
    "fr_drug_brand_name": "FAMPYRA",
    "fr_drug_common_name": "fampridine",
    "en_ingredients": "FAMPRIDINE",
    "fr_ingredients": "Fampridine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET (EXTENDED-RELEASE)",
    "drug_dosage_form_fr": "Comprimé (à libération prolongée)",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "14 tablets per bottle (x4 Bottles)",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173167,
    "drug": {
      "current_status": "MARKETED",
      "id": 17790,
      "drug_code": 78850,
      "updated_date": "2025-05-15T02:32:04-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256249,
          "ingredient": {
            "id": 2204,
            "ingredient_code": 1,
            "en_name": "OLANZAPINE",
            "fr_name": "Olanzapine"
          },
          "ingredient_supplied_ind": "I",
          "strength": "10",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02303175",
      "brand_name": "PMS-OLANZAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0128783002"
    },
    "created_date": "2022-10-31T17:52:59-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02303175",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "anticipated_start_date": "2022-11-14T00:00:00-05:00",
    "estimated_end_date": "2023-01-10T00:00:00-05:00",
    "actual_end_date": "2022-12-19T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-09T11:36:36-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-OLANZAPINE",
    "en_drug_common_name": "OLANZAPINE",
    "fr_drug_brand_name": "pms-OLANZAPINE",
    "fr_drug_common_name": "OLANZAPINE",
    "en_ingredients": "OLANZAPINE",
    "fr_ingredients": "Olanzapine",
    "drug_strength": "10MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173170,
    "drug": {
      "current_status": "MARKETED",
      "id": 57733,
      "drug_code": 95278,
      "updated_date": "2025-05-15T02:35:53-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8262538,
          "ingredient": {
            "id": 934,
            "ingredient_code": 11130,
            "en_name": "FLUOXETINE",
            "fr_name": "Fluoxétine (Chlorhydrate de fluoxétine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "60",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": false
        }
      ],
      "din": "02464659",
      "brand_name": "PMS-FLUOXETINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0116847009"
    },
    "created_date": "2022-10-31T18:04:56-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02464659",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N06AB",
    "atc_description": "ANTIDEPRESSANTS",
    "anticipated_start_date": "2022-11-28T00:00:00-05:00",
    "estimated_end_date": "2023-01-09T00:00:00-05:00",
    "actual_end_date": "2023-01-06T00:00:00-05:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 7,
      "en_reason": "Disruption of the manufacture of the drug.",
      "fr_reason": "Interruption de la fabrication du médicament",
      "active": true
    },
    "updated_date": "2023-01-07T06:00:03-05:00",
    "status": "resolved",
    "en_drug_brand_name": "PMS-FLUOXETINE",
    "en_drug_common_name": "FLUOXETINE",
    "fr_drug_brand_name": "pms-FLUOXETINE",
    "fr_drug_common_name": "FLUOXETINE",
    "en_ingredients": "FLUOXETINE",
    "fr_ingredients": "FLUOXETINE",
    "drug_strength": "60MG",
    "drug_dosage_form": "CAPSULE",
    "drug_dosage_form_fr": "Capsule",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "100",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173173,
    "drug": {
      "current_status": "MARKETED",
      "id": 17162,
      "drug_code": 78191,
      "updated_date": "2025-05-15T02:31:57-04:00",
      "company": {
        "id": 60,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:15-04:00",
        "company_code": 3550,
        "mfr_code": "PMS07",
        "name": "PHARMASCIENCE INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": false,
        "address_notification_flag": false,
        "address_other": false,
        "address_report_display": true,
        "suite_number": "100",
        "street_name": "6111 ROYALMOUNT AVE",
        "province": "QUEBEC",
        "country": "CANADA",
        "city": "MONTREAL",
        "postal_code": "H4P 2T4",
        "post_office_box": ""
      },
      "drug_ingredients": [
        {
          "id": 8256058,
          "ingredient": {
            "id": 2538,
            "ingredient_code": 11718,
            "en_name": "QUETIAPINE",
            "fr_name": "Quétiapine (Fumarate de quétiapine)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "200",
          "strength_unit": "MG",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "",
          "base": true
        }
      ],
      "din": "02296594",
      "brand_name": "PMS-QUETIAPINE",
      "brand_name_fr": "",
      "descriptor": "",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131858003"
    },
    "created_date": "2022-10-31T18:11:12-04:00",
    "type": {
      "id": 2,
      "label": "discontinuance"
    },
    "din": "02296594",
    "company_name": "PHARMASCIENCE INC",
    "atc_number": "N05AH",
    "atc_description": "ANTIPSYCHOTICS",
    "discontinuation_date": "2022-10-31T00:00:00-04:00",
    "decision_reversal": false,
    "en_discontinuation_comments": "Other format available (100)",
    "fr_discontinuation_comments": "Autre format disponible (100)",
    "discontinuance_reason": {
      "id": 1,
      "en_reason": "Business reasons",
      "fr_reason": "Raisons commerciales",
      "active": true
    },
    "updated_date": "2022-11-01T05:00:04-04:00",
    "status": "discontinued",
    "en_drug_brand_name": "PMS-QUETIAPINE",
    "en_drug_common_name": "QUETIAPINE",
    "fr_drug_brand_name": "pms-QUETIAPINE",
    "fr_drug_common_name": "QUETIAPINE",
    "en_ingredients": "QUETIAPINE",
    "fr_ingredients": "QUETIAPINE",
    "drug_strength": "200MG",
    "drug_dosage_form": "TABLET",
    "drug_dosage_form_fr": "Comprimé",
    "drug_route": "ORAL\r\nORAL",
    "drug_route_fr": "Orale\r\nOrale",
    "drug_package_quantity": "500",
    "resolved": false,
    "avoided": false,
    "advance": false,
    "late_submission": false,
    "shortage_duplicated": false,
    "discontinuance_duplicated": false,
    "draft": false,
    "discontinuation_duplication": true,
    "shortage_duplication": true,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173205,
    "drug": {
      "current_status": "MARKETED",
      "id": 16966,
      "drug_code": 77968,
      "updated_date": "2025-05-15T02:31:55-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8255987,
          "ingredient": {
            "id": 3290,
            "ingredient_code": 18938,
            "en_name": "INSULIN GLULISINE",
            "fr_name": "Insuline glulisine (source: ADN recombiné)"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02294346",
      "brand_name": "APIDRA",
      "brand_name_fr": "",
      "descriptor": "3ML SOLOSTAR PRE-FILLED PEN",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0151630001"
    },
    "created_date": "2022-10-31T21:23:46-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02294346",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2023-07-31T00:00:00-04:00",
    "actual_start_date": "2022-10-26T00:00:00-04:00",
    "actual_end_date": "2023-07-11T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-07-12T05:00:02-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard d'approvisionnement. La pénurie peut être intermittente, car Sanofi peut recevoir des expéditions partielles, d'ici jusqu'à la résolution complète prévue à la « date estimée de fin ».La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "APIDRA",
    "en_drug_common_name": "APIDRA SOLOSTAR",
    "fr_drug_brand_name": "APIDRA",
    "fr_drug_common_name": "APIDRA SOLOSTAR",
    "en_ingredients": "INSULIN GLULISINE",
    "fr_ingredients": "INSULIN GLULISINE",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "5",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  },
  {
    "id": 173210,
    "drug": {
      "current_status": "MARKETED",
      "id": 65762,
      "drug_code": 95881,
      "updated_date": "2025-05-15T02:36:11-04:00",
      "company": {
        "id": 78,
        "created_date": "2017-03-09T13:22:34-05:00",
        "updated_date": "2025-05-15T02:30:16-04:00",
        "company_code": 12538,
        "mfr_code": "",
        "name": "SANOFI-AVENTIS CANADA INC",
        "company_type": "DIN_OWNER",
        "address_mailing_flag": true,
        "address_billing_flag": true,
        "address_notification_flag": true,
        "address_other": false,
        "address_report_display": false,
        "suite_number": "",
        "street_name": "1755 STEELES AVENUE WEST",
        "province": "ONTARIO",
        "country": "CANADA",
        "city": "TORONTO",
        "postal_code": "M2R 3T4",
        "post_office_box": "",
        "contact_information": "email: CAINTERNET@sanofi.com\r\nTelephone: 1-800-265-7927"
      },
      "drug_ingredients": [
        {
          "id": 8262866,
          "ingredient": {
            "id": 2314,
            "ingredient_code": 11115,
            "en_name": "INSULIN LISPRO",
            "fr_name": "Insuline lispro"
          },
          "ingredient_supplied_ind": "I",
          "strength": "100",
          "strength_unit": "UNIT",
          "strength_type": "",
          "dosage_value": "",
          "dosage_unit": "ML",
          "base": false
        }
      ],
      "din": "02469901",
      "brand_name": "ADMELOG",
      "brand_name_fr": "",
      "descriptor": "10ML VIAL",
      "pediatric_flag": false,
      "accession_number": "",
      "number_of_ais": "1",
      "ai_group_no": "0131614001"
    },
    "created_date": "2022-10-31T21:42:01-04:00",
    "type": {
      "id": 1,
      "label": "shortage"
    },
    "din": "02469901",
    "company_name": "SANOFI-AVENTIS CANADA INC",
    "atc_number": "A10AB",
    "atc_description": "INSULINS AND ANALOGUES",
    "estimated_end_date": "2023-07-31T00:00:00-04:00",
    "actual_start_date": "2022-10-31T00:00:00-04:00",
    "actual_end_date": "2023-06-14T00:00:00-04:00",
    "decision_reversal": false,
    "shortage_reason": {
      "id": 10,
      "en_reason": "Other (Please describe in comments)",
      "fr_reason": "Autre (Veuillez décrire dans les commentaires)",
      "active": true
    },
    "updated_date": "2023-06-15T19:16:17-04:00",
    "status": "resolved",
    "en_comments": "Supply delay. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.",
    "fr_comments": "Retard d'approvisionnement. La pénurie peut être intermittente, car Sanofi peut recevoir des expéditions partielles, d'ici jusqu'à la résolution complète prévue à la « date estimée de fin ».La date estimée de disponibilité représente des estimées de disponibilités à l’entrepôt de Sanofi. Les dates de disponibilités à l’entrepôt des distributeurs peuvent varier. Les pharmacies sont invitées à communiquer avec leurs distributeurs préférentiels pour obtenir la date de disponibilité des produits.",
    "en_drug_brand_name": "ADMELOG",
    "en_drug_common_name": "ADMELOG VIAL",
    "fr_drug_brand_name": "ADMELOG",
    "fr_drug_common_name": "ADMELOG VIAL",
    "en_ingredients": "INSULIN LISPRO",
    "fr_ingredients": "Insuline lispro",
    "drug_strength": "100UNIT",
    "drug_dosage_form": "SOLUTION",
    "drug_dosage_form_fr": "Solution",
    "drug_route": "SUBCUTANEOUS\r\nSUBCUTANEOUS",
    "drug_route_fr": "Sous-cutanée\r\nSous-cutanée",
    "drug_package_quantity": "10 mL vial, 1 vial/box",
    "resolved": true,
    "avoided": false,
    "advance": true,
    "late_submission": false,
    "shortage_duplicated": true,
    "discontinuance_duplicated": true,
    "draft": false,
    "discontinuation_duplication": false,
    "shortage_duplication": false,
    "unknown_estimated_end_date": false,
    "marker_a1": false,
    "marker_a2": false,
    "marker_a3": false,
    "marker_b1": false,
    "marker_b2": false,
    "marker_b3": false,
    "late_marker_disabled": false,
    "tier_3": false
  }
]